| For: | Sumida Y, Nakajima A, Itoh Y. Limitations of liver biopsy and non-invasive diagnostic tests for the diagnosis of nonalcoholic fatty liver disease/nonalcoholic steatohepatitis. World J Gastroenterol 2014; 20(2): 475-485 [PMID: 24574716 DOI: 10.3748/wjg.v20.i2.475] |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v20/i2/475.htm |
| Number | Citing Articles |
| 1 |
Yuanye Jiang, Xiaoyu Zhuang, Jiaqi Zhang, Meng Li, Shengnan Du, Jiyun Tian, Yifu Yuan, Guang Ji, Cheng Hu. Clinical characterization and proteomic profiling of lean nonalcoholic fatty liver disease. Frontiers in Endocrinology 2023; 14 doi: 10.3389/fendo.2023.1171397
|
| 2 |
. 2018; doi: 10.70675/9940a56ezff2cz48e9za264zeac84288e158
|
| 3 |
Yusuf Yilmaz, Fatih Eren. A Bayesian approach to an integrated multimodal noninvasive diagnosis of definitive nonalcoholic steatohepatitis in the spectrum of nonalcoholic fatty liver disease. European Journal of Gastroenterology & Hepatology 2014; 26(11) doi: 10.1097/MEG.0000000000000184
|
| 4 |
João Paulo Leal Schambeck, Gabriele Carra Forte, João Bruno Fachinetto Kotlinski, Guilherme Stuker, Pedro Simões dos Santos Pilau , Cristina Carra Forte, Angela de Figueiredo Pinto Agostini, Luis Carlos Anflor Junior, Fernando Ferreira Gazzoni , Rubens Gabriel Feijó Andrade, Bruno Hochhegger. Magnetic resonance elastography and morphological alteration of the hepatic parenchyma. Scientia Medica 2025; 35(1) doi: 10.15448/1980-6108.2025.1.48061
|
| 5 |
David JM Bauer, Vladimir Matic, Ruxandra Mare, Laura Maiocchi, David Chromy, Theresa Müllner-Bucsics, Mattias Mandorfer, Sandra Mustapic, Ioan Sporea, Giovanna Ferraioli, Ivica Grgurevic, Thomas Reiberger. Point Shear Wave Elastography by ElastPQ for Fibrosis Screening in Patients with NAFLD: A Prospective, Multicenter Comparison to Vibration-Controlled Elastography. Ultraschall in der Medizin - European Journal of Ultrasound 2023; 44(02) doi: 10.1055/a-1724-7289
|
| 6 |
Optimal diagnosis and management of non-alcoholic fatty liver disease. Asian Biomedicine 2022; 16(1) doi: 10.2478/abm-2022-0001
|
| 7 |
Xinting Pan, Xiaoxu Xie, Hewei Peng, Xiaoling Cai, Huiquan Li, Qizhu Hong, Yunli Wu, Xu Lin, Shanghua Xu, Xian-e Peng. Risk Prediction for Non-alcoholic Fatty Liver Disease Based on Biochemical and Dietary Variables in a Chinese Han Population. Frontiers in Public Health 2020; 8 doi: 10.3389/fpubh.2020.00220
|
| 8 |
Chuang Li, Weiwei Kong, Lixia Kang, Tiehan Zhang, Weiqun Zhang, Weidong Wang. Study on the correlation between urinary retinol-binding protein and nonalcoholic fatty liver disease. Journal of Medical Biochemistry 2021; 40(1) doi: 10.5937/jomb0-24666
|
| 9 |
Dong Hee Lee, Il Jo, Hye Sun Lee, Jeonghyun Kang. Combined impact of myosteatosis and liver steatosis on prognosis in stage I–III colorectal cancer patients. Journal of Cachexia, Sarcopenia and Muscle 2023; 14(6) doi: 10.1002/jcsm.13369
|
| 10 |
Altayeb Ahmed, Madeleine Cule, Jimmy D. Bell, Naveed Sattar, Hanieh Yaghootkar. Differing genetic variants associated with liver fat and their contrasting relationships with cardiovascular diseases and cancer. Journal of Hepatology 2024; 81(6) doi: 10.1016/j.jhep.2024.06.030
|
| 11 |
Karishma Shelley, Amy Articolo, Rakesh Luthra, Michael Charlton. Clinical characteristics and management of patients with nonalcoholic steatohepatitis in a real-world setting: analysis of the Ipsos NASH therapy monitor database. BMC Gastroenterology 2023; 23(1) doi: 10.1186/s12876-023-02794-4
|
| 12 |
Charlotte Costentin, Cyrielle Caussy, Dominique Valla, Pierre Gourdy, Lawrence Serfaty, Jean-Michel Petit, Vincent Leroy, Aldo Trylesinski, Bruno Guerci. Proposition d’un parcours de soin pour les patients à risque de stéatohépatite non-alcoolique avec fibrose avancée : consensus DELPHI. Médecine des Maladies Métaboliques 2023; 17(3) doi: 10.1016/j.mmm.2023.02.002
|
| 13 |
Gong Feng, Xue-Ping Li, Chun-Yan Niu, Man-Ling Liu, Qin-qin Yan, Li-Ping Fan, Ya Li, Ke-Lin Zhang, Jie Gao, Mei-Rui Qian, Na He, Man Mi. Bioinformatics analysis reveals novel core genes associated with nonalcoholic fatty liver disease and nonalcoholic steatohepatitis. Gene 2020; 742 doi: 10.1016/j.gene.2020.144549
|
| 14 |
Yufei Qin, Yaru You, Yishu Yu, Yiling Xie, Yating Sha, Jinxin Feng, Yingnan Zeng, Jiaqi Zhang, Ziyi Lei, Caicai Lu, Mingxi Fang, Mengchao Cui, Kaixiang Zhou. Microviscosity-gated excited-state partitioning in a NIR-II molecular rotor for disease imaging and imaging-guided photothermal therapy. Materials Today Bio 2026; 39 doi: 10.1016/j.mtbio.2026.103342
|
| 15 |
Heather Collis, Sara F. Hansson, Patrik Nasr, Cecilia Jönsson, Mathias Liljeblad, Björn Carlsson, Showgy Ma'ayeh, Boxi Zhang, Jana de Wiljes, Mattias Ekstedt, Stergios Kechagias, Jane Knöchel. Discovery of Epidermal Growth Factor‐Like 7 as a Potential Non‐Invasive Biomarker for Fibrosis and Mortality Risk in MASLD. Clinical and Translational Science 2026; 19(10) doi: 10.1111/cts.70716
|
| 16 |
LORENA CASTRO S., GUILLERMO SILVA P.. HÍGADO GRASO NO ALCOHÓLICO. Revista Médica Clínica Las Condes 2015; 26(5) doi: 10.1016/j.rmclc.2015.09.006
|
| 17 |
Asahiro Morishita, Yoshihiro Kamada, Yoshio Sumida, Taeang Arai, Hirokazu Takahashi, Yuya Seko, Hidenori Toyoda, Hideki Hayashi, Kanji Yamaguchi, Michihiro Iwaki, Masato Yoneda, Toshihide Shima, Hideki Fujii, Kazuhito Kawata, Kengo Tomita, Miwa Kawanaka, Yuichi Yoshida, Tadashi Ikegami, Kazuo Notsumata, Satoshi Oeda, Masanori Atsukawa, Hideaki Fukushima, Hideki Kobara, Eiji Miyoshi, Shinichi Aishima, Takeshi Okanoue, Yoshito Itoh, Atsushi Nakajima. Sequential Fibrosis-4 Index and Mac-2 Binding Protein Glycosylation Isomer Combination Improve Detection of Advanced Fibrosis in Metabolic Dysfunction–Associated Steatotic Liver Disease: A Multicenter Study. Gastro Hep Advances 2026; 5(5) doi: 10.1016/j.gastha.2026.100901
|
| 18 |
Jiaye Liu, Ibrahim Ayada, Xiaofang Zhang, Ling Wang, Yang Li, Tianfu Wen, Zhongren Ma, Marco J. Bruno, Robert J. de Knegt, Wanlu Cao, Maikel P. Peppelenbosch, Mohsen Ghanbari, Zhihui Li, Qiuwei Pan. Estimating Global Prevalence of Metabolic Dysfunction-Associated Fatty Liver Disease in Overweight or Obese Adults. Clinical Gastroenterology and Hepatology 2022; 20(3) doi: 10.1016/j.cgh.2021.02.030
|
| 19 |
Maryam Taghdir, Akram Salehi, Karim Parastouei, Sepideh Abbaszadeh. Relationship between diet quality and nonalcoholic fatty liver disease predictor indices in Iranian patients with metabolic syndrome: A cross‐sectional study. Food Science & Nutrition 2023; 11(10) doi: 10.1002/fsn3.3549
|
| 20 |
Yufei Qin, Jiaming Guo, Huiyan Zhang, Jiaqi Zhang, Yingnan Zeng, Yuan Gao, Hualong Fu, Zhong Guo, Mengchao Cui, Kaixiang Zhou. Water-Soluble Viscosity-Activated Molecular Rotor for In Situ Imaging of Liver Damage in the NIR-II Window. ACS Sensors 2026; 11(6) doi: 10.1021/acssensors.6c00771
|
| 21 |
Fareeha Arshad, Raja Chinnappan, Dieter C. Broering, Dimitri Aristotle Raptis, Tanveer Ahmad Mir, Mohammed Imran Khan, Ahmed Yaqinuddin. Clinical biomarkers and biosensors for early detection of metabolic dysfunction-associated steatohepatitis (MASH): a translational perspective. Frontiers in Bioengineering and Biotechnology 2026; 14 doi: 10.3389/fbioe.2026.1748835
|
| 22 |
Irma Garcia-Martinez, Rosa Alen, Patricia Rada, Angela M. Valverde. Insights Into Extracellular Vesicles as Biomarker of NAFLD Pathogenesis. Frontiers in Medicine 2020; 7 doi: 10.3389/fmed.2020.00395
|
| 23 |
Ke Ding, Manrong Liu, Xue Wei, Ruisui Huang, Jiong Chen, Shanjin Lu, Dacheng Wang, Wei Lu. Comparison of MR-PWI quantitative and semi-quantitative parameters for the evaluation of liver fibrosis. BMC Medical Imaging 2021; 21(1) doi: 10.1186/s12880-020-00539-3
|
| 24 |
Keisuke Kakisaka, Yuji Suzuki, Yudai Fujiwara, Tamami Abe, Miki Yonezawa, Hidekatsu Kuroda, Kazuyuki Ishida, Tamotsu Sugai, Yasuhiro Takikawa. Evaluation of ballooned hepatocytes as a risk factor for future progression of fibrosis in patients with non-alcoholic fatty liver disease. Journal of Gastroenterology 2018; 53(12) doi: 10.1007/s00535-018-1468-9
|
| 25 |
Ysabel C. Ilagan-Ying, Bubu A. Banini, Albert Do, Robert Lam, Joseph K. Lim. Screening, Diagnosis, and Staging of Non-Alcoholic Fatty Liver Disease (NAFLD): Application of Society Guidelines to Clinical Practice. Current Gastroenterology Reports 2023; 25(10) doi: 10.1007/s11894-023-00883-8
|
| 26 |
Hongye Peng, Shaojie Duan. Comment on “Development and Validation of Machine Learning‐Based Marker for Early Detection and Prognosis Stratification of Nonalcoholic Fatty Liver Disease”. Advanced Science 2025; 12(41) doi: 10.1002/advs.202515549
|
| 27 |
Jonathan R. Dillman, Andrew T. Trout, Amy E. Taylor, Leticia Khendek, Jennifer L. Kasten, Rachel M. Sheridan, Divya Sharma, Rebekah A. Karns, Cyd Castro-Rojas, Bin Zhang, Alexander G. Miethke. Association Between MR Elastography Liver Stiffness and Histologic Liver Fibrosis in Children and Young Adults With Autoimmune Liver Disease. American Journal of Roentgenology 2024; 223(1) doi: 10.2214/AJR.24.31108
|
| 28 |
Vincent Gao, Michelle T. Long, Shridhar R. Singh, Youjin Kim, Xuehong Zhang, Gail Rogers, Paul F. Jacques, Daniel Levy, Jiantao Ma. A Healthy Diet is Associated with a Lower Risk of Hepatic Fibrosis. The Journal of Nutrition 2023; 153(5) doi: 10.1016/j.tjnut.2023.03.038
|
| 29 |
Marcio H. Miname, Raul D. Santos. Fatty liver, inflamed blood and calcified coronary arteries: Lessons and uncertainties from the multiethnic study of atherosclerosis -commentary on the study of Al Rifai et al.. Atherosclerosis 2015; 239(2) doi: 10.1016/j.atherosclerosis.2015.02.041
|
| 30 |
Amal A. Mohamed, Ahmed El-Demery, Eman Al-Hussain, Shroouk Mousa, Ahmed Abdel Halim, Sahar M. Mostafa, Reda S. Abdelghany, Seham M. Mahmoud, Mohammad A. Elkady, Khaled Raafat, Alshymaa A. Hassnine, Mohamed M. Omran. NAFLD mark: an accurate model based on microRNA-34 for diagnosis of non-alcoholic fatty liver disease patients. Journal of Genetic Engineering and Biotechnology 2021; 19(1) doi: 10.1186/s43141-021-00257-5
|
| 31 |
Gyuri Kim, Yong-ho Lee, Young Min Park, Jungghi Kim, Heesuk Kim, Byung-Wan Lee, Eun Seok Kang, Bong-Soo Cha, Hyun Chul Lee, Dae Jung Kim. Use of a Diabetes Self-Assessment Score to Predict Nonalcoholic Fatty Liver Disease and Nonalcoholic Steatohepatitis. Medicine 2015; 94(27) doi: 10.1097/MD.0000000000001103
|
| 32 |
Mona A Hegazy, Ibrahim Abd ALgwad, Soheir Abuel Fadl, Mohamed Sayed Hassan, Laila Ahmed Rashed, Maha A Hussein. Serum Micro-RNA-122 Level as a Simple Noninvasive Marker of MAFLD Severity. Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2021; doi: 10.2147/DMSO.S291595
|
| 33 |
Amirhossein Sahebkar, Elena Sancho, David Abelló, Jordi Camps, Jorge Joven. Novel circulating biomarkers for non‐alcoholic fatty liver disease: A systematic review. Journal of Cellular Physiology 2018; 233(2) doi: 10.1002/jcp.25779
|
| 34 |
Tamara Milovanovic, Sanja Dragasevic, Milica Stojkovic Lalosevic, Sanja Zgradic, Biljana Milicic, Igor Dumic, Stefan Kmezic, Dusan Saponjski, Andrija Antic, Velimir Markovic, Dragan Popovic. Ultrasonographic Evaluation of Fatty Pancreas in Serbian Patients with Non Alcoholic Fatty Liver Disease—A Cross Sectional Study. Medicina 2019; 55(10) doi: 10.3390/medicina55100697
|
| 35 |
Christopher D. Byrne, Giovanni Targher. NAFLD: A multisystem disease. Journal of Hepatology 2015; 62(1) doi: 10.1016/j.jhep.2014.12.012
|
| 36 |
Hira Hanif, Muzammil M. Khan, Mukarram J. Ali, Pir A. Shah, Jinendra Satiya, Daryl T.Y. Lau, Aysha Aslam. A New Endemic of Concomitant Nonalcoholic Fatty Liver Disease and Chronic Hepatitis B. Microorganisms 2020; 8(10) doi: 10.3390/microorganisms8101526
|
| 37 |
Mahdi Barazesh, Sajad Jalili, Morteza Akhzari, Fouzieyeh Faraji, Ebrahim Khorramdin. Recent Progresses on Pathophysiology, Diagnosis, Therapeutic Modalities,
and Management of Non-alcoholic Fatty Liver Disorder. Current Drug Therapy 2024; 19(1) doi: 10.2174/1574885518666230417111247
|
| 38 |
Ahmed M. F. Mansour, Essam M. Bayoumy, Ahmed M. ElGhandour, Mohamed Darwish El-Talkawy, Sameh M. Badr, Ahmed El-Metwally Ahmed. Assessment of hepatic fibrosis and steatosis by vibration-controlled transient elastography and controlled attenuation parameter versus non-invasive assessment scores in patients with non-alcoholic fatty liver disease. Egyptian Liver Journal 2020; 10(1) doi: 10.1186/s43066-020-00044-w
|
| 39 |
Èlia Navarro-Masip, Nuria Mestres Petit, Blanca Salinas-Roca , Fernando Herrerías, Felip Vilardell, Mari Cruz de la Fuente, Judit Pallares, Maite Santamaría, Marta Zorzano-Martínez, Enric Sánchez , Xavier Matías-Guiu , Carolina López-Cano, Ana Gloria Soler, Josep León-Mengíbar, Marta Bueno, Albert Lecube. Metabolic Dysfunction-Associated Steatotic Liver Disease in Severe Obesity and Concordance between Invasive (Biopsy) and Noninvasive (OWLiver®) Diagnoses. Obesity Facts 2024; 17(5) doi: 10.1159/000538765
|
| 40 |
Ashwin Parchani, Ravi Gupta, Ravi Kant, Lokesh K. Saini, Rohit Gupta. Evaluation of Hepatic Steatosis and Fibrosis Using Transient Elastography in Patients With Obstructive Sleep Apnea. Journal of Clinical and Experimental Hepatology 2024; 14(2) doi: 10.1016/j.jceh.2023.09.010
|
| 41 |
Ahmed Gaber, Hassan A. Youness, Alaa Hamdy, Hammam M. Abdelaal, Ammar M. Hassan. Automatic Classification of Fatty Liver Disease Based on Supervised Learning and Genetic Algorithm. Applied Sciences 2022; 12(1) doi: 10.3390/app12010521
|
| 42 |
Hamed Zamanian, Ahmad Shalbaf, Maryam Parvizi, Roohallah Alizadehsani, Ru‐San Tan, U. Rajendra Acharya. Automated Detection of Non‐Alcoholic Fatty Liver Disease Using Histopathological Images: A Systematic Review. WIREs Data Mining and Knowledge Discovery 2025; 15(3) doi: 10.1002/widm.70044
|
| 43 |
Judith Aron-Wisnewsky, Chloé Vigliotti, Julia Witjes, Phuong Le, Adriaan G. Holleboom, Joanne Verheij, Max Nieuwdorp, Karine Clément. Gut microbiota and human NAFLD: disentangling microbial signatures from metabolic disorders. Nature Reviews Gastroenterology & Hepatology 2020; 17(5) doi: 10.1038/s41575-020-0269-9
|
| 44 |
Karel Dvorak, Jan Stritesky, Jaromir Petrtyl, Libor Vitek, Renata Sroubkova, Martin Lenicek, Vaclav Smid, Martin Haluzik, Radan Bruha, Pavel Strnad. Use of Non-Invasive Parameters of Non-Alcoholic Steatohepatitis and Liver Fibrosis in Daily Practice - An Exploratory Case-Control Study. PLoS ONE 2014; 9(10) doi: 10.1371/journal.pone.0111551
|
| 45 |
Kazuko Kotoku, Ryoma Michishita, Takuro Matsuda, Shotaro Kawakami, Natsumi Morito, Yoshinari Uehara, Yasuki Higaki. The Association between Decreased Kidney Function and FIB-4 Index Value, as Indirect Liver Fibrosis Indicator, in Middle-Aged and Older Subjects. International Journal of Environmental Research and Public Health 2021; 18(13) doi: 10.3390/ijerph18136980
|
| 46 |
Mohammed, MD Amr, Tahmasebi, MD Aylin, Kim, BS Sooji, Alnoury, MD Mostafa, E. Wessner, MS, MBA, RDMS, RVT Corinne, Siu Xiao, MD Tania, W. Gould, MD Sharon, A. May, MD Lauren, Kecskemethy, MS Ed, RDN, CBDT Heidi, T. Saul, MD David, R. Eisenbrey, PhD John. Evaluation of Liver Fibrosis on Grayscale Ultrasound in a Pediatric Population Using a Cloud-based Transfer Learning Artificial Intelligence Platform. ADVANCED ULTRASOUND IN DIAGNOSIS AND THERAPY 2024; 8(4) doi: 10.37015/AUDT.2024.240048
|
| 47 |
Marine Dubois, Maxime Ronot, Pauline Houssel-Debry, Vanessa Brun, Michel Rayar, Magali Auger, Luc Beuzit, Bruno Turlin, Christophe Aubé, Anita Paisant. Performance of B-mode ratio and 2D shear wave elastography for the detection and quantification of hepatic steatosis and fibrosis after liver transplantation. European Journal of Gastroenterology & Hepatology 2020; 32(2) doi: 10.1097/MEG.0000000000001500
|
| 48 |
Rebecca L. Koch, James B. Stanton, Susan McClatchy, Gary A. Churchill, Steven W. Craig, Darian N. Williams, Mallory E. Johns, Kylah R. Chase, Dana L. Thiesfeldt, Jessica C. Flynt, Robert Pazdro. Discovery of genomic loci for liver health and steatosis reveals overlap with glutathione redox genetics. Redox Biology 2024; 75 doi: 10.1016/j.redox.2024.103248
|
| 49 |
Josep Franch-Nadal, Llorenç Caballeria, Manel Mata-Cases, Didac Mauricio, Carolina Giraldez-García, José Mancera, Albert Goday, Xavier Mundet-Tudurí, Enrique Regidor, Yu Wang. Fatty liver index is a predictor of incident diabetes in patients with prediabetes: The PREDAPS study. PLOS ONE 2018; 13(6) doi: 10.1371/journal.pone.0198327
|
| 50 |
Wassiem Takhman, Mohammad A. Nour, Anas Merai, Lubna Saudi, Mosab Maree, Ahmed Awad ghanem, Jihad Hamaida, Basma Damiri. Characteristics of non-alcoholic fatty liver disease in Palestinian diabetics: A cross-sectional study. Palestinian Medical and Pharmaceutical Journal 2023; 8(3) doi: 10.59049/2790-0231.1250
|
| 51 |
Non-invasive identification of alcoholic liver disease. 2025 International Conference on Advances in Technology and Computing (ICATC) 2025; doi: 10.1109/ICATC68823.2025.11407635
|
| 52 |
Norio Akuta, Yusuke Kawamura, Yasuji Arase, Satoshi Saitoh, Shunichiro Fujiyama, Hitomi Sezaki, Tetsuya Hosaka, Masahiro Kobayashi, Mariko Kobayashi, Yoshiyuki Suzuki, Fumitaka Suzuki, Kenji Ikeda, Hiromitsu Kumada. Hepatocellular carcinoma is the most common liver-related complication in patients with histopathologically-confirmed NAFLD in Japan. BMC Gastroenterology 2018; 18(1) doi: 10.1186/s12876-018-0900-1
|
| 53 |
Chunxiang Zhang, Hua Ma, Daniel DeRoche, Eric M. Gale, Pamela Pantazopoulos, Nicholas J. Rotile, Himashinie Diyabalanage, Valerie Humblet, Peter Caravan, Iris Y. Zhou. Manganese-based type I collagen-targeting MRI probe for in vivo imaging of liver fibrosis. npj Imaging 2025; 3(1) doi: 10.1038/s44303-025-00075-1
|
| 54 |
Masafumi Oyama, Tadashi Namisaki, Akihiko Shibamoto, Satoshi Iwai, Masayoshi Takami, Yuki Tsuji, Yukihisa Fujinaga, Hiroaki Takaya, Takashi Inoue, Norihisa Nishimura, Shinya Sato, Koh Kitagawa, Kosuke Kaji, Akira Mitoro, Kiyoshi Asada, Hiroyuki Masuda, Junichi Hanatani, Hitoshi Yoshiji. Creatinine-to-Cystatin C Ratio Combined with FIB-4 and ELF for Noninvasive Fibrosis Assessment in MASLD. International Journal of Molecular Sciences 2025; 26(19) doi: 10.3390/ijms26199560
|
| 55 |
Takeshi Okanoue, Hayao Ebise, Toshihiro Kai, Masayuki Mizuno, Toshihide Shima, Junji Ichihara, Mikio Aoki. A simple scoring system using type IV collagen 7S and aspartate aminotransferase for diagnosing nonalcoholic steatohepatitis and related fibrosis. Journal of Gastroenterology 2018; 53(1) doi: 10.1007/s00535-017-1355-9
|
| 56 |
Abhishek Aravind, Avinash G. Bahirvani, Ronald Quiambao, Teresa Gonzalo. Machine Learning Technology for Evaluation of Liver Fibrosis, Inflammation Activity and Steatosis (LIVERFASt<sup>TM</sup>). Journal of Intelligent Learning Systems and Applications 2020; 12(02) doi: 10.4236/jilsa.2020.122003
|
| 57 |
Manorama Swain, Preetam Nath, Prasant Kumar Parida, Jimmy Narayan, Pradeep Kumar Padhi, Girish Kumar Pati, Ayaskanta Singh, Bijay Misra, Debasis Misra, Sanjib Kumar Kar, Manas Kumar Panigrahi, Chudamani Meher, Omprakash Agrawal, Niranjan Rout, Kaumudee Pattnaik, Pallavi Bhuyan, Pramila Kumari Mishra, Shivaram Prasad Singh. Biochemical Profile of Nonalcoholic Fatty Liver Disease Patients in Eastern India with Histopathological Correlation. Indian Journal of Clinical Biochemistry 2017; 32(3) doi: 10.1007/s12291-016-0612-7
|
| 58 |
Iris Y. Zhou, Kenneth K. Tanabe, Bryan C. Fuchs, Peter Caravan. Collagen-targeted molecular imaging in diffuse liver diseases. Abdominal Radiology 2020; 45(11) doi: 10.1007/s00261-020-02677-2
|
| 59 |
Shamsul Mohd Zain, Hwa‐Li Tan, Zahurin Mohamed, Wah‐Kheong Chan, Sanjiv Mahadeva, Roma Choudhury Basu, Rosmawati Mohamed. Use of simple scoring systems for a public health approach in the management of non‐alcoholic fatty liver disease patients. JGH Open 2020; 4(6) doi: 10.1002/jgh3.12414
|
| 60 |
Dimitrios A. Koutoukidis, Elizabeth Morris, John A. Henry, Yusra Shammoon, Matthew Zimmerman, Moscho Michalopoulou, Susan A. Jebb, Paul Aveyard, Jee-Fu Huang. What proportion of people have a follow-up biopsy in randomized trials of treatments for non-alcoholic steatohepatitis?: A systematic review and meta-analysis. PLOS ONE 2021; 16(4) doi: 10.1371/journal.pone.0250385
|
| 61 |
Shuang Zhe Lin, Yuan Wen Chen, Jian Gao Fan. Non‐alcoholic fatty liver disease to metabolic dysfunction‐associated fatty liver disease: Conceptual changes for clinicians, researchers and patients. Journal of Digestive Diseases 2020; 21(11) doi: 10.1111/1751-2980.12944
|
| 62 |
. 2023; doi: 10.70675/af88f718zcdbaz4595za290z2534107b33b8
|
| 63 |
Lauren D. Hagenstein, Joseph Jenkins, Colby Adamson, Jourdain Dong, John Moore, Jing Gao. Ultrasound normalized local variance to assess metabolic dysfunction-associated steatotic liver disease. Clinical Imaging 2024; 116 doi: 10.1016/j.clinimag.2024.110326
|
| 64 |
Sechang Oh, Natsumi Oshida, Noriko Someya, Tsuyoshi Maruyama, Tomonori Isobe, Yoshikazu Okamoto, Taeho Kim, Bokun Kim, Junichi Shoda. Whole‐body vibration for patients with nonalcoholic fatty liver disease: a 6‐month prospective study. Physiological Reports 2019; 7(9) doi: 10.14814/phy2.14062
|
| 65 |
Sukhbir Singh, Neelam Sharma, Saurabh Shukla, Tapan Behl, Sumeet Gupta, Md. Khalid Anwer, Celia Vargas-De-La-Cruz, Simona Gabriela Bungau, Cristina Brisc. Understanding the Potential Role of Nanotechnology in Liver Fibrosis: A Paradigm in Therapeutics. Molecules 2023; 28(6) doi: 10.3390/molecules28062811
|
| 66 |
Shaghayegh Khanmohammadi, Parisa Fallahtafti, Amirhossein Habibzadeh, Ali Ezzatollahi Tanha, Amir Ali Alamdari, Parsa Fallahtafti, Mohammad Shafi Kuchay. Effectiveness of body roundness index for the prediction of nonalcoholic fatty liver disease: a systematic review and meta-analysis. Lipids in Health and Disease 2025; 24(1) doi: 10.1186/s12944-025-02544-3
|
| 67 |
Ziying Yin, Matthew C. Murphy, Jiahui Li, Kevin J. Glaser, Amy S. Mauer, Taofic Mounajjed, Terry M. Therneau, Heshan Liu, Harmeet Malhi, Armando Manduca, Richard L. Ehman, Meng Yin. Prediction of nonalcoholic fatty liver disease (NAFLD) activity score (NAS) with multiparametric hepatic magnetic resonance imaging and elastography. European Radiology 2019; 29(11) doi: 10.1007/s00330-019-06076-0
|
| 68 |
Keyur Patel, Diego Moreno Baca, Natalia Konstantelos, Ginnie Ng, Urja Lathia. Cardiometabolic comorbidity and health outcomes of persons with metabolic dysfunction–associated steatotic liver disease (MASLD) in Ontario, Canada. Canadian Liver Journal 2026; 9(3) doi: 10.3138/canlivj-2026-0020
|
| 69 |
Kazuya Kariyama, Hidenori Toyoda, Takashi Kumada, Satoshi Yasuda, Yoshihiko Tachi, Takanori Hirai, Shohei Shiota, Akiko Wakuta, Kazuhiro Nouso. Utility of the fibrosis-3 index for predicting liver fibrosis 5 years after achieving sustained virological response in patients with chronic hepatitis C. Clinics and Research in Hepatology and Gastroenterology 2025; 49(7) doi: 10.1016/j.clinre.2025.102625
|
| 70 |
Xiaoyu Duan, Souvik Sarkar, Victoria Lyo, Sean Romeo, Benjamin A. Spencer, Karen E. Matsukuma, Valentina Medici, Michael T. Corwin, Ramsey D. Badawi, Guobao Wang. Quantification of 18F-FDG Delivery Rate for Liver Inflammation Using Shortened Dynamic PET Imaging Protocols. Journal of Nuclear Medicine 2025; 66(11) doi: 10.2967/jnumed.124.269434
|
| 71 |
Mehnoosh Torkzaban, Corinne E. Wessner, Dina Halegoua-DeMarzio, Andrej Lyshchik, Kibo Nam. Diagnostic Performance of Quantitative Ultrasound Parameters in Non-alcoholic Fatty Liver Disease. Academic Radiology 2024; 31(1) doi: 10.1016/j.acra.2023.07.001
|
| 72 |
Karl Nadolsky, Donna R. Cryer, Amy Articolo, Travis Fisher, Jennifer Schneider, Mary Rinella. Nonalcoholic steatohepatitis diagnosis and treatment from the perspective of patients and primary care physicians: a cross-sectional survey. Annals of Medicine 2023; 55(1) doi: 10.1080/07853890.2023.2211349
|
| 73 |
Yuanqiang Lin, Hequn Li, Chunxiang Jin, Hui Wang, Bo Jiang, Azra Alizad. The diagnostic accuracy of liver fibrosis in non-viral liver diseases using acoustic radiation force impulse elastography: A systematic review and meta-analysis. PLOS ONE 2020; 15(1) doi: 10.1371/journal.pone.0227358
|
| 74 |
Juan Wu, Shen Tian, Hao Li, Zhou Xu, Shu Li, Yu-ling Chen, Xin-yu Liang, Jun Xiao, Jing-yu Song, Rui-ling She, Chen-yu Ma, Jun-han Feng, Zhao-xing Li, Zhi-yu Jiang, Zi-wei Zhang, Kai-nan Wu, Ling-quan Kong. Population-specific cut-off points of fatty liver index: a study based on the National Health and Nutrition Examination Survey data. BMC Gastroenterology 2022; 22(1) doi: 10.1186/s12876-022-02303-z
|
| 75 |
Marcin Kosmalski, Agnieszka Śliwińska, Józef Drzewoski. Non-Alcoholic Fatty Liver Disease or Type 2 Diabetes Mellitus—The Chicken or the Egg Dilemma. Biomedicines 2023; 11(4) doi: 10.3390/biomedicines11041097
|
| 76 |
Julia Karady, Robert W McGarrah, Maggie Nguyen, Stephanie N Giamberardino, Nandini Meyersohn, Michael T Lu, Pedro V Staziaki, Stefan B Puchner, Daniel O Bittner, Borek Foldyna, Thomas Mayrhofer, Margery A Connelly, Andre Tchernof, Phillip J White, Khurram Nasir, Kathleen Corey, Deepak Voora, Neha Pagidipati, Geoffrey S Ginsburg, William E Kraus, Udo Hoffmann, Pamela S Douglas, Svati H Shah, Maros Ferencik. Lipoprotein subclasses are associated with Hepatic steatosis: insights from the prospective multicenter imaging study for the evaluation of chest pain (PROMISE) clinical trial. American Journal of Preventive Cardiology 2024; 18 doi: 10.1016/j.ajpc.2024.100680
|
| 77 |
Hamzah M. Alghzawi, Sweta Sahu, Aditya Rana, Rhobi Mwita, Sri Gundapaneni, Dushyant Dahiya. Integrated serum metabolomics and MRI biomarkers for MASLD: a practical framework for noninvasive staging and monitoring. Abdominal Radiology 2026; doi: 10.1007/s00261-026-05573-3
|
| 78 |
Sercin Ozkok, Mine Sorkun, Servet Erdemli, Mahmut B. Dogan, Ahmet Aslan, Ilker K. Yucel, Ahmet Celebi. Liver parenchymal changes and association with cardiac magnetic resonance imaging findings in repaired tetralogy of Fallot: an intravoxel incoherent motion magnetic resonance imaging study. Pediatric Radiology 2022; 52(5) doi: 10.1007/s00247-021-05271-w
|
| 79 |
Shih‐Hsi Song, Ying‐Chi Wong, Tzee‐Chung Wu, Ching‐Feng Huang. Pediatric non‐alcoholic fatty liver disease predicted by anthropometric values through transient elastography. Pediatrics International 2021; 63(2) doi: 10.1111/ped.14395
|
| 80 |
Ana Carolina Cardoso, Cristiane Valle Tovo, Nathalie Carvalho Leite, Ibrahim A. El Bacha, Fernanda Luiza Calçado, Gabriela Perdomo Coral, Glauco Navas Sammarco, Claudia Cravo, Roberto José Carvalho Filho, Renata de Mello Perez, Ronir Raggio Luiz, Edison Roberto Parise, Cristiane A. Villela-Nogueira. Validation and Performance of FibroScan®-AST (FAST) Score on a Brazilian Population with Nonalcoholic Fatty Liver Disease. Digestive Diseases and Sciences 2022; 67(11) doi: 10.1007/s10620-021-07363-x
|
| 81 |
Stergios Kechagias, Mattias Ekstedt, Christian Simonsson, Patrik Nasr. Non-invasive diagnosis and staging of non-alcoholic fatty liver disease. Hormones 2022; 21(3) doi: 10.1007/s42000-022-00377-8
|
| 82 |
Xingyue Wei, Yuanyuan Wang, Lianshuang Wang, Mengze Gao, Qiong He, Yao Zhang, Jianwen Luo. Simultaneous grading diagnosis of liver fibrosis, inflammation, and steatosis using multimodal quantitative ultrasound and artificial intelligence framework. Medical & Biological Engineering & Computing 2024; doi: 10.1007/s11517-024-03159-z
|
| 83 |
Jinchunzi Yang, Elisa Félix-Soriano, Alejandro Martínez-Gayo, Javier Ibañez-Santos, Neira Sáinz, J Alfredo Martínez, María J. Moreno-Aliaga. SIRT1 and FOXO1 role on MASLD risk: effects of DHA-rich n-3 PUFA supplementation and exercise in aged obese female mice and in post-menopausal overweight/obese women. Journal of Physiology and Biochemistry 2024; 80(3) doi: 10.1007/s13105-024-01044-9
|
| 84 |
Rohit Nathan, Deepanshu Jain, Simona Rossi. CON: This Patient Should Have a Noninvasive Assessment of Liver Staging. Clinical Liver Disease 2019; 14(3) doi: 10.1002/cld.822
|
| 85 |
Xiaolin Liu, Yongfeng Wang, Yanan Ming, Yanyan Song, Jingyi Zhang, Xiaoyu Chen, Minde Zeng, Yimin Mao, Hervé Guillou. S100A9: A Potential Biomarker for the Progression of Non-Alcoholic Fatty Liver Disease and the Diagnosis of Non-Alcoholic Steatohepatitis. PLOS ONE 2015; 10(5) doi: 10.1371/journal.pone.0127352
|
| 86 |
Jihong Liu, Wen Zhang, Chunmiao Zhou, Mengmei Li, Xin Wang, Wei Zhang, Zhenzhen Liu, Luling Wu, Tony D. James, Ping Li, Bo Tang. Precision Navigation of Hepatic Ischemia–Reperfusion Injury Guided by Lysosomal Viscosity-Activatable NIR-II Fluorescence. Journal of the American Chemical Society 2022; 144(30) doi: 10.1021/jacs.2c03832
|
| 87 |
Norio Akuta, Yusuke Kawamura, Yasuji Arase, Satoshi Saitoh, Shunichiro Fujiyama, Hitomi Sezaki, Tetsuya Hosaka, Masahiro Kobayashi, Mariko Kobayashi, Yoshiyuki Suzuki, Fumitaka Suzuki, Kenji Ikeda, Hiromitsu Kumada. PNPLA3 genotype and fibrosis-4 index predict cardiovascular diseases of Japanese patients with histopathologically-confirmed NAFLD. BMC Gastroenterology 2021; 21(1) doi: 10.1186/s12876-021-02020-z
|
| 88 |
Cameron Gofton, Jacob George. Dawn of an era of effective treatments for MAFLD. Portal Hypertension & Cirrhosis 2024; 3(4) doi: 10.1002/poh2.96
|
| 89 |
M. Kim, B.-K. Kang, D.W. Jun, Y. Kim. MR elastography of the liver: comparison of three measurement methods. Clinical Radiology 2020; 75(9) doi: 10.1016/j.crad.2020.05.015
|
| 90 |
Shaoqing Xiong, Weier Liang, Xueqian Chen, Yong Zhang, Yongning Bian, Dongdong Su. Tracking hepatic ischemia-reperfusion injury in situ by a fluorogenic probe. Sensors and Actuators B: Chemical 2025; 441 doi: 10.1016/j.snb.2025.138012
|
| 91 |
Tess Armstrong, Karrie V. Ly, Smruthi Murthy, Shahnaz Ghahremani, Grace Hyun J. Kim, Kara L. Calkins, Holden H. Wu. Free-breathing quantification of hepatic fat in healthy children and children with nonalcoholic fatty liver disease using a multi-echo 3-D stack-of-radial MRI technique. Pediatric Radiology 2018; 48(7) doi: 10.1007/s00247-018-4127-7
|
| 92 |
Harry P. F. Peters, Patrick Schrauwen, Petra Verhoef, Christopher D. Byrne, David J. Mela, Andreas F. H. Pfeiffer, Ulf Risérus, Frits R. Rosendaal, Vera Schrauwen-Hinderling. Liver fat: a relevant target for dietary intervention? Summary of a Unilever workshop. Journal of Nutritional Science 2017; 6 doi: 10.1017/jns.2017.13
|
| 93 |
Marta Wojciechowska, Stefano Malacrino, Dylan Windell, Emma L. Culver, Jessica K. Dyson, Jens Rittscher. Enhancing liver fibrosis measurement: Deep learning and uncertainty analysis across multi-center cohorts. Journal of Pathology Informatics 2026; 21 doi: 10.1016/j.jpi.2026.100653
|
| 94 |
Marion Imbault, Alex Faccinetto, Bruno-Félix Osmanski, Antoine Tissier, Thomas Deffieux, Jean-Luc Gennisson, Valérie Vilgrain, Mickaël Tanter. Robust sound speed estimation for ultrasound-based hepatic steatosis assessment. Physics in Medicine and Biology 2017; 62(9) doi: 10.1088/1361-6560/aa6226
|
| 95 |
Xiaoqin Xu, Jiang Li, Yanqi Fu, Jie Li, Wenqi Shen, Xiao Tan, Ningjian Wang, Bin Wang, Yingli Lu. A plasma metabolome‐derived model predicts severe liver outcomes of nonalcoholic fatty liver disease in the UK Biobank. Diabetes, Obesity and Metabolism 2025; 27(9) doi: 10.1111/dom.16533
|
| 96 |
George BB Goh, Danny Issa, Rocio Lopez, Srinivasan Dasarathy, Jaividhya Dasarathy, Ruth Sargent, Carol Hawkins, Rish K Pai, Lisa Yerian, Amer Khiyami, Mangesh R Pagadala, Achuthan Sourianarayanane, Naim Alkhouri, Arthur J McCullough. The development of a non‐invasive model to predict the presence of non‐alcoholic steatohepatitis in patients with non‐alcoholic fatty liver disease. Journal of Gastroenterology and Hepatology 2016; 31(5) doi: 10.1111/jgh.13235
|
| 97 |
Johanna K. DiStefano, Glenn S. Gerhard. Long Noncoding RNAs and Human Liver Disease. Annual Review of Pathology: Mechanisms of Disease 2022; 17(1) doi: 10.1146/annurev-pathol-042320-115255
|
| 98 |
Ha Neul Kim, Hong Jae Jeon, Hei Gwon Choi, In Sun Kwon, Woo Sun Rou, Jeong Eun Lee, Tae Hee Lee, Seok Hyun Kim, Byung Seok Lee, Kyung Sook Shin, Hyun Jung Lee, Hyuk Soo Eun. CT-based Hounsfield unit values reflect the degree of steatohepatitis in patients with low-grade fatty liver disease. BMC Gastroenterology 2023; 23(1) doi: 10.1186/s12876-023-02717-3
|
| 99 |
Madeleine Chang, Devon Chang, Sudha Kodali, Stephen A. Harrison, Mark Ghobrial, Naim Alkhouri, Mazen Noureddin. Degree of Discordance Between FIB-4 and Transient Elastography: An Application of Current Guidelines on General Population Cohort. Clinical Gastroenterology and Hepatology 2024; 22(7) doi: 10.1016/j.cgh.2024.02.008
|
| 100 |
Hong Kiat Lim, Gary P. Jeffrey, Grant A. Ramm, Carolina Soekmadji. Pathogenesis of Viral Hepatitis-Induced Chronic Liver Disease: Role of Extracellular Vesicles. Frontiers in Cellular and Infection Microbiology 2020; 10 doi: 10.3389/fcimb.2020.587628
|
| 101 |
Qingnan Meng, Xiaoying Li, Xuelian Xiong. Identification of Hub Genes Associated With Non-alcoholic Steatohepatitis Using Integrated Bioinformatics Analysis. Frontiers in Genetics 2022; 13 doi: 10.3389/fgene.2022.872518
|
| 102 |
Shohei Kimura, Yutaka Yasui, Nobuharu Tamaki, Mayu Higuchi, Takuya Shima, Mina Taguchi, Yudai Yamazaki, Risa Seike, Naoki Uchihara, Yuki Tanaka, Ryohei Kobayashi, Junko Yagita, Yuka Kasano, Yasuyuki Komiyama, Kenta Takaura, Hitomi Takada, Shohei Tanaka, Chiaki Maeyashiki, Yuka Takahashi, Hiroyuki Nakanishi, Kaoru Tsuchiya, Namiki Izumi, Masayuki Kurosaki. Association Between Early and Long-Term Changes in Liver Stiffness in Patients with MASLD Undergoing Serial Magnetic Resonance Elastography. Diagnostics 2026; 16(12) doi: 10.3390/diagnostics16121833
|
| 103 |
Min-Jin Kwak, Byeonghyeok Park, Hyejin Choi, Wonjun Hong, Daye Mun, Seon-Hui Son, Yong-Soon Choi, Duleepa Pathiraja, Ju-Young Eor, Sangdon Ryu, Jun-Kyum Kim, Kwang-Youn Whang, Kwangcheol Casey Jeong, In-Geol Choi, Younghoon Kim. Gut microbial extracellular vesicles modulate the development of metabolic dysfunction-associated steatohepatitis through the gut-liver axis. Pharmacological Research 2026; 227 doi: 10.1016/j.phrs.2026.108184
|
| 104 |
Ying-Hsiu Lin, Yin-Yin Liao, Chih-Kuang Yeh, Kuen-Cheh Yang, Po-Hsiang Tsui. Ultrasound Entropy Imaging of Nonalcoholic Fatty Liver Disease: Association with Metabolic Syndrome. Entropy 2018; 20(12) doi: 10.3390/e20120893
|
| 105 |
Jeongin Yoo, Jeong Min Lee, Ijin Joo, Dong Ho Lee, Jeong Hee Yoon, Hyo-Jin Kang, Su Joa Ahn. Prospective Validation of Repeatability of Shear Wave Dispersion Imaging for Evaluation of Non-alcoholic Fatty Liver Disease. Ultrasound in Medicine & Biology 2019; 45(10) doi: 10.1016/j.ultrasmedbio.2019.06.411
|
| 106 |
Hsiang-Yang Ma, Zhuhuang Zhou, Shuicai Wu, Yung-Liang Wan, Po-Hsiang Tsui. A Computer-Aided Diagnosis Scheme For Detection Of Fatty Liver In Vivo Based On Ultrasound Kurtosis Imaging. Journal of Medical Systems 2016; 40(1) doi: 10.1007/s10916-015-0395-z
|
| 107 |
Arsenii V Telichko, Rehman Ali, Thurston Brevett, Huaijun Wang, Jose G Vilches-Moure, Sukumar U Kumar, Ramasamy Paulmurugan, Jeremy J Dahl. Noninvasive estimation of local speed of sound by pulse-echo ultrasound in a rat model of nonalcoholic fatty liver. Physics in Medicine & Biology 2022; 67(1) doi: 10.1088/1361-6560/ac4562
|
| 108 |
Tomotaka Yazaki, Hiroshi Tobita, Shuichi Sato, Tatsuya Miyake, Masatoshi Kataoka, Shunji Ishihara. Combinational elastography for assessment of liver fibrosis in patients with liver injury. Journal of International Medical Research 2022; 50(6) doi: 10.1177/03000605221100126
|
| 109 |
Muhammad Moseeb Ali Hashim, Muhammad Aizaz Mohsin Khan, Muhammad Usama Ashraf, Saniya Mohsin, Kamran Zahoor, Javeria Niazi, Aiza Khan, Sania Muzaffar, Madiha Makhdumi, Omar Ahmed Ibad, Talha Kamran Khan, Sohaib Khalid. Pathological Evolution and Internal Medicine Management of Nonalcoholic Fatty Liver Disease (NAFLD) in the Era of Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD). Cureus 2025; doi: 10.7759/cureus.86963
|
| 110 |
Da Hea Seo, Young Ju Suh, Yongin Cho, Seong Hee Ahn, Seongha Seo, Seongbin Hong, Yong-ho Lee, Young Ju Choi, Eunjig Lee, So Hun Kim. Advanced Liver Fibrosis Is Associated with Chronic Kidney Disease in Patients with Type 2 Diabetes Mellitus and Nonalcoholic Fatty Liver Disease. Diabetes & Metabolism Journal 2022; 46(4) doi: 10.4093/dmj.2021.0130
|
| 111 |
Xinting Cai, Susanne Rospleszcz, Birger Mensel, Ulf Schminke, Jens-Peter Kühn, Ali Alexander Aghdassi, Corinna Storz, Roberto Lorbeer, Christopher L Schlett, Wolfgang Rathmann, Michael Roden, Simon Hohenester, Robin Bülow, Fabian Bamberg, Annette Peters, Barbara Thorand, Henry Völzke, Jana Nano. Association between hepatic fat and subclinical vascular disease burden in the general population. BMJ Open Gastroenterology 2021; 8(1) doi: 10.1136/bmjgast-2021-000709
|
| 112 |
Xiaoyu Jiang, Chaoyang Jin, Hakmook Kang, Gracie Piantek, Zhongliang Zu, John C. Gore, Junzhong Xu. Repeatability of in vivo MR cytometry for measuring cell size and density in healthy human livers. Magnetic Resonance Imaging 2026; 126 doi: 10.1016/j.mri.2025.110563
|
| 113 |
Thomas Jensen, Amanda Wieland, Melanie Cree-Green, Kristen Nadeau, Shelby Sullivan. Clinical workup of fatty liver for the primary care provider. Postgraduate Medicine 2019; 131(1) doi: 10.1080/00325481.2019.1546532
|
| 114 |
P. P. Gimadiev, A. R. Niiazov, V. E. Mukhin, P. P. Ogurtsov. THE DIAGNOSTIC IMPORTANCE OF CIRCULATING MICRORNA FOR NON-ALCOHOLIC FATTY LIVER DISEASE: LITERATURE REVIEW. Russian Clinical Laboratory Diagnostics 2019; 64(12) doi: 10.18821/0869-2084-2019-64-12-723-729
|
| 115 |
Dimitrios A. Koutoukidis, Susan A. Jebb, Paul Aveyard, Nerys M. Astbury. The Effect of Moderate Weight Loss on a Non-Invasive Biomarker of Liver Fibrosis: A Randomised Controlled Trial. Obesity Facts 2020; 13(2) doi: 10.1159/000505667
|
| 116 |
Saptarshi Bhattacharyya, Ming-Lung Yu, Phumelele Yvonne Siphepho, Jee-Fu Huang, Chia-Yen Dai, Wan-Long Chuang, Shu-Chi Wang. Retrospective analysis of steatosis effect on antiviral response and hepatocellular carcinoma risk in chronic hepatitis C. Antiviral Research 2025; 240 doi: 10.1016/j.antiviral.2025.106203
|
| 117 |
Shutaro Sumiyoshi, Jun Kiuchi, Yoshiaki Kuriu, Tomohiro Arita, Hiroki Shimizu, Wataru Takaki, Takuma Ohashi, Yusuke Yamamoto, Hirotaka Konishi, Ryo Morimura, Atsushi Shiozaki, Hisashi Ikoma, Takeshi Kubota, Hitoshi Fujiwara, Kazuma Okamoto, Eigo Otsuji. Postoperative liver dysfunction is associated with poor long-term outcomes in patients with colorectal cancer: a retrospective cohort study. BMC Gastroenterology 2023; 23(1) doi: 10.1186/s12876-023-02762-y
|
| 118 |
Shuai Cheng, Wenhao Lv, Tingjing You, Shengmin Zhang. Influence variables of ultrasound-derived fat fraction in liver fat content measurement: preprandial and postprandial states. Abdominal Radiology 2025; 50(11) doi: 10.1007/s00261-025-04909-9
|
| 119 |
Iris Y. Zhou, Sydney B. Montesi, Eman A. Akam, Peter Caravan. Molecular Imaging. 2021; doi: 10.1016/B978-0-12-816386-3.00077-6
|
| 120 |
Feng Fang, Jui Fang, Qiang Li, Dar-In Tai, Yung-Liang Wan, Kazuki Tamura, Tadashi Yamaguchi, Po-Hsiang Tsui. Ultrasound Assessment of Hepatic Steatosis by Using the Double Nakagami Distribution: A Feasibility Study. Diagnostics 2020; 10(8) doi: 10.3390/diagnostics10080557
|
| 121 |
Manpreet Kaur, Shanmathi Murugesan, Sachpreet Singh, Katherine N Uy, Jasjeet Kaur, Navina Mann, Rajneet K Sekhon. The Influence of Coffee on Reducing Metabolic Dysfunction-Associated Steatotic Liver Disease in Patients With Type 2 Diabetes: A Review. Cureus 2023; doi: 10.7759/cureus.50118
|
| 122 |
K.C. van Son, L.C. te Nijenhuis-Noort, S.C. Boone, D.O. Mook-Kanamori, A.G. Holleboom, P.R. Roos, H.J. Lamb, G. Alblas, M.J. Coenraad, F.R. Rosendaal, R. de Mutsert, M.E. Tushuizen. Prevalence of metabolic dysfunction-associated steatotic liver disease (MASLD) in a middle-aged population with overweight and normal liver enzymes, and diagnostic accuracy of noninvasive proxies. Medicine 2024; 103(1) doi: 10.1097/MD.0000000000034934
|
| 123 |
Neilson Silveira de Souza, Théo Cordeiro Veiga Vitório, Raphael Augusto de Souza, Marcos Antônio Dórea Machado, Helma Pinchemel Cotrim. Artificial Intelligence for Fibrosis Diagnosis in Metabolic-Dysfunction-Associated Steatotic Liver Disease: A Systematic Review. Diagnostics 2026; 16(2) doi: 10.3390/diagnostics16020261
|
| 124 |
Bianzhe Wu, ZeRong Huang, Jinglin Liang, Hong Yang, Wei Wang, Shuangping Huang, LiDa Chen, Qinghua Huang. GLCV-NET: An automatic diagnosis system for advanced liver fibrosis using global–local cross view in B-mode ultrasound images. Computer Methods and Programs in Biomedicine 2024; 257 doi: 10.1016/j.cmpb.2024.108440
|
| 125 |
Tatjana Dell, Verena Tischler, Dario Zocholl, Narine Mesropyan, Alice Margarida Jacob, Johannes Chang, Bernhard Schmidt, Claus Christian Pieper, Alexander Isaak, Patrick Kupczyk, Carsten Meyer, Julian Luetkens, Christian Strassburg, Christian Jansen, Daniel Kuetting. Photon-counting CT-derived hepatic extracellular volume quantification for noninvasive risk stratification of clinically significant portal hypertension (CSPH): a prospective cohort study. European Radiology 2025; 36(5) doi: 10.1007/s00330-025-12222-8
|
| 126 |
Elham Karimi, Reyhane Mokhtari Hemami, Mohammd hossein Somi, Neda Gilani, Alireza Ostadrahimi, Masoud Shirmohamadi, Aarefeh Jafarzadeh kohneloo, Shahrzad Tavakkoli, Elnaz Faramarzi, Mahdieh Safaei. The association between anthropometric indices with non-alcoholic fatty liver in the Azar cohort population. Scientific Reports 2026; 16(1) doi: 10.1038/s41598-026-40671-8
|
| 127 |
Juan P Arab, Roberto Candia, Rodrigo Zapata, Cristián Muñoz, Juan P Arancibia, Jaime Poniachik, Alejandro Soza, Francisco Fuster, Javier Brahm, Edgar Sanhueza, Jorge Contreras, M Carolina Cuellar, Marco Arrese, Arnoldo Riquelme. Management of nonalcoholic fatty liver disease: An evidence-based clinical practice review. World Journal of Gastroenterology 2014; 20(34): 12182-12201 doi: 10.3748/wjg.v20.i34.12182
|
| 128 |
Osama Alzoubi, Ahmad Arar, Viraj Singh, Sukru M. Erturk, Ferenc Mozes, Michael Pavlides. MRI in liver cirrhosis. Portal Hypertension & Cirrhosis 2022; 1(1) doi: 10.1002/poh2.6
|
| 129 |
Maciej Adler, Licia Larocca, Francesca M. Trovato, Heather Marcinkowski, Yasmin Pasha, Simon D. Taylor-Robinson. Evaluating the risk of hepatocellular carcinoma in patients with prominently elevated liver stiffness measurements by FibroScan: a multicentre study. HPB 2016; 18(8) doi: 10.1016/j.hpb.2016.05.005
|
| 130 |
Zahra Dehnavi, Farkhonde Razmpour, Mahmoud Belghaisi Naseri, Mohsen Nematy, Seyed Ali Alamdaran, Hassan Ali Vatanparast, Mohsen Azimi Nezhad, Bita Abbasi, Azita Ganji. Fatty Liver Index (FLI) in Predicting Non-alcoholic Fatty Liver Disease (NAFLD). Hepatitis Monthly 2018; 18(2) doi: 10.5812/hepatmon.63227
|
| 131 |
Xu Wang, Jiewen Xie, Juan Pang, Hanyue Zhang, Xu Chen, Jiesheng Lin, Qing Li, Qian Chen, Jing Ma, Xiping Xu, Yan Yang, Wenhua Ling, Yuming Chen. Serum SHBG Is Associated With the Development and Regression of Nonalcoholic Fatty Liver Disease: A Prospective Study. The Journal of Clinical Endocrinology & Metabolism 2020; 105(3) doi: 10.1210/clinem/dgz244
|
| 132 |
Azin S. Janani, Sasan Ahdi Rezaeieh, Amin Darvazehban, Ali Zamani, Aida Brankovic, Beadaa Mohammed, Graeme A. Macdonald, Amin M. Abbosh. Hepatic Steatosis Detection Using Differential Effective Permittivity. IEEE Transactions on Antennas and Propagation 2021; 69(12) doi: 10.1109/TAP.2021.3090508
|
| 133 |
Zixuan Li, Xiaoying Wu, Zebin Chen, Xiuqing Wei, Weiqing Chen. Association between low-normal thyroid function and advanced liver fibrosis in metabolic dysfunction-associated fatty liver disease patients: a retrospective cohort study. Gastroenterology Report 2023; 12 doi: 10.1093/gastro/goad076
|
| 134 |
Daiane Gonçalves de Oliveira, Fabiana de Faria Ghetti, Ana Paula Boroni Moreira, Helen Hermana Miranda Hermsdorff, Juliano Machado de Oliveira, Lincoln Eduardo Villela Vieira de Castro Ferreira. Association between dietary total antioxidant capacity and hepatocellular ballooning in nonalcoholic steatohepatitis: a cross-sectional study. European Journal of Nutrition 2019; 58(6) doi: 10.1007/s00394-018-1776-0
|
| 135 |
Zhuo Chang, Chen-Hao Peng, Kai-Jung Chen, Guang-Kui Xu. Enhancing liver fibrosis diagnosis and treatment assessment: a novel biomechanical markers-based machine learning approach. Physics in Medicine & Biology 2024; 69(11) doi: 10.1088/1361-6560/ad4c4e
|
| 136 |
Jingmin Song, Heqing Wang, Xiaolian Gao, Fen Yang, Xinhong Zhu, Guiyuan Qiao, Ting Gan, Junxiu Tao. The serum hepcidin and the hepcidin/ferritin ratio in NAFLD: a systematic review and meta-analysis. BMC Gastroenterology 2025; 25(1) doi: 10.1186/s12876-025-03620-9
|
| 137 |
Nikolaos Perakakis, Stergios A. Polyzos, Alireza Yazdani, Aleix Sala-Vila, Jannis Kountouras, Athanasios D. Anastasilakis, Christos S. Mantzoros. Non-invasive diagnosis of non-alcoholic steatohepatitis and fibrosis with the use of omics and supervised learning: A proof of concept study. Metabolism 2019; 101 doi: 10.1016/j.metabol.2019.154005
|
| 138 |
Norio Akuta, Yusuke Kawamura, Shunichiro Fujiyama, Hitomi Sezaki, Tetsuya Hosaka, Masahiro Kobayashi, Mariko Kobayashi, Satoshi Saitoh, Fumitaka Suzuki, Yoshiyuki Suzuki, Yasuji Arase, Kenji Ikeda, Hiromitsu Kumada. Predictors of Insulin Secretion in Japanese Patients with Histopathologically-confirmed Non-alcoholic Fatty Liver Disease. Internal Medicine 2020; 59(3) doi: 10.2169/internalmedicine.3555-19
|
| 139 |
Waqas B. Khalid, Nadim Farhat, Linda Lavery, Josh Jarnagin, James P. Delany, Kang Kim. Non-invasive Assessment of Liver Fat in ob/ob Mice Using Ultrasound-Induced Thermal Strain Imaging and Its Correlation with Hepatic Triglyceride Content. Ultrasound in Medicine & Biology 2021; 47(4) doi: 10.1016/j.ultrasmedbio.2020.12.014
|
| 140 |
Sarit Anavi, Zecharia Madar, Oren Tirosh. Non-alcoholic fatty liver disease, to struggle with the strangle: Oxygen availability in fatty livers. Redox Biology 2017; 13 doi: 10.1016/j.redox.2017.06.008
|
| 141 |
Anıl Delik, Sadık Dinçer, Hikmet Akkız. The role of genetic and epigenetic factors in non alcoholic fatty liver disease (NAFLD) pathogenesis. Meta Gene 2020; 24 doi: 10.1016/j.mgene.2020.100647
|
| 142 |
Xin-Yun Tan, Hui-Hui Zou, Xinjuan Huang, Man-Jie Guo, Ruo-Ling Yu, Xue-Lian Liu, Ting Peng, Xuan Yang, Chun-Xiang Qin. Comparison of the identification and practicability of non-invasive diagnostic indicators under NAFLD, MAFLD and MASLD in China: a cross-sectional study. BMJ Open 2026; 16(4) doi: 10.1136/bmjopen-2024-094809
|
| 143 |
Alshaima Alhinai, Keyur Patel, Vivian A. Fonseca, Giada Sebastiani. Non-invasive diagnosis of nonalcoholic fatty liver disease in patients with type 2 diabetes. Journal of Diabetes and its Complications 2021; 35(9) doi: 10.1016/j.jdiacomp.2021.107978
|
| 144 |
Rohit Loomba, Anjali Jain, Anna Mae Diehl, Cynthia D. Guy, Dana Portenier, Ranjan Sudan, Seema Singh, Claire Faulkner, Lisa Richards, Kelly D. Hester, Lauren Okada, Xiao-jun Li, Larry Mimms, Manal F. Abdelmalek. Validation of Serum Test for Advanced Liver Fibrosis in Patients With Nonalcoholic Steatohepatitis. Clinical Gastroenterology and Hepatology 2019; 17(9) doi: 10.1016/j.cgh.2018.11.004
|
| 145 |
Hyun Hee Lee, Han Ro, Ji Yong Jung, Jae Hyun Chang, Wookyung Chung, Ae Jin Kim. The Fatty Liver Index’s Association with Incident Chronic Kidney Disease in Korean Middle-Aged Adults: A Community-Based Cohort Study. Journal of Clinical Medicine 2024; 13(6) doi: 10.3390/jcm13061616
|
| 146 |
|
| 147 |
Yuji Ogawa, Yasushi Honda, Takaomi Kessoku, Wataru Tomeno, Kento Imajo, Masato Yoneda, Miwa Kawanaka, Hiroyuki Kirikoshi, Masafumi Ono, Masataka Taguri, Satoru Saito, Takeharu Yamanaka, Koichiro Wada, Atsushi Nakajima. Wisteria floribunda agglutinin‐positive Mac‐2‐binding protein and type 4 collagen 7S: useful markers for the diagnosis of significant fibrosis in patients with non‐alcoholic fatty liver disease. Journal of Gastroenterology and Hepatology 2018; 33(10) doi: 10.1111/jgh.14156
|
| 148 |
Young-Sun Lee, Yang Jae Yoo, Young Kul Jung, Ji Hoon Kim, Yeon Seok Seo, Hyung Joon Yim, In Hee Kim, Soo Yeon Lee, Baek-Hui Kim, Jeong Woo Kim, Chang Hee Lee, Jong Eun Yeon, So Young Kwon, Soon Ho Um, Kwan Soo Byun. Multiparametric MR Is a Valuable Modality for Evaluating Disease Severity of Nonalcoholic Fatty Liver Disease. Clinical and Translational Gastroenterology 2020; 11(4) doi: 10.14309/ctg.0000000000000157
|
| 149 |
José Timaná, Hector Chahuara, Lokesh Basavarajappa, Adrian Basarab, Kenneth Hoyt, Roberto Lavarello. Simultaneous imaging of ultrasonic relative backscatter and attenuation coefficients for quantitative liver steatosis assessment. Scientific Reports 2023; 13(1) doi: 10.1038/s41598-023-33964-9
|
| 150 |
P. Praveen Raj, Rachel M. Gomes, Saravana Kumar, Palanisamy Senthilnathan, Purushothaman Karthikeyan, Annapoorni Shankar, Chinnusamy Palanivelu. The effect of surgically induced weight loss on nonalcoholic fatty liver disease in morbidly obese Indians: “NASHOST” prospective observational trial. Surgery for Obesity and Related Diseases 2015; 11(6) doi: 10.1016/j.soard.2015.02.006
|
| 151 |
Duanping Sun, Ying Ma, Maoqiang Wu, Zuanguang Chen, Luyong Zhang, Jing Lu. Recent progress in aptamer-based microfluidics for the detection of circulating tumor cells and extracellular vesicles. Journal of Pharmaceutical Analysis 2023; 13(4) doi: 10.1016/j.jpha.2023.03.001
|
| 152 |
Zhijie Xu, Pengyuan He, Jianzhong Xian, Wuzhu Lu, Jingxian Shu, Wentao Luo, Chongjie Gan, Ruoman Ke, Jinyu Xia, Zongping Han, Mingxing Huang. Association between Nonalcoholic Fatty Liver Disease and Bone Mineral Density in HIV-Infected Patients Receiving Long-term TDF-Based Antiretroviral Therapy. Current HIV Research 2021; 19(1) doi: 10.2174/1570162X18999200917120449
|
| 153 |
Jiahui Li, Hao Wu, Kevin J. Glaser, Fang-Shu Ou, Armando Manduca, Sudhakar K. Venkatesh, Claude Sirlin, Rohit Loomba, Vijay H. Shah, Richard L. Ehman, Alina M. Allen, Meng Yin. Simplified definition and imaging-based stratification of at-risk MASH using magnetic resonance elastography. Hepatology Communications 2026; 10(9) doi: 10.1097/HC9.0000000000001024
|
| 154 |
Raj A. Shah, Kris V. Kowdley. Obeticholic acid for the treatment of nonalcoholic steatohepatitis. Expert Review of Gastroenterology & Hepatology 2020; 14(5) doi: 10.1080/17474124.2020.1748498
|
| 155 |
Mazen Noureddin, Edward Mena, Raj Vuppalanchi, Niharika Samala, Micaela Wong, Fabiana Pacheco, Prido Polanco, Celine Sakkal, Ani Antaramian, Devon Chang, Nabil Noureddin, Anita Kohli, Stephen A. Harrison, Samer Gawrieh, Naim Alkhouri, Emily Truong. Increased accuracy in identifying NAFLD with advanced fibrosis and cirrhosis: independent validation of the Agile 3+ and 4 scores. Hepatology Communications 2023; 7(5) doi: 10.1097/HC9.0000000000000055
|
| 156 |
Bo Zhu, Siu-Lung Chan, Jack Li, Kathryn Li, Hao Wu, Kui Cui, Hong Chen. Non-alcoholic Steatohepatitis Pathogenesis, Diagnosis, and Treatment. Frontiers in Cardiovascular Medicine 2021; 8 doi: 10.3389/fcvm.2021.742382
|
| 157 |
Camilla Akbari, Maja Dodd, Per Stål, Patrik Nasr, Mattias Ekstedt, Stergios Kechagias, Johan Vessby, Fredrik Rorsman, Xiao Zhang, Tongtong Wang, Thomas Jemielita, Gail Fernandes, Samuel S. Engel, Hannes Hagström, Ying Shang. Long-term major adverse liver outcomes in 1,260 patients with non-cirrhotic NAFLD. JHEP Reports 2024; 6(2) doi: 10.1016/j.jhepr.2023.100915
|
| 158 |
Young-Sun Lee, Ha Seok Lee, Sung Won Chang, Chan Uk Lee, Jung Sun Kim, Young Kul Jung, Ji Hoon Kim, Yeon Seok Seo, Hyung Joon Yim, Chang Hee Lee, Sang Uk Woo, Jae Hong Seo, Jong Eun Yeon, Soon Ho Um, Kwan Soo Byun. Underlying nonalcoholic fatty liver disease is a significant factor for breast cancer recurrence after curative surgery. Medicine 2019; 98(39) doi: 10.1097/MD.0000000000017277
|
| 159 |
A. Lum Han, Hee Kyung Lee. Comparison of the Diagnostic Performance of Steatosis Indices for Discrimination of CT-Diagnosed Metabolic Dysfunction-Associated Fatty Liver Disease. Metabolites 2022; 12(7) doi: 10.3390/metabo12070664
|
| 160 |
Iris Y. Zhou, Onofrio A. Catalano, Peter Caravan. Advances in functional and molecular MRI technologies in chronic liver diseases. Journal of Hepatology 2020; 73(5) doi: 10.1016/j.jhep.2020.06.020
|
| 161 |
Iryna Klymas, Liudmyla Khimion. Aminotransferases activity on additional therapy in rheumatoid arthritis patients with liver disease.. Journal of Clinical Medicine of Kazakhstan 2024; 21(2) doi: 10.23950/jcmk/14398
|
| 162 |
Dae-Jeong Koo, Mi Yeon Lee, Inha Jung, Sun Joon Moon, Hyemi Kwon, Se Eun Park, Eun-Jung Rhee, Won-Young Lee, Ming-Lung Yu. Baseline homeostasis model assessment of insulin resistance associated with fibrosis progression in patients with nonalcoholic fatty liver disease without diabetes: A cohort study. PLOS ONE 2021; 16(8) doi: 10.1371/journal.pone.0255535
|
| 163 |
Hae Kyung Kim, Minyoung Lee, Yong-ho Lee, Eun Seok Kang, Bong-Soo Cha, Byung-Wan Lee. Renal Tubular Damage Marker, Urinary N-acetyl-β-D-Glucosaminidase, as a Predictive Marker of Hepatic Fibrosis in Type 2 Diabetes Mellitus. Diabetes & Metabolism Journal 2022; 46(1) doi: 10.4093/dmj.2020.0273
|
| 164 |
Peter J. Altshuler, Hien Dang, Adam M. Frank, Ashesh P. Shah, Jaime Glorioso, Tingting Zhan, Arturo Rios Diaz, Osama Shaheen, Carlo B. Ramirez, Warren R. Maley, Adam S. Bodzin. Evaluating Outcomes Related to Donor and Recipient Metabolic Environment: Macrosteatotic Allografts and Nonalcoholic Steatohepatitis. Liver Transplantation 2022; 28(4) doi: 10.1002/lt.26313
|
| 165 |
Eirini Martinou, Marinos Pericleous, Irena Stefanova, Vasha Kaur, Angeliki M. Angelidi. Diagnostic Modalities of Non-Alcoholic Fatty Liver Disease: From Biochemical Biomarkers to Multi-Omics Non-Invasive Approaches. Diagnostics 2022; 12(2) doi: 10.3390/diagnostics12020407
|
| 166 |
Miwa Kawanaka, Takashi Fushimi, Tomohiro Tanikawa, Noriiyo Urata, Ken Haruma, Hirofumi Kawamoto, Motoyuki Otsuka. The new assay type IV collagen 7S (CLEIA) is a useful test to identify progressive fibrosis in chronic liver disease: A study based on magnetic resonance elastography. Hepatology Research 2025; 55(7) doi: 10.1111/hepr.14202
|
| 167 |
Niki Katsiki, Dimitrios Tousoulis. Diabetes mellitus and comorbidities: A bad romance. Hellenic Journal of Cardiology 2020; 61(1) doi: 10.1016/j.hjc.2020.02.009
|
| 168 |
Fariba Ahmadizar, Zobair M. Younossi. Exploring Biomarkers in Nonalcoholic Fatty Liver Disease Among Individuals With Type 2 Diabetes Mellitus. Journal of Clinical Gastroenterology 2025; 59(1) doi: 10.1097/MCG.0000000000002079
|
| 169 |
Jialu Zhang, Yihao Huang, Miao Sun, Shuang Wan, Chaoyong Yang, Yanling Song. Recent Advances in Aptamer-Based Liquid Biopsy. ACS Applied Bio Materials 2022; 5(5) doi: 10.1021/acsabm.1c01202
|
| 170 |
Laura J. Brattain, Arinc Ozturk, Brian A. Telfer, Manish Dhyani, Joseph R. Grajo, Anthony E. Samir. Image Processing Pipeline for Liver Fibrosis Classification Using Ultrasound Shear Wave Elastography. Ultrasound in Medicine & Biology 2020; 46(10) doi: 10.1016/j.ultrasmedbio.2020.05.016
|
| 171 |
Hao Jin, Baiyun Wang, Ting Mei, Longfei Yin, Yishu Tang, Guohua Wu. Serum Raman Spectroscopy Combined With a Support Vector Machine for Rapid Diagnosis of Hepatitis B and Liver Cirrhosis. Journal of Raman Spectroscopy 2026; 57(5) doi: 10.1002/jrs.70120
|
| 172 |
Ziqi Zhou, Lingli Sang, Jin Wang, Lin Song, Lejia Zhu, Yangmei Wang, Jing Xiao, Yulong Lian. Relationships among N,N-dimethylformamide exposure, CYP2E1 and TM6SF2 genes, and non-alcoholic fatty liver disease. Ecotoxicology and Environmental Safety 2021; 228 doi: 10.1016/j.ecoenv.2021.112986
|
| 173 |
A. S. Bockarie, Y. A. Nartey, P. Nsiah, E. K. M. Edzie, D. Tuoyire, S. Acquah, S. Eliason, B. Nkum. Fatty liver biomarkers and insulin resistance indices in the prediction of non‐alcoholic fatty liver disease in Ghanaian patients. Endocrinology, Diabetes & Metabolism 2023; 6(6) doi: 10.1002/edm2.456
|
| 174 |
Zhifeng You, Lyu Zhou, Wenjing Li, Chenyu Huang, Yanan Du. Mechanical microenvironment as a key cellular regulator in the liver. Acta Mechanica Sinica 2019; 35(2) doi: 10.1007/s10409-019-00857-y
|
| 175 |
Juhee Lee, Garam Jo, Dahyun Park, Hee Ju Jun, Jae Hyun Bae, Min-Jeong Shin. The Association between Advanced Liver Fibrosis and Mortality Is Modified by Dietary Quality among Korean Adults: Results from the Korea National Health and Nutrition Examination Survey with Mortality Data. Nutrients 2023; 15(6) doi: 10.3390/nu15061501
|
| 176 |
Sara Shojaei Zarghani, Nima Rahimi Kashkooli, Zahra Bagheri, Mahdy Tabatabaei, Mohammad Reza Fattahi, Ali Reza Safarpour. Dietary selenium intake in relation to non-alcoholic fatty liver disease assessed by fatty liver index and hepatic steatosis index; a cross-sectional study on the baseline data of prospective PERSIAN Kavar cohort study.. BMC Endocrine Disorders 2023; 23(1) doi: 10.1186/s12902-023-01307-4
|
| 177 |
Margaret Morrison, Heather Y. Hughes, Susanna Naggie, Wing-Kin Syn. Nonalcoholic Fatty Liver Disease Among Individuals with HIV Mono-infection: A Growing Concern?. Digestive Diseases and Sciences 2019; 64(12) doi: 10.1007/s10620-019-05861-7
|
| 178 |
Mimi Kim, Dae Won Jun, Huiyul Park, Bo-Kyeong Kang, Yoshio Sumida. Sequential Combination of FIB-4 Followed by M2BPGi Enhanced Diagnostic Performance for Advanced Hepatic Fibrosis in an Average Risk Population. Journal of Clinical Medicine 2020; 9(4) doi: 10.3390/jcm9041119
|
| 179 |
Laurens A. van Kleef, Milan J. Sonneveld, Maryam Kavousi, M. Arfan Ikram, Robert A. de Man, Robert J. de Knegt. Fatty liver disease is not associated with increased mortality in the elderly: A prospective cohort study. Hepatology 2023; 77(2) doi: 10.1002/hep.32635
|
| 180 |
M. V. Kruchinina, M. F. Osipenko, A. A. Shestov, M. V. Parulikova. Fatty acid composition of blood serum and erythrocyte membranes in men with steatosis and steatohepatitis with normal transaminase activity. Sechenov Medical Journal 2024; 15(2) doi: 10.47093/2218-7332.2024.15.2.48-60
|
| 181 |
Yan Li, Jiahao Wang, Gengyu Xu, Yixin Si, Kaiyao Huang, Yinquan Ye, Yun Peng, Yuanyuan Liu. Comparison of accuracy of CT parameters across chest, low-dose lung, and abdominal CT in diagnosing steatotic liver disease. BMC Medical Imaging 2025; 25(1) doi: 10.1186/s12880-025-01791-1
|
| 182 |
Yoshihiro Kamada, Takahiro Nakamura, Satoko Isobe, Kumiko Hosono, Yukiko Suama, Yukie Ohtakaki, Arihito Nauchi, Naoto Yasuda, Soh Mitsuta, Kouichi Miura, Takuma Yamamoto, Tatsunori Hosono, Akihiro Yoshida, Ippei Kawanishi, Hideaki Fukushima, Masao Kinoshita, Atsushi Umeda, Yuichi Kinoshita, Kana Fukami, Toshio Miyawaki, Hideki Fujii, Yuichi Yoshida, Miwa Kawanaka, Hideyuki Hyogo, Asahiro Morishita, Hideki Hayashi, Hiroshi Tobita, Kengo Tomita, Tadashi Ikegami, Hirokazu Takahashi, Masato Yoneda, Dae Won Jun, Yoshio Sumida, Takeshi Okanoue, Atsushi Nakajima. SWOT analysis of noninvasive tests for diagnosing NAFLD with severe fibrosis: an expert review by the JANIT Forum. Journal of Gastroenterology 2023; 58(2) doi: 10.1007/s00535-022-01932-1
|
| 183 |
Limei Li, Yan Song, Yongquan Shi, Liangliang Sun. Thyroid Hormone Receptor-β Agonists in NAFLD Therapy: Possibilities and Challenges. The Journal of Clinical Endocrinology & Metabolism 2023; 108(7) doi: 10.1210/clinem/dgad072
|
| 184 |
Ayushi Agrawal, Yousef Javanmardi, Sara A. Watson, Bianca Serwinski, Boris Djordjevic, Wenbin Li, Amir R. Aref, Russell W. Jenkins, Emad Moeendarbary. Mechanical signatures in cancer metastasis. npj Biological Physics and Mechanics 2025; 2(1) doi: 10.1038/s44341-024-00007-x
|
| 185 |
Masanori Abe, Teruki Miyake, Atsushi Kuno, Yasuharu Imai, Yoshiyuki Sawai, Keisuke Hino, Yuichi Hara, Shuhei Hige, Michiie Sakamoto, Gotaro Yamada, Masayoshi Kage, Masaaki Korenaga, Yoichi Hiasa, Masashi Mizokami, Hisashi Narimatsu. Association between Wisteria floribunda agglutinin-positive Mac-2 binding protein and the fibrosis stage of non-alcoholic fatty liver disease. Journal of Gastroenterology 2015; 50(7) doi: 10.1007/s00535-014-1007-2
|
| 186 |
Mei-Hui Wang, Chuan-Yi Chien, Hung-Man Yu, Ping-Yen Wang, Wuu-Jyh Lin. Use of 111In-Hexavalent Lactoside for Liver Reserve Estimation in Rodents with Thioacetamide-Induced Hepatic Fibrosis. Molecular Pharmaceutics 2018; 15(10) doi: 10.1021/acs.molpharmaceut.8b00326
|
| 187 |
Joshua Hanson, Chaodong Wu, Kenneth Hoyt. Quantitative Multifrequency Ultrasound Imaging Using Narrowband Pulsing for Tissue Characterization. Investigative Radiology 2026; 61(9) doi: 10.1097/RLI.0000000000001269
|
| 188 |
LAN GE, BAOMIN SHI, YE SONG, YUAN LI, SHUO WANG, XIUYAN WANG. Clinical value of real-time elastography quantitative parameters in evaluating the stage of liver fibrosis and cirrhosis. Experimental and Therapeutic Medicine 2015; 10(3) doi: 10.3892/etm.2015.2628
|
| 189 |
Carlos A. Vaccaro, Walter Pavicic, Adrián Gadano, Marcelo Risk, Marcelo Figar, Susana Llesuy, Tamara Piñero, Julieta Trinks, Valeria Burgos, Flavia Mazzini, Jorge Alberbide, Ana Basquiera, Marcela Bolontrade, María Isabel Giménez, Federico Jauk, Julieta Argüero. Investigación traslacional en microbioma (intramic): un área de interés común y creciente en el imtib, hospital italiano e instituto universitario. Revista del Hospital Italiano de Buenos Aires 2020; 40(1) doi: 10.51987/Rev.Hosp.Ital.B.Aires.v40i1.492
|
| 190 |
Devon Chang, Emily Truong, Edward A. Mena, Fabiana Pacheco, Micaela Wong, Maha Guindi, Tsuyoshi T. Todo, Nabil Noureddin, Walid Ayoub, Ju Dong Yang, Irene K. Kim, Anita Kohli, Naim Alkhouri, Stephen Harrison, Mazen Noureddin. Machine learning models are superior to noninvasive tests in identifying clinically significant stages of NAFLD and NAFLD‐related cirrhosis. Hepatology 2023; 77(2) doi: 10.1002/hep.32655
|
| 191 |
Norio Akuta, Yusuke Kawamura, Fumitaka Suzuki, Satoshi Saitoh, Yasuji Arase, Hideo Kunimoto, Yushi Sorin, Shunichiro Fujiyama, Hitomi Sezaki, Tetsuya Hosaka, Masahiro Kobayashi, Yoshiyuki Suzuki, Mariko Kobayashi, Kenji Ikeda, Hiromitsu Kumada. Impact of circulating miR-122 for histological features and hepatocellular carcinoma of nonalcoholic fatty liver disease in Japan. Hepatology International 2016; 10(4) doi: 10.1007/s12072-016-9729-2
|
| 192 |
Ahmed Medhat Hegazy, Ayman Samir Farid, Ahmed S. Hafez, Rania M. Eid, Soad M. Nasr. Hepatoprotective and immunomodulatory effects of copper-nicotinate complex against fatty liver in rat model. Veterinary World 2019; 12(12) doi: 10.14202/vetworld.2019.1903-1910
|
| 193 |
Shohei Kimura, Nobuharu Tamaki, Mayu Higuchi, Takuya Shima, Mina Taguchi, Yudai Yamazaki, Risa Seike, Naoki Uchihara, Yuki Tanaka, Ryohei Kobayashi, Junko Yagita, Yuka Kasano, Yasuyuki Komiyama, Kenta Takaura, Hitomi Takada, Shohei Tanaka, Chiaki Maeyashiki, Yutaka Yasui, Hiroyuki Nakanishi, Kaoru Tsuchiya, Namiki Izumi, Masayuki Kurosaki. Diagnostic Accuracy of FIB-4 Index and FIB-3 Index for Advanced Fibrosis in Chronic Liver Disease and Age-Specific Thresholds. Journal of Clinical Medicine 2025; 14(23) doi: 10.3390/jcm14238473
|
| 194 |
Rania Essam-el-dein Mohamed, Mohamed A. Amin, Hazem M. Omar, Hossam Eldeen M. Soliman, Hazem Zakaria. Hepatic magnetic resonance elastography: can it be an alternative to invasive biopsy preceding living donor liver transplantation?. Egyptian Journal of Radiology and Nuclear Medicine 2020; 51(1) doi: 10.1186/s43055-020-00324-w
|
| 195 |
Gavin Low, Ryan K. W. Chee, Yu Jun Wong, Puneeta Tandon, Florin Manolea, Stephanie Locas, Craig Ferguson, Wendy Tu, Mitchell P. Wilson. Abbreviated Multiparametric MR Solution (the “Liver Triple Screen”), the Future of Non-Invasive MR Quantification of Liver Fat, Iron, and Fibrosis. Diagnostics 2024; 14(21) doi: 10.3390/diagnostics14212373
|
| 196 |
Stéphanie André‐Dumont, Nicolas Lanthier. What Can We Learn From Longitudinal Measurements of Liver Stiffness in Metabolic Dysfunction‐Associated Steatotic Liver Disease?. Liver International 2026; 46(6) doi: 10.1111/liv.70680
|
| 197 |
Naoki Tanaka, Takefumi Kimura, Naoyuki Fujimori, Tadanobu Nagaya, Michiharu Komatsu, Eiji Tanaka. Current status, problems, and perspectives of non-alcoholic fatty liver disease research. World Journal of Gastroenterology 2019; 25(2): 163-177 doi: 10.3748/wjg.v25.i2.163
|
| 198 |
Salem Alsaqal, Paul Hockings, Håkan Ahlström, Anders Gummesson, Anders Hedström, Johannes Hulthe, Lars Johansson, Heiko G. Niessen, Corinna Schoelch, Christian Schultheis, Johan Vessby, Alkwin Wanders, Fredrik Rorsman, Charlotte Ebeling Barbier. The Combination of MR Elastography and Proton Density Fat Fraction Improves Diagnosis of Nonalcoholic Steatohepatitis. Journal of Magnetic Resonance Imaging 2022; 56(2) doi: 10.1002/jmri.28040
|
| 199 |
Jessie Torgersen, Craig W. Newcomb, Dean M. Carbonari, Shanae M. Smith, Katherine L. Brecker, Chamith S. Rajapakse, Brandon C. Jones, Christiana Cottrell, Rasleen Grewal, Jennifer C. Price, Joshua F. Baker, Jay R. Kostman, Stacey Trooskin, Rebecca A. Hubbard, Babette S. Zemel, Mary B. Leonard, Vincent Lo Re III, Hamidreza Karimi-Sari. Magnetic resonance evaluation of three-dimensional liver fat fraction by hepatitis C status and associations with inflammatory cytokines. PLOS One 2025; 20(7) doi: 10.1371/journal.pone.0327668
|
| 200 |
Yongqing Zhou, Ping Li, Xin Wang, Chuanchen Wu, Nannan Fan, Xiaoning Liu, Lijie Wu, Wei Zhang, Wen Zhang, Zhenzhen Liu, Bo Tang. In situvisualization of peroxisomal viscosity in the liver of mice with non-alcoholic fatty liver disease by near-infrared fluorescence and photoacoustic imaging. Chemical Science 2020; 11(44) doi: 10.1039/D0SC02922J
|
| 201 |
Paloma Almeda‐Valdes, Carlos A. Aguilar‐Salinas, Misael Uribe, Samuel Canizales‐Quinteros, Nahum Méndez‐Sánchez. Impact of anthropometric cut‐off values in determining the prevalence of metabolic alterations. European Journal of Clinical Investigation 2016; 46(11) doi: 10.1111/eci.12672
|
| 202 |
Aylin Billur Şendur, Halit Nahit Şendur. A Standardized Approach for MRI‐PDFF is Necessary in the Assessment of Diagnostic Performances of the Ultrasound‐Based Hepatic Fat Quantification Tools. Journal of Ultrasound in Medicine 2022; 41(12) doi: 10.1002/jum.16102
|
| 203 |
Konstantinos Malandris, Anastasia Katsoula, Aris Liakos, Thomas Karagiannis, Emmanouil Sinakos, Olga Giouleme, Philippos Klonizakis, Eleni Theocharidou, Eleni Gigi, Eleni Bekiari, Apostolos Tsapas. Diagnostic accuracy of Agile‐4 score for liver cirrhosis in patients with metabolic dysfunction‐associated steatotic liver disease. A systematic review and meta‐analysis of diagnostic test accuracy studies. Diabetes, Obesity and Metabolism 2025; 27(3) doi: 10.1111/dom.16142
|
| 204 |
Gyuri Kim, Seung‐Eun Lee, You‐Bin Lee, Ji Eun Jun, Jiyeon Ahn, Ji Cheol Bae, Sang‐Man Jin, Kyu Yeon Hur, Jae Hwan Jee, Moon‐Kyu Lee, Jae Hyeon Kim. Relationship Between Relative Skeletal Muscle Mass and Nonalcoholic Fatty Liver Disease: A 7‐Year Longitudinal Study. Hepatology 2018; 68(5) doi: 10.1002/hep.30049
|
| 205 |
Praveen Sharma. Value of Liver Function Tests in Cirrhosis. Journal of Clinical and Experimental Hepatology 2022; 12(3) doi: 10.1016/j.jceh.2021.11.004
|
| 206 |
Sumitro Kosasih, Wong Zhi Qin, Rafiz Abdul Rani, Nazefah Abd Hamid, Ngiu Chai Soon, Shamsul Azhar Shah, Yazmin Yaakob, Raja Affendi Raja Ali. Relationship between Serum Cytokeratin-18, Control Attenuation Parameter, NAFLD Fibrosis Score, and Liver Steatosis in Nonalcoholic Fatty Liver Disease. International Journal of Hepatology 2018; 2018 doi: 10.1155/2018/9252536
|
| 207 |
M. V. Kruchinina, M. V. Parulikova, S. A. Kurilovich, A. A. Gromov, M. V. Shashkov, A. S. Sokolova, V. N. Kruchinin. Serum and erythrocyte membrane fatty acid levels may be used as biomarkers to assess the severity of NAFLD. Experimental and Clinical Gastroenterology 2021; (7) doi: 10.31146/1682-8658-ecg-191-7-12-22
|
| 208 |
O. O. Karshina, I. S. Sabirov. Possibilities and disadvantages of modern non-invasive methods of diagnostics of metabolic-associated fatty liver disease. Experimental and Clinical Gastroenterology 2024; (10) doi: 10.31146/1682-8658-ecg-230-10-162-170
|
| 209 |
Pinggui Lei, Na Hu, Yuhui Wu, Maowen Tang, Chong Lin, Luoyi Kong, Lingfeng Zhang, Peng Luo, Lawrence Wing‐Chi Chan. Radiobioinformatics: A novel bridge between basic research and clinical practice for clinical decision support in diffuse liver diseases. iRADIOLOGY 2023; 1(2) doi: 10.1002/ird3.24
|
| 210 |
Amjad M. Ahmed, Mohamed E. Ebid, Amr M. Ajlan, Mouaz H. Al-Mallah. Low-dose attenuation correction in diagnosis of non-alcoholic fatty liver disease. Abdominal Radiology 2017; 42(10) doi: 10.1007/s00261-017-1166-8
|
| 211 |
Lingling Wu, Yidi Wang, Lin Zhu, Yilong Liu, Teng Wang, Dan Liu, Yanling Song, Chaoyong Yang. Aptamer-Based Liquid Biopsy. ACS Applied Bio Materials 2020; 3(5) doi: 10.1021/acsabm.9b01194
|
| 212 |
Sevde Nur FIRAT, Abdullah DURHAN, Serap EREL, Cavit ÇULHA. The relationship between non-alcoholic fatty liver disease and breast cancer: a retrospective case-control study. Journal of Health Sciences and Medicine 2022; 5(1) doi: 10.32322/jhsm.993960
|
| 213 |
Antti Hokkanen, Hanna Hämäläinen, Tiina M. Laitinen, Tomi P. Laitinen. Test–Retest Reliability of the Assessment of Fatty Liver Disease Using Low-Dose Computed Tomography in Cardiac Patients. Frontiers in Medicine 2021; 8 doi: 10.3389/fmed.2021.656658
|
| 214 |
Jiaping Gu, Jiale Chai. An interpretable machine learning model for prediction of significant liver fibrosis in comorbid chronic hepatitis B and nonalcoholic fatty liver disease: a retrospective development and validation study. BMC Gastroenterology 2026; 26(1) doi: 10.1186/s12876-025-04594-4
|
| 215 |
Ladan Yazdani, Iman Rafati, Marc Gesnik, Frank Nicolet, Boris Chayer, Guillaume Gilbert, Anton Volniansky, Damien Olivié, Jeanne-Marie Giard, Giada Sebastiani, Bich N. Nguyen, An Tang, Guy Cloutier. Ultrasound Shear Wave Attenuation Imaging for Grading Liver Steatosis in Volunteers and Patients With Non-alcoholic Fatty Liver Disease: A Pilot Study. Ultrasound in Medicine & Biology 2023; 49(10) doi: 10.1016/j.ultrasmedbio.2023.06.020
|
| 216 |
Soichi Iritani, Norio Akuta, Yusuke Kawamura, Akira Kajiwara, Kayoko Kasuya, Shunichiro Fujiyama, Hitomi Sezaki, Tetsuya Hosaka, Masahiro Kobayashi, Mariko Kobayashi, Satoshi Saito, Fumitaka Suzuki, Yasuji Arase, Kenji Ikeda, Yoshiyuki Suzuki, Hiromitsu Kumada. Non-invasive predictors of prognosis of Asian patients with histopathologically-confirmed lean nonalcoholic fatty liver disease. BMC Gastroenterology 2020; 20(1) doi: 10.1186/s12876-020-01509-3
|
| 217 |
Shu‐Fu Shih, Sevgi Gokce Kafali, Kara L. Calkins, Holden H. Wu. Uncertainty‐aware physics‐driven deep learning network for free‐breathing liver fat and R2* quantification using self‐gated stack‐of‐radial MRI. Magnetic Resonance in Medicine 2023; 89(4) doi: 10.1002/mrm.29525
|
| 218 |
Norio Akuta, Yusuke Kawamura, Shunichiro Fujiyama, Hitomi Sezaki, Tetsuya Hosaka, Masahiro Kobayashi, Mariko Kobayashi, Satoshi Saitoh, Fumitaka Suzuki, Yoshiyuki Suzuki, Yasuji Arase, Kenji Ikeda, Hiromitsu Kumada. SGLT2 Inhibitor Treatment Outcome in Nonalcoholic Fatty Liver Disease Complicated with Diabetes Mellitus: The Long-term Effects on Clinical Features and Liver Histopathology. Internal Medicine 2020; 59(16) doi: 10.2169/internalmedicine.4398-19
|
| 219 |
Markos Kalligeros, Laurent Castera, Emmanuel A. Tsochatzis, Naim Alkhouri. Noninvasive Testing for Metabolic Dysfunction-Associated Steatohepatitis (MASH) and Fibrosis. Clinics in Liver Disease 2026; 30(2) doi: 10.1016/j.cld.2025.12.004
|
| 220 |
Pankaj Aggarwal, Mazen Noureddin, Stephen Harrison, Sophie Jeannin, Naim Alkhouri. Nonalcoholic steatohepatitis (NASH) cirrhosis: a snapshot of therapeutic agents in clinical development and the optimal design for clinical trials. Expert Opinion on Investigational Drugs 2022; 31(2) doi: 10.1080/13543784.2022.2032640
|
| 221 |
Yasushi Honda, Kento Imajo, Takashi Kobayashi, Takaomi Kessoku, Yuji Ogawa, Wataru Tomeno, Masato Yoneda, Noritoshi Kobayashi, Satoru Saito, Atsushi Nakajima. Autotaxin is a valuable biomarker for the prediction of liver fibrosis in patients with non‐alcoholic fatty liver disease. Hepatology Research 2019; 49(10) doi: 10.1111/hepr.13382
|
| 222 |
Norio Akuta, Chizuru Watanabe, Yusuke Kawamura, Yasuji Arase, Satoshi Saitoh, Shunichiro Fujiyama, Hitomi Sezaki, Tetsuya Hosaka, Masahiro Kobayashi, Mariko Kobayashi, Yoshiyuki Suzuki, Fumitaka Suzuki, Kenji Ikeda, Hiromitsu Kumada. Effects of a sodium‐glucose cotransporter 2 inhibitor in nonalcoholic fatty liver disease complicated by diabetes mellitus: Preliminary prospective study based on serial liver biopsies. Hepatology Communications 2017; 1(1) doi: 10.1002/hep4.1019
|
| 223 |
Eduardo J. Arista Romeu, Josué D. Rivera Fernández, Karen Roa Tort, Alma Valor, Galileo Escobedo, Diego A. Fabila Bustos, Suren Stolik, José Manuel de la Rosa, Carolina Guzmán. Combined methods of optical spectroscopy and artificial intelligence in the assessment of experimentally induced non-alcoholic fatty liver. Computer Methods and Programs in Biomedicine 2021; 198 doi: 10.1016/j.cmpb.2020.105777
|
| 224 |
. 2018; doi: 10.70675/7e2a3e12z1d1az4ff8zba53za5c2c8a13381
|
| 225 |
Henry R. Wilman, Matt Kelly, Steve Garratt, Paul M. Matthews, Matteo Milanesi, Amy Herlihy, Micheal Gyngell, Stefan Neubauer, Jimmy D. Bell, Rajarshi Banerjee, E. Louise Thomas, Sheng-Nan Lu. Characterisation of liver fat in the UK Biobank cohort. PLOS ONE 2017; 12(2) doi: 10.1371/journal.pone.0172921
|
| 226 |
Rifat Ara, Maisha Tasnim, Mirana Rahman, Ananna Sarker, Mahanaj Kabir, Sushmoy Saha, Md Ahad Bakas, Nasima Sultana, Khaleda Akter. Prognostic Value of Liver Enzymes (ALT, AST) in Assessing Severity of Metabolic Dysfunction-Associated Fatty Liver Disease. TAJ: Journal of Teachers Association 2026; 39(1) doi: 10.70818/taj.v39i1.0742
|
| 227 |
Nina Bastati, Matthias Perkonigg, Daniel Sobotka, Sarah Poetter-Lang, Romana Fragner, Andrea Beer, Alina Messner, Martin Watzenboeck, Svitlana Pochepnia, Jakob Kittinger, Alexander Herold, Antonia Kristic, Jacqueline C. Hodge, Stefan Traussnig, Michael Trauner, Ahmed Ba-Ssalamah, Georg Langs. Correlation of histologic, imaging, and artificial intelligence features in NAFLD patients, derived from Gd-EOB-DTPA-enhanced MRI: a proof-of-concept study. European Radiology 2023; 33(11) doi: 10.1007/s00330-023-09735-5
|
| 228 |
Eduardo J. Arista Romeu, Galileo Escobedo, Adriana Campos-Espinosa, Ivette Irais Romero-Bello, Javier Moreno-González, Diego A. Fabila-Bustos, Alma Valor Reed, Suren Stolik Isakina, José Manuel de la Rosa Vázquez, Carolina Guzmán. Diffuse reflectance spectroscopy accurately discriminates early and advanced grades of fatty liver in mice. Journal of Biomedical Optics 2018; 23(11) doi: 10.1117/1.JBO.23.11.115005
|
| 229 |
Alexandra Jichitu, Simona Bungau, Ana Maria Alexandra Stanescu, Cosmin Mihai Vesa, Mirela Marioara Toma, Cristiana Bustea, Stela Iurciuc, Marius Rus, Nicolae Bacalbasa, Camelia Cristina Diaconu. Non-Alcoholic Fatty Liver Disease and Cardiovascular Comorbidities: Pathophysiological Links, Diagnosis, and Therapeutic Management. Diagnostics 2021; 11(4) doi: 10.3390/diagnostics11040689
|
| 230 |
Koen C. van Son, Maarten E. Tushuizen, Adriaan G. Holleboom, Joost P.H. Drenth. A non-invasive score for nonalcoholic fatty liver disease (NAFLD) cirrhosis. European Journal of Internal Medicine 2022; 98 doi: 10.1016/j.ejim.2022.02.025
|
| 231 |
Hiroki Nishikawa, Yukio Osaki, Ekihiro Seki. Liver Cirrhosis: Evaluation, Nutritional Status, and Prognosis. Mediators of Inflammation 2015; 2015(1) doi: 10.1155/2015/872152
|
| 232 |
Shui Qin Chai, Wen Yi Lv, Jia Hui He, Chun Hong Li, Yuan Fang Li, Chun Mei Li, Cheng Zhi Huang. Dual Energy Transfer-Based Fluorescent Nanoprobe for Imaging miR-21 in Nonalcoholic Fatty Liver Cells with Low Background. Analytical Chemistry 2019; 91(10) doi: 10.1021/acs.analchem.9b00841
|
| 233 |
Hüseyin Ali Öztürk, Erdinc Gulumsek, Dilan Damla Ozturk, Fatih Necip Arici, Begüm Şeyda Avci, Bektaş Işık, Mehmet Can Erişen, Bercem Berent Kaya, İrfan Alişan, Cahit Dincer, Ahmet Gazi Mustan, Tayyibe Saler, Hilmi Erdem Sümbül. Evaluation of Metabolic Dysfunction-Associated Steatotic Liver Disease in Patients with Type 2 Diabetes Mellitus. Sakarya Medical Journal 2025; 15(1) doi: 10.31832/smj.1636384
|
| 234 |
Helle Sedighi Frandsen, Joel Mario Vej-Nielsen, Lauren Elizabeth Smith, Lang Sun, Karoline Lindgaard Mikkelsen, Annemette Præstegaard Thulesen, Christina Erika Hagensen, Fuquan Yang, Adelina Rogowska-Wrzesinska. Mapping Proteome and Lipidome Changes in Early-Onset Non-Alcoholic Fatty Liver Disease Using Hepatic 3D Spheroids. Cells 2022; 11(20) doi: 10.3390/cells11203216
|
| 235 |
Beyza O. Bilgin, Murat Sunbul, Haluk T. Kani, Coskun O. Demirtas, Caglayan Keklikkiran, Yusuf Yilmaz. Arterial stiffness is associated independently with liver stiffness in biopsy-proven nonalcoholic fatty liver disease: a transient elastography study. European Journal of Gastroenterology & Hepatology 2020; 32(1) doi: 10.1097/MEG.0000000000001471
|
| 236 |
Takashi Nishimura, Toshifumi Tada, Yasuaki Suzuki, Kento Imajo, Katsutoshi Sugimoto, Sadanobu Ogawa, Hidenori Toyoda, Tamami Abe, Hidekatsu Kuroda, Masashi Hirooka, Asako Nogami, Satoshi Oeda, Hirokazu Takahashi, Tomoyuki Akita, Reiichiro Kondo, Takuma Nakatsuka, Ryosuke Tateishi, Yoichi Hiasa, Yuichiro Eguchi, Atsushi Nakajima, Hirohisa Yano, Shigehiro Kokubu, Junko Tanaka, Fuminori Moriyasu, Masayoshi Kage, Takashi Kumada, Hiroko Iijima. Diagnostic Impact of Two‐Dimensional Shear Wave Elastography for Liver Fibrosis: A Multicenter Retrospective Study. Hepatology Research 2026; 56(9) doi: 10.1111/hepr.70194
|
| 237 |
David Hudson, Tamoor Afzaal, Hasan Bualbanat, Raaed AlRamdan, Nisha Howarth, Pavithra Parthasarathy, Alia AlDarwish, Emily Stephenson, Yousef Almahanna, Maytham Hussain, Luis Antonio Diaz, Juan Pablo Arab. Modernizing metabolic dysfunction-associated steatotic liver disease diagnostics: the progressive shift from liver biopsy to noninvasive techniques. Therapeutic Advances in Gastroenterology 2024; 17 doi: 10.1177/17562848241276334
|
| 238 |
Derya Yıldırım, Ayça Tamer, Mahinur Cerit, Hamit Küçük, Halit Nahit Şendur. HEPATOSTEATOZ DEĞERLENDİRMEDE ETKİN BİR ÖLÇEĞİN PSÖRİATİK ARTRİTLİ HASTALARDA KULLANIMI: DOKU ATENUASYON GÖRÜNTÜLEME. Kırıkkale Üniversitesi Tıp Fakültesi Dergisi 2024; 26(2) doi: 10.24938/kutfd.1394513
|
| 239 |
Alyssa Y. Choi, Xiaodong Li, Wenchang Guo, Vishal S. Chandan, Jason Samarasena, John G. Lee, Kenneth J. Chang, Ke-Qin Hu. Performance of Endoscopic Ultrasound-Guided Versus Percutaneous Liver Biopsy in Diagnosing Stage 3–4 Fibrosis. Digestive Diseases and Sciences 2023; 68(9) doi: 10.1007/s10620-023-08019-8
|
| 240 |
M.M. Zhaivoronok, N.V. Deresh, I. Sporea, O.B. Dynnyk, S.V. Feysa, O.A. Pushkarenko, O.A. Fedusenko, O.V. Shcherbina, N.M. Kobyliak. Multimodal assessment of hepatic steatosis heterogeneity: segmental MRI-PDFF and ultrasound attenuation coefficient measurement. INTERNATIONAL JOURNAL OF ENDOCRINOLOGY (Ukraine) 2026; 22(2) doi: 10.22141/2224-0721.22.2.2026.1683
|
| 241 |
Kousuke Izumi, Shunhei Yamashina, Tsutomu Fujimura, Sumio Watanabe, Kenichi Ikejima. Autophagic dysfunction in the liver enhances the expression of insoluble nuclear proteins 14-3-3ζ and importin α4. Life Sciences 2022; 298 doi: 10.1016/j.lfs.2022.120491
|
| 242 |
Franco Poma-Soto, Jasper Anckaert, Francisco Avila Cobos, Justine Nuytens, Hanne Van Droogenbroeck, Kimberly Verniers, Marieke Vromman, Sarah M. Briké, Nico Callewaert, David Cassiman, Dirk De Bacquer, Eveline Dirinck, Sven Francque, Wilhelmus J. Kwanten, Leander Meuris, Lotte Schoenmakers, Hans Van Vlierberghe, Xavier Verhelst, An Verrijken, Luisa Vonghia, Jo Vandesompele, Anneleen Decock. Plasma cell‐free transcriptome profiling in blood plasma from chronic liver disease patients. Scientific Data 2026; 13(1) doi: 10.1038/s41597-026-07470-2
|
| 243 |
Hirotaka Shoji, Sachiyo Yoshio, Yohei Mano, Erina Kumagai, Masaya Sugiyama, Masaaki Korenaga, Taeang Arai, Norio Itokawa, Masanori Atsukawa, Hiroshi Aikata, Hideyuki Hyogo, Kazuaki Chayama, Tomohiko Ohashi, Kiyoaki Ito, Masashi Yoneda, Yuichi Nozaki, Takumi Kawaguchi, Takuji Torimura, Masanori Abe, Yoichi Hiasa, Moto Fukai, Toshiya Kamiyama, Akinobu Taketomi, Masashi Mizokami, Tatsuya Kanto. Interleukin-34 as a fibroblast-derived marker of liver fibrosis in patients with non-alcoholic fatty liver disease. Scientific Reports 2016; 6(1) doi: 10.1038/srep28814
|
| 244 |
Redha Ali, Hailong Li, Scott B. Reeder, David Harris, William Masch, Anum Aslam, Krishna P. Shanbhogue, Nehal A. Parikh, Lili He, Jonathan R. Dillman. Development and validation of a deep learning model for liver shear stiffness regression using abdominal multiparametric MRI across multiple sites and vendors. European Radiology 2026; 36(8) doi: 10.1007/s00330-026-12448-0
|
| 245 |
Waqas B. Khalid, Xucai Chen, Kang Kim. Multifocus Thermal Strain Imaging Using a Curved Linear Array Transducer for Identification of Lipids in Deep Tissue. Ultrasound in Medicine & Biology 2021; 47(7) doi: 10.1016/j.ultrasmedbio.2021.03.005
|
| 246 |
Xiao-Lin Liu, Qin Pan, Rui-Nan Zhang, Feng Shen, Shi-Yan Yan, Chao Sun, Zheng-Jie Xu, Yuan-Wen Chen, Jian-Gao Fan. Disease-specific miR-34a as diagnostic marker of non-alcoholic steatohepatitis in a Chinese population. World Journal of Gastroenterology 2016; 22(44): 9844-9852 doi: 10.3748/wjg.v22.i44.9844
|
| 247 |
Norio Akuta, Yusuke Kawamura, Mariko Kobayashi, Yasuji Arase, Satoshi Saitoh, Shunichiro Fujiyama, Hitomi Sezaki, Tetsuya Hosaka, Masahiro Kobayashi, Yoshiyuki Suzuki, Fumitaka Suzuki, Kenji Ikeda, Hiromitsu Kumada. TERT Promoter Mutation in Serum Cell-Free DNA Is a Diagnostic Marker of Primary Hepatocellular Carcinoma in Patients with Nonalcoholic Fatty Liver Disease. Oncology 2021; 99(2) doi: 10.1159/000510366
|
| 248 |
Hilmar K Lückhoff, Frederik C Kruger, Maritha J Kotze. Composite prognostic models across the non-alcoholic fatty liver disease spectrum: Clinical application in developing countries. World Journal of Hepatology 2015; 7(9): 1192-1208 doi: 10.4254/wjh.v7.i9.1192
|
| 249 |
Shivani R Kale, Geeta Karande, Anand Gudur, Aishwarya Garud, Monika S Patil, Satish Patil. Recent Trends in Liver Cancer: Epidemiology, Risk Factors, and Diagnostic Techniques. Cureus 2024; doi: 10.7759/cureus.72239
|
| 250 |
Phuc Le, Moosa Tatar, Srinivasan Dasarathy, Naim Alkhouri, William H. Herman, Glen B. Taksler, Abhishek Deshpande, Wen Ye, Olajide A. Adekunle, Arthur McCullough, Michael B. Rothberg. Estimated Burden of Metabolic Dysfunction–Associated Steatotic Liver Disease in US Adults, 2020 to 2050. JAMA Network Open 2025; 8(1) doi: 10.1001/jamanetworkopen.2024.54707
|
| 251 |
Tengrui Cao, Qian Zhu, Chao Tong, Aheyeerke Halengbieke, Xuetong Ni, Jianmin Tang, Yumei Han, Qiang Li, Xinghua Yang. Establishment of a machine learning predictive model for non-alcoholic fatty liver disease: A longitudinal cohort study. Nutrition, Metabolism and Cardiovascular Diseases 2024; 34(6) doi: 10.1016/j.numecd.2024.02.004
|
| 252 |
Navneet Kaur, Gitanjali Goyal, Ravinder Garg, Chaitanya Tapasvi, Sonia Chawla, Rajneet Kaur. Potential role of noninvasive biomarkers during liver fibrosis. World Journal of Hepatology 2021; 13(12): 1919-1935 doi: 10.4254/wjh.v13.i12.1919
|
| 253 |
Lauren A. Newman, Kate Muller, Andrew Rowland. Circulating cell-specific extracellular vesicles as biomarkers for the diagnosis and monitoring of chronic liver diseases. Cellular and Molecular Life Sciences 2022; 79(5) doi: 10.1007/s00018-022-04256-8
|
| 254 |
Martin Tibuakuu, Caroline Jjingo, Gregory Dale Kirk, David Lee Thomas, Ronald Gray, Victor Ssempijja, Fred Nalugoda, David Serwadda, Ponsiano Ocama, Christopher Kenneth Opio, David Erwin Kleiner, Thomas Charles Quinn, Steven James Reynolds. Elevated liver stiffness without histological evidence of liver fibrosis in rural Ugandans. Journal of Viral Hepatitis 2020; 27(10) doi: 10.1111/jvh.13320
|
| 255 |
Nurullah Dag, Gulnur Igci, Fatma Hilal Yagin, Muhammed Salih Hanci, Ramazan Kutlu. Interobserver Reproducibility of Ultrasound Attenuation Imaging Technology in Liver Fat Quantification. Journal of Clinical Ultrasound 2025; 53(3) doi: 10.1002/jcu.23877
|
| 256 |
Norio Akuta, Yusuke Kawamura, Yasuji Arase, Fumitaka Suzuki, Hitomi Sezaki, Tetsuya Hosaka, Masahiro Kobayashi, Mariko Kobayashi, Satoshi Saitoh, Yoshiyuki Suzuki, Kenji Ikeda, Hiromitsu Kumada. Relationships between Genetic Variations of PNPLA3, TM6SF2 and Histological Features of Nonalcoholic Fatty Liver Disease in Japan. Gut and Liver 2016; 10(3) doi: 10.5009/gnl15163
|
| 257 |
Bandana Kumari, Sadhana Sharma, Ramesh Kumar, Satish Dipankar, Bijaya N Naik, Ayan Banerjee, Sushil Kumar. Efficacy of Lipid Ratios and Platelet Distribution Width for Assessment of Liver Fibrosis in Patients With Non-alcoholic Fatty Liver Disease. Cureus 2022; doi: 10.7759/cureus.21110
|
| 258 |
A.C. Igual Rouilleault, S. Jiménez, J. Moreno, E. Belmonte, J.R. Ayuso, Á. García-Criado. Hallazgos por imagen de las enfermedades hepáticas por depósito. Radiología 2026; 68(4) doi: 10.1016/j.rx.2025.02.005
|
| 259 |
Huseyin Ali Ozturk, Hilmi Erdem Sumbul. Liver stiffness and serum galectin 3 level significantly increases in patients with prediabetes: a fibroscan study. PeerJ 2025; 13 doi: 10.7717/peerj.19377
|
| 260 |
Qiuting Cao, Cheng Yan, Xinjun Han, Yu Wang, Liqin Zhao. Quantitative Evaluation of Nonalcoholic Fatty Liver in Rat by Material Decomposition Techniques using Rapid-switching Dual Energy CT. Academic Radiology 2022; 29(6) doi: 10.1016/j.acra.2021.07.027
|
| 261 |
Florian Huwyler, Jonas Binz, Leslie Cunningham, Matthias Pfister, Martin J. Schuler, Mark W. Tibbitt, Pierre-Alain Clavien. Beyond preservation: future machine perfusion for liver assessment and repair. Nature Reviews Gastroenterology & Hepatology 2025; 22(10) doi: 10.1038/s41575-025-01111-6
|
| 262 |
Anil Chauhan, Laith R. Sultan, Emma E. Furth, Lisa P. Jones, Vandana Khungar, Chandra M. Sehgal. Diagnostic accuracy of hepatorenal index in the detection and grading of hepatic steatosis. Journal of Clinical Ultrasound 2016; 44(9) doi: 10.1002/jcu.22382
|
| 263 |
Zhijie Li, Qianhua Li, Yijia Liu, Yao Chen, Jinzheng Zhang, Haiyan Zhang, Guoqiang Feng. In Situ Imaging of Extracellular Vesicles and Non-Alcoholic Fatty Liver Disease with a Near-Infrared Fluorescent Viscosity Probe. Analytical Chemistry 2025; 97(35) doi: 10.1021/acs.analchem.5c02797
|
| 264 |
Michael Tseng, Taseen Syed, Mohammad Siddiqui. Hepatology. 2025; doi: 10.1016/B978-0-443-26710-9.00004-3
|
| 265 |
. 2023; doi: 10.70675/84d3e300z4ca6z4b7fzacabz407c52ca0697
|
| 266 |
Eun‐Hee Nah, Seon Cho, Suyoung Kim, Hye‐Sun Kim, Han‐Ik Cho. Diagnostic performance of Mac‐2 binding protein glycosylation isomer (M2BPGi) in screening liver fibrosis in health checkups. Journal of Clinical Laboratory Analysis 2020; 34(8) doi: 10.1002/jcla.23316
|
| 267 |
Vidyani Suryadevara, Shaiju S. Nazeer, Hari Sreedhar, Oluwatobi Adelaja, André Kajdacsy-Balla, Viswanathan Natarajan, Michael J. Walsh. Infrared spectral microscopy as a tool to monitor lung fibrosis development in a model system. Biomedical Optics Express 2020; 11(7) doi: 10.1364/BOE.394730
|
| 268 |
Paulina Vidal-Cevallos, Norberto Chávez-Tapia, Emmanuel Tsochatzis. Metabolic Dysfunction-Associated Steatotic Liver Disease. 2024; doi: 10.1007/978-981-97-9519-2_5
|
| 269 |
Qian Li, Manish Dhyani, Joseph R Grajo, Claude Sirlin, Anthony E Samir. Current status of imaging in nonalcoholic fatty liver disease. World Journal of Hepatology 2018; 10(8): 530-542 doi: 10.4254/wjh.v10.i8.530
|
| 270 |
Jenny Lee, Yasaman Vali, Jerome Boursier, Rene Spijker, Quentin M. Anstee, Patrick M. Bossuyt, Mohammad H. Zafarmand. Prognostic accuracy of FIB‐4, NAFLD fibrosis score and APRI for NAFLD‐related events: A systematic review. Liver International 2021; 41(2) doi: 10.1111/liv.14669
|
| 271 |
Yukiko Kobayashi, Hina Tatsumi, Mikako Hattori, Hiroki Sugiyama, Sayori Wada, Masashi Kuwahata, Saiyu Tanaka, Kazuyuki Kanemasa, Yoshio Sumida, Yuji Naito, Michiaki Fukui, Yasuhiro Kido. Comparisons of dietary intake in Japanese with non-alcoholic fatty liver disease and type 2 diabetes mellitus. Journal of Clinical Biochemistry and Nutrition 2016; 59(3) doi: 10.3164/jcbn.16-7
|
| 272 |
Wenyi Jin, Yilun Xu, Weiwei Zhu, Ziqiang Xia, Jinming Wu. Development and validation of a noninvasive clinical scoring system to predict significant fibrosis in patients with nonalcoholic fatty liver disease. Clinica Chimica Acta 2021; 514 doi: 10.1016/j.cca.2020.12.012
|
| 273 |
Karrie V. Ly, Tess Armstrong, Joanna Yeh, Shahnaz Ghahremani, Grace H. Kim, Holden H. Wu, Kara L. Calkins. Free‐breathing Magnetic Resonance Imaging Assessment of Body Composition in Healthy and Overweight Children. Journal of Pediatric Gastroenterology and Nutrition 2019; 68(6) doi: 10.1097/MPG.0000000000002309
|
| 274 |
Sonia Samuel, Ahmad Abulawi, Raza Malik. Hepatitis C and Nonalcoholic Steatohepatitis in the 21st Century: Impact on Liver Disease and Liver Transplantation. Gastroenterology Insights 2023; 14(3) doi: 10.3390/gastroent14030018
|
| 275 |
Maria AL de Carli, Luiz A. de Carli, Marcos B. Correa, Gerson Junqueira, Cristiane Valle Tovo, Gabriela P. Coral. Performance of noninvasive scores for the diagnosis of advanced liver fibrosis in morbidly obese with nonalcoholic fatty liver disease. European Journal of Gastroenterology & Hepatology 2020; 32(3) doi: 10.1097/MEG.0000000000001519
|
| 276 |
Szu‐Jen Wang, Yung‐Ho Wang, Jee‐Fu Huang, En‐Sheng Lin, Wei‐Shiun Chen, Chia‐Yang Li, Chia‐Yen Dai, Wan‐Long Chuang, Ming‐Lung Yu, Shu‐Chi Wang. The Proteomic Profiling of Circulating Extracellular Vesicles of Western Diet and Chemical‐Induced Murine MASH Model. The Kaohsiung Journal of Medical Sciences 2026; 42(2) doi: 10.1002/kjm2.70107
|
| 277 |
Aukelien C. Dimitriu-Leen, Arthur J.H.A. Scholte. Hepatic FDG uptake in patients with NAFLD: An important prognostic factor for cardio-cerebrovascular events?. Journal of Nuclear Cardiology 2017; 24(3) doi: 10.1007/s12350-015-0380-4
|
| 278 |
Tess Armstrong, Karrie V. Ly, Shahnaz Ghahremani, Kara L. Calkins, Holden H. Wu. Free-breathing 3-D quantification of infant body composition and hepatic fat using a stack-of-radial magnetic resonance imaging technique. Pediatric Radiology 2019; 49(7) doi: 10.1007/s00247-019-04384-7
|
| 279 |
David J. M. Bauer, Annalisa De SilvestriI, Ruxandra Mare, Laura Maiocchi, Ambra Raimondi, Georg Semmler, Mattias Mandorfer, Ioan Sporea, Giovanna Ferraioli, Thomas Reiberger. Two-dimensional shear wave elastography (ElastQ) accurately rules out liver fibrosis and rules in advanced chronic liver disease across liver disease etiologies: a prospective multicenter study. Ultrasonography 2023; 42(4) doi: 10.14366/usg.23069
|
| 280 |
Emilie Toft Skovgaard, Thomas Wiggers, Morten Karsdal, Jens Peter Goetze, Diana Julie Leeming, Keyur Patel. Serum Markers of Fibroinflammatory Activity PRO-C3 and CPa9-HNE Are Associated with Liver-Related Outcomes in Patients with Chronic Hepatitis C. The Journal of Infectious Diseases 2026; 233(5) doi: 10.1093/infdis/jiaf552
|
| 281 |
Maha Hasab Allah, Rabab Maamoun Salama, Mohamad Saeed Marie, Ahmed Alsaeed Mandur, Heba Omar. Utility of point shear wave elastography in characterisation of focal liver lesions. Expert Review of Gastroenterology & Hepatology 2018; 12(2) doi: 10.1080/17474124.2018.1415144
|
| 282 |
Quantitative Magnetic Resonance Imaging. Advances in Magnetic Resonance Technology and Applications 2020; 1 doi: 10.1016/B978-0-12-817057-1.00029-9
|
| 283 |
Lynna Alnimer, Mazen Noureddin. Non-invasive imaging biomarkers for liver steatosis in non-alcoholic fatty liver disease: present and future. Clinical and Molecular Hepatology 2023; 29(2) doi: 10.3350/cmh.2023.0104
|
| 284 |
Gasim Ibrahim Gasim, Fahd Mohamed Elshehri, Mahmoud Mahmoud Kheidr, Fahad Khalid Alshubaily, ElZaki Mohamed ElZaki, Imad R. Musa. The Use of Computed Tomography in the Diagnosis of Fatty Liver and Abdominal Fat Distribution among a Saudi Population. Open Access Macedonian Journal of Medical Sciences 2017; 5(6) doi: 10.3889/oamjms.2017.187
|
| 285 |
Mahinur Cerit, Halit Nahit Şendur, Emetullah Cindil, Gonca Erbaş, Mehmet Muhittin Yalçın, Ethem Turgay Cerit, Seriyye Allahverdiyeva, Suna Özhan Oktar, Cem Yücel. Quantification of liver fat content with ultrasonographic attenuation measurement function: Correlation with unenhanced multidimensional computerized tomography. Clinical Imaging 2020; 65 doi: 10.1016/j.clinimag.2020.04.028
|
| 286 |
Kun Wang, Jingwen Bao, Minghui Wang, Yanjie Yu, Min Wang. Prospective comparative diagnostic performance of quantitative ultrasound parameters for the measurement of hepatic steatosis in a biopsy-proven metabolic dysfunction associated steatotic liver disease cohort. British Journal of Radiology 2025; 98(1165) doi: 10.1093/bjr/tqae212
|
| 287 |
Mehnoosh Torkzaban, Corinne E. Wessner, Dina Halegoua-DeMarzio, Shuchi K. Rodgers, Andrej Lyshchik, Kibo Nam. Diagnostic Performance Comparison Between Ultrasound Attenuation Measurements From Right and Left Hepatic Lobes for Steatosis Detection in Non-alcoholic Fatty Liver Disease. Academic Radiology 2023; 30(9) doi: 10.1016/j.acra.2022.12.025
|
| 288 |
Jinmei Yao, Ying Zhao, Juanwen Zhang, Yani Hong, Huanle Lu, Jianping Wu. Serum amylase levels are decreased in Chinese non-alcoholic fatty liver disease patients. Lipids in Health and Disease 2014; 13(1) doi: 10.1186/1476-511X-13-185
|
| 289 |
Yoshio Sumida, Toshihide Shima, Yasuhide Mitsumoto, Takafumi Katayama, Atsushi Umemura, Kanji Yamaguchi, Yoshito Itoh, Masashi Yoneda, Takeshi Okanoue. Epidemiology, Pathogenesis, and Diagnostic Strategy of Diabetic Liver Disease in Japan. International Journal of Molecular Sciences 2020; 21(12) doi: 10.3390/ijms21124337
|
| 290 |
Agostino Palladino, Matthew Gee, Victoria Shalhoub, David Kiaei. Analytical performance of the Enhanced Liver Fibrosis (ELF) Test on the Atellica IM Analyzer. Clinica Chimica Acta 2023; 548 doi: 10.1016/j.cca.2023.117461
|
| 291 |
Linh Nhat Boi Nguyen, Thong Duy Vo. Comparison of Triglyceride-Glucose Index Indices and Fatty Liver Index in Predicting Metabolic Dysfunction-Associated Fatty Liver Disease: A Cross-Sectional Study Conducted in Vietnam. Life 2025; 15(11) doi: 10.3390/life15111702
|
| 292 |
Wonbeak Yoo, Donjeta Gjuka, Heather L. Stevenson, Xiaoling Song, Hong Shen, Suk Young Yoo, Jing Wang, Michael Fallon, George N. Ioannou, Stephen A. Harrison, Laura Beretta, Silvia C. Sookoian. Fatty acids in non-alcoholic steatohepatitis: Focus on pentadecanoic acid. PLOS ONE 2017; 12(12) doi: 10.1371/journal.pone.0189965
|
| 293 |
Jong Man Kim, Sang Yun Ha, Jae-Won Joh, Dong Hyun Sinn, Woo Kyung Jeong, Gyu-Seong Choi, Geum Youn Gwak, Choon Hyuck David Kwon, Young Kon Kim, Yong Han Paik, Joon Hyeok Lee, Won Jae Lee, Suk-Koo Lee, Cheol Keun Park. Predicting Hepatic Steatosis in Living Liver Donors via Noninvasive Methods. Medicine 2016; 95(7) doi: 10.1097/MD.0000000000002718
|
| 294 |
Nadia Al Mazrouei, Mostafa Mohsen ElGharbawy, Mahitab Gamal, Shaimaa Emad, Amal Ahmed Mohamed, Osama Mohamed Ibrahim, Asim Ahmed Elnour, Marafi Jammaa Ahmed, Semira Abdi Beshir, Vineetha Menon, Sami Fatehi Abdalla, Ali Awadallah Saeed, Heba Ali ElRamly, Anna Di Sessa. Evaluating liver type fatty acid binding protein as a diagnostic and prognostic biomarker in metabolic dysfunction-associated steatotic liver disease in pediatric patients. PLOS One 2025; 20(9) doi: 10.1371/journal.pone.0333581
|
| 295 |
S. K. Ternovoy, G. A. Shiryaev, D. V. Ustyuzhanin, D. T. Abdurakhmanov. EVALUATION OF LIPID CONTENT IN PATIENTS WITH LIVER STEATOSIS AND STEATOHEPATITIS USING PROTON MR-SPECTROSCOPY. Medical Visualization 2018; (4) doi: 10.24835/1607-0763-2018-4-50-58
|
| 296 |
Matthias Buechter, Guido Gerken. Liver Function—How to Screen and to Diagnose: Insights from Personal Experiences, Controlled Clinical Studies and Future Perspectives. Journal of Personalized Medicine 2022; 12(10) doi: 10.3390/jpm12101657
|
| 297 |
Wei Yoon Poh, Amirah Azzeri, Shamsul Mohd Zain, Rosmawati Mohamed, Kim Sui Wan, Xe Hui Lee, Maznah Dahlui, Fatiha Hana Shabaruddin, Seth Agyei Domfeh. Cost-effectiveness of various referral pathways to identify advanced fibrosis among type 2 diabetes mellitus patients with metabolic dysfunction-associated steatotic liver disease in primary care setting in Malaysia. PLOS One 2026; 21(5) doi: 10.1371/journal.pone.0350263
|
| 298 |
Manar N. Amin, Muhammad A. Rushdi, Raghda N. Marzaban, Ayman Yosry, Kang Kim, Ahmed M. Mahmoud. Wavelet-based computationally-efficient computer-aided characterization of liver steatosis using conventional B-mode ultrasound images. Biomedical Signal Processing and Control 2019; 52 doi: 10.1016/j.bspc.2019.03.010
|
| 299 |
Megumi Shiomi, Yoichi Tanaka, Tesshu Takada, Katsuya Otori. Determining whether the effect of liraglutide on non‐alcoholic fatty liver disease depends on reductions in the body mass index. JGH Open 2020; 4(5) doi: 10.1002/jgh3.12384
|
| 300 |
Iris Y. Zhou, Veronica Clavijo Jordan, Nicholas J. Rotile, Eman Akam, Smitha Krishnan, Gunisha Arora, Hema Krishnan, Hannah Slattery, Noah Warner, Nathaniel Mercaldo, Christian T. Farrar, Jeremy Wellen, Robert Martinez, Franklin Schlerman, Kenneth K. Tanabe, Bryan C. Fuchs, Peter Caravan. Advanced MRI of Liver Fibrosis and Treatment Response in a Rat Model of Nonalcoholic Steatohepatitis. Radiology 2020; 296(1) doi: 10.1148/radiol.2020192118
|
| 301 |
Irina Cardoso-Lezama, Erika Ramos-Tovar, Jaime Arellanes-Robledo, Eduardo E. Vargas-Pozada, Verónica Rocío Vásquez-Garzón, Saúl Villa-Treviño, Pablo Muriel. Serum α-SMA is a potential noninvasive biomarker of liver fibrosis. Toxicology Mechanisms and Methods 2024; 34(1) doi: 10.1080/15376516.2023.2244061
|
| 302 |
Mohammadjavad Sotoudeheian. Agile 3+ and Metabolic Dysfunction-Associated Fatty Liver Disease:
Detecting Advanced Fibrosis based on Reported Liver Stiffness
Measurement in FibroScan and Laboratory Findings. The International Journal of Gastroenterology and Hepatology Diseases 2024; 3 doi: 10.2174/0126662906302851240604042954
|
| 303 |
Audrey Kovatsch, Hanna Honcharova‐Biletska, Daniel Segna, Klaus Steigmiller, Sena Blümel, Rudolf A. Deibel, Tobias Kühlewindt, Georg Leinenkugel, Sandra Müller, Eva Furrer, Khoschy Schawkat, Cäcilia S. Reiner, Achim Weber, Beat Müllhaupt, Michael Scharl, Christoph Gubler, Christoph Jüngst. Performance of two‐dimensional shear wave elastography and transient elastography compared to liver biopsy for staging of liver fibrosis. European Journal of Clinical Investigation 2023; 53(7) doi: 10.1111/eci.13980
|
| 304 |
Yoshio Sumida. The Association of Low Free Testosterone with Histological Severity of Nonalcoholic Fatty Liver Disease in Japanese Men. Gastroenterology & Hepatology: Open Access 2015; 2(4) doi: 10.15406/ghoa.2015.02.00052
|
| 305 |
Honglei Wang, Yeqing Gu, Lixiao Zheng, Li Liu, Ge Meng, Hongmei Wu, Yang Xia, Xue Bao, Hongbin Shi, Shaomei Sun, Xing Wang, Ming Zhou, Qiyu Jia, Kun Song, Qing Zhang, Kaijun Niu. Association between bedtime and the prevalence of newly diagnosed non‐alcoholic fatty liver disease in adults. Liver International 2018; 38(12) doi: 10.1111/liv.13896
|
| 306 |
Thaer S. A. Abdalla, Anastasios D. Giannou, Ahmed S. A. Abdalla, Jakob R. Izbicki, Anna Dupreé, Oliver Mann, Stefan Wolter. The Effect of Non‐Alcoholic Fatty Liver Disease on Weight Loss and Resolution of Obesity‐Related Disorders After Bariatric Surgery. World Journal of Surgery 2023; 47(12) doi: 10.1007/s00268-023-07153-8
|
| 307 |
Po-Hsiang Tsui, Yung-Liang Wan. Effects of Fatty Infiltration of the Liver on the Shannon Entropy of Ultrasound Backscattered Signals. Entropy 2016; 18(9) doi: 10.3390/e18090341
|
| 308 |
Yuzhan Huang, Fei Ji, Xingyue Wei, Hengrong Lan, Qiong He, Wei Lyu, Meng Yang, Jianwen Luo. Non-invasive HIV Viral Load Prediction Based on Liver Quantitative Ultrasound. 2024 IEEE Ultrasonics, Ferroelectrics, and Frequency Control Joint Symposium (UFFC-JS) 2024; doi: 10.1109/UFFC-JS60046.2024.10793907
|
| 309 |
Kazuyoshi Ohkawa, Tasuku Nakabori, Kaori Mukai, Kazuhiro Kozumi, Makiko Urabe, Yugo Kai, Ryoji Takada, Kenji Ikezawa, Yuko Yamaguchi, Takuya Nagao, Hatsune Enomoto, Hidehisa Tachiki, Ayako Higuchi, Noriyuki Watanabe, Takahiro Nakayama, Sanaz Alaeejahromi. Clinical validation of the suppressive impact of letrozole on liver fibrosis in patients with breast cancer undergoing continuous letrozole administration: A retrospective study. PLOS ONE 2024; 19(10) doi: 10.1371/journal.pone.0311930
|
| 310 |
Norio Akuta, Yusuke Kawamura, Chizuru Watanabe, Akihiro Nishimura, Minoru Okubo, Yasumichi Mori, Shunichiro Fujiyama, Hitomi Sezaki, Tetsuya Hosaka, Masahiro Kobayashi, Mariko Kobayashi, Satoshi Saitoh, Fumitaka Suzuki, Yoshiyuki Suzuki, Yasuji Arase, Kenji Ikeda, Hiromitsu Kumada. Impact of sodium glucose cotransporter 2 inhibitor on histological features and glucose metabolism of non‐alcoholic fatty liver disease complicated by diabetes mellitus. Hepatology Research 2019; 49(5) doi: 10.1111/hepr.13304
|
| 311 |
Kazuki Tahara, Takemi Akahane, Tadashi Namisaki, Kei Moriya, Hideto Kawaratani, Kosuke Kaji, Hiroaki Takaya, Yasuhiko Sawada, Naotaka Shimozato, Shinya Sato, Soichiro Saikawa, Keisuke Nakanishi, Takuya Kubo, Yukihisa Fujinaga, Masanori Furukawa, Koh Kitagawa, Takahiro Ozutsumi, Yuuki Tsuji, Daisuke Kaya, Hiroyuki Ogawa, Hirotetsu Takagi, Koji Ishida, Akira Mitoro, Hitoshi Yoshiji. Thyroid‐stimulating hormone is an independent risk factor of non‐alcoholic fatty liver disease. JGH Open 2020; 4(3) doi: 10.1002/jgh3.12264
|
| 312 |
Aleksandra Leszczynska, Benedikt Kaufmann, Hana Sung, Christian Stoess, Agustina Reca, Andrea Kim, Yeon-Kyung Choi, Chelsea Tran, Sung-Eun Kim, Davide Povero, Bruce Wolfe, Trevor Crafts, Akiko Eguchi, Ariel E. Feldstein. Profiling of extracellular vesicles from primary hepatocytes, organoids, and mash patients identifies cell injury-specific signatures. Scientific Reports 2026; 16(1) doi: 10.1038/s41598-026-40490-x
|
| 313 |
Ahmed A. Hassan, Mohiee E.-D.A. El-Aziz Awad, Hanan H. Soliman, Reda A.F. Usef, Dina S. Ata. Serum ferritin level as a noninvasive marker for detection and staging of hepatocellular injury, liver fibrosis, and steatosis in children and adolescents with nonalcoholic fatty liver disease. Alexandria Journal of Pediatrics 2021; 34(3) doi: 10.4103/1687-9945.337837
|
| 314 |
TSUYOSHI MASHITANI, RYUICHI NOGUCHI, YASUSHI OKURA, TADASHI NAMISAKI, AKIRA MITORO, HITOSHI ISHII, TOSHIYA NAKATANI, EIRYO KIKUCHI, HIROTO MORIYASU, MASAMI MATSUMOTO, SHINYA SATO, TATSUICHI AN, HIROSHI MORITA, SIGEYUKI AIZAWA, YASUNORI TOKUOKA, MASATOSHI ISHIKAWA, YOSHINOBU MATSUMURA, HIROMASA OHIRA, ATSUKO KOGURE, KAZUHIRO NOGUCHI, HITOSHI YOSHIJI. Efficacy of alogliptin in preventing non-alcoholic fatty liver disease progression in patients with type 2 diabetes. Biomedical Reports 2016; 4(2) doi: 10.3892/br.2016.569
|
| 315 |
Hiroshi Ishiba, Yoshio Sumida, Seita Kataoka, Masaaki Kuroda, Satoshi Akabame, Kiichiro Tomiyasu, Muhei Tanaka, Masahiro Arai, Hiroyoshi Taketani, Yuya Seko, Akira Okajima, Tasuku Hara, Atsushi Umemura, Taichiro Nishikawa, Kanji Yamaguchi, Michihisa Moriguchi, Hironori Mitsuyoshi, Kohichiroh Yasui, Yoshito Itoh. Association of coronary artery calcification with liver fibrosis in Japanese patients with non‐alcoholic fatty liver disease. Hepatology Research 2016; 46(11) doi: 10.1111/hepr.12665
|
| 316 |
Sven M. Francque, Ann Driessen. Metabolic Dysfunction-Associated Steatotic Liver Disease. 2024; doi: 10.1007/978-981-97-9519-2_6
|
| 317 |
Inhwan Lee, Jinkyung Cho, Jinkook Park, Hyunsik Kang. Association of hand-grip strength and non-alcoholic fatty liver disease index in older adults. Journal of Exercise Nutrition & Biochemistry 2018; 22(4) doi: 10.20463/jenb.2018.0031
|
| 318 |
Basil N Nduma, Yazan A Al-Ajlouni, Basile Njei. The Application of Artificial Intelligence (AI)-Based Ultrasound for the Diagnosis of Fatty Liver Disease: A Systematic Review. Cureus 2023; doi: 10.7759/cureus.50601
|
| 319 |
Bien Van Tran, Kouichi Ujita, Ayako Taketomi-Takahashi, Hiromi Hirasawa, Takayuki Suto, Yoshito Tsushima, Xi Chen. Reliability of ultrasound hepatorenal index and magnetic resonance imaging proton density fat fraction techniques in the diagnosis of hepatic steatosis, with magnetic resonance spectroscopy as the reference standard. PLOS ONE 2021; 16(8) doi: 10.1371/journal.pone.0255768
|
| 320 |
Ryo Katsumata, Miwa Kawanaka, Katsunori Ishii, Tomohiro Tanikawa, Noriyo Urata, Ken Nishino, Mitsuhiko Suehiro, Hirofumi Kawamoto. Characteristics of advanced liver fibrosis among patients with lower FIB-4 index or NAFLD fibrosis score. Kanzo 2022; 63(7) doi: 10.2957/kanzo.63.342
|
| 321 |
Xue Bai, Gaoxing Su, Shumei Zhai. Recent Advances in Nanomedicine for the Diagnosis and Therapy of Liver Fibrosis. Nanomaterials 2020; 10(10) doi: 10.3390/nano10101945
|
| 322 |
Qing-Yuan Li, Tao Gong, Yi-Ke Huang, Lan Kang, Charlotte A Warner, He Xie, Li-Min Chen, Xiao-Qiong Duan. Role of noncoding RNAs in liver fibrosis. World Journal of Gastroenterology 2023; 29(9): 1446-1459 doi: 10.3748/wjg.v29.i9.1446
|
| 323 |
Jinfeng Xiao, Xinxin Zhang, Chonggui Zhu, Yian Gu, Longhao Sun, Xiaoyu Liang, Qing He. Development, Validation, and Application of a Scoring Model for Non-alcoholic Steatohepatitis. Obesity Surgery 2023; 33(10) doi: 10.1007/s11695-023-06804-y
|
| 324 |
Reshu Khandelwal, Anuradha S Dassanayake, Hari S Conjeevaram, Shivaram P Singh. Non-alcoholic fatty liver disease in diabetes: When to refer to the hepatologist?. World Journal of Diabetes 2021; 12(9): 1479-1493 doi: 10.4239/wjd.v12.i9.1479
|
| 325 |
Mid-Eum Moon, Dong Hyuk Jung, Seok-Jae Heo, Byoungjin Park, Yong Jae Lee. Oxidative Balance Score and New-Onset Type 2 Diabetes Mellitus in Korean Adults without Non-Alcoholic Fatty Liver Disease: Korean Genome and Epidemiology Study-Health Examinees (KoGES-HEXA) Cohort. Antioxidants 2024; 13(1) doi: 10.3390/antiox13010107
|
| 326 |
Halit Nahit Şendur, Doğa Özdemir Kalkan, Mahi Nur Cerit, Gökalp Kalkan, Aylin Billur Şendur, Suna Özhan Oktar. Hepatic Fat Quantification With Novel Ultrasound Based Techniques: A Diagnostic Performance Study Using Magnetic Resonance Imaging Proton Density Fat Fraction as Reference Standard. Canadian Association of Radiologists Journal 2023; 74(2) doi: 10.1177/08465371221123696
|
| 327 |
Hikmat Pramukti, Evy Yunihastuti, Rino A Gani, Ikhwan Rinaldi, Irsan Hasan, Suzy Maria. Non-alcoholic fatty liver disease among people living with HIV on long-term antiretroviral therapy in Indonesia: Prevalence and related factors. SAGE Open Medicine 2024; 12 doi: 10.1177/20503121241292678
|
| 328 |
Takashi Ohtani, Masato Shimada, Kouki Takahashi, Sayuri Hakoda, Yukihiro Tomita, Kiyotaka Takeuchi, Satomi Kanai, Tasuku Wakabayashi, Ayaki Kitano, Kenji Takata, Toshiki Tateishi, Tetsuya Tsujikawa. Segmental fECV measurement using PCD-CT as an early predictor of liver function decline in chronic liver disease. Abdominal Radiology 2025; 51(6) doi: 10.1007/s00261-025-05307-x
|
| 329 |
Ijin Joo, Jae Young Lee, Dong Ho Lee, Ju Hyeon Jeon, Hyeyoung Kim, Nam-Joon Yi, Kwang-Woong Lee, Kyung-Suk Suh. Contrast-Enhanced Ultrasound Using Perfluorobutane-Containing Microbubbles in the Assessment of Liver Allograft Damage: An Exploratory Prospective Study. Ultrasound in Medicine & Biology 2017; 43(3) doi: 10.1016/j.ultrasmedbio.2016.11.012
|
| 330 |
Wataru Tomeno, Kento Imajo, Yukiko Kuwada, Yuji Ogawa, Minako Kikuchi, Yasushi Honda, Takayuki Kato, Takaomi Kessoku, Hiroyuki Kirikoshi, Masato Yoneda, Tetsuji Kitahora, Satoru Saito, Yukihiko Ozawa, Atsushi Nakajima. Distribution of liver stiffness in non‐alcoholic fatty liver disease with higher fibrosis‐4 index than low cut‐off index. Journal of Gastroenterology and Hepatology 2019; 34(8) doi: 10.1111/jgh.14559
|
| 331 |
Rodrigo Bremer Nones, Cláudia Pontes Ivantes, Maria Lucia Alves Pedroso. Can FIB4 and NAFLD fibrosis scores help endocrinologists refer patients with non-alcoholic fat liver disease to a hepatologist?. Archives of Endocrinology and Metabolism 2017; 61(3) doi: 10.1590/2359-3997000000233
|
| 332 |
Indian National Association for Study of the Liver (INASL) Guidance Paper on Nomenclature, Diagnosis and Treatment of Nonalcoholic Fatty Liver Disease (NAFLD). Journal of Clinical and Experimental Hepatology 2023; 13(2) doi: 10.1016/j.jceh.2022.11.014
|
| 333 |
Kun Wang, Qun Liu, Jing Wang, Minghui Wang, Jinqiao Zhang, Yanjie Yu, Ling Liu, Hairong Liu. Noninvasive Assessment of Hepatic Steatosis in Metabolic Dysfunction‐Associated Steatotic Liver Disease Patients by Using Ultrasound Attenuation Imaging. Journal of Ultrasound in Medicine 2026; 45(6) doi: 10.1002/jum.70156
|
| 334 |
Èlia Navarro-Masip, Núria Mestres, Marta Zorzano-Martínez, Blanca Salinas-Roca, Enric Sánchez, Carolina López-Cano, Fernando Herrerías, Mari Cruz de la Fuente, Maite Santamaría, Josep León-Mengíbar, Ana-Gloria Soler, Marta Bueno, Albert Lecube. Mid-term Effects of Bariatric Surgery on Metabolic Dysfunction-Associated Fatty Liver Disease Remission and Predictive Factors: A Prospective Study with a Focus on Non-invasive Diagnosis. Obesity Surgery 2024; 34(3) doi: 10.1007/s11695-024-07071-1
|
| 335 |
Quentin M Anstee, Kate Hallsworth, Niall Lynch, Adrien Hauvespre, Eid Mansour, Sam Kozma, Juliana Bottomley, Gary Milligan, James Piercy, Victoria Higgins. Alignment of Physician-Stated vs Clinically Derived Reference Fibrosis Score in Patients with Non-Alcoholic Steatohepatitis: A Real-World European Survey. Pragmatic and Observational Research 2023; doi: 10.2147/POR.S392320
|
| 336 |
Abdulrahman Ismaiel, Oana Sabina Ciobanu, Mohamed Ismaiel, Daniel-Corneliu Leucuta, Stefan-Lucian Popa, Liliana David, Dilara Ensar, Nahlah Al Srouji, Dan L. Dumitrascu. Atherogenic Index of Plasma in Non-Alcoholic Fatty Liver Disease: Systematic Review and Meta-Analysis. Biomedicines 2022; 10(9) doi: 10.3390/biomedicines10092101
|
| 337 |
Nienke P. M. Wassenaar, Koen C. van Son, Bas Voermans, Kirsi M. A. van Eekhout, Marian A. Troelstra, Stan Driessen, Anne Line Mak, Julia J. Witjes, Anne-Marieke van Dijk, Veera Houttu, Diona Zwirs, Elizabeth Shumbayawonda, Max Nieuwdorp, Michail Doukas, Joanne Verheij, Aart J. Nederveen, Oliver J. Gurney-Champion, Adriaan G. Holleboom. Combination of quantitative MRI and laboratory markers for the detection and staging of metabolic dysfunction-associated steatotic liver disease. European Radiology 2026; 36(8) doi: 10.1007/s00330-026-12451-5
|
| 338 |
V. Nivethitha, Roy Arokiam Daniel, Aninda Debnath, Vignesh Dwarakanathan, Girish Jeer, G. Kavipriya. Diagnostic accuracy of artificial intelligence models for imaging detection of hepatic steatosis through systematic review and meta analysis. Scientific Reports 2025; 15(1) doi: 10.1038/s41598-025-17386-3
|
| 339 |
Marcin Hachuła, Michał Kosowski, Marcin Basiak, Bogusław Okopień. Does Therapy with Glucagon-like Peptide 1 Receptor Agonists Have an Effect on Biochemical Markers of Metabolic-Dysfunction-Associated Steatotic Liver Disease (MASLD)? Pleiotropic Metabolic Effect of Novel Antidiabetic Drugs in Patients with Diabetes—Interventional Study. Pharmaceuticals 2023; 16(9) doi: 10.3390/ph16091190
|
| 340 |
Cornelius von Morze. Detecting liver injury non‐invasively using hyperpolarized 13C MRI. Liver International 2018; 38(6) doi: 10.1111/liv.13726
|
| 341 |
Laurens A. van Kleef, Ibrahim Ayada, Louise J.M. Alferink, Qiuwei Pan, Robert J. de Knegt. Metabolic dysfunction–associated fatty liver disease improves detection of high liver stiffness: The Rotterdam Study. Hepatology 2022; 75(2) doi: 10.1002/hep.32131
|
| 342 |
Sol Jae Lee, Seung Up Kim. Noninvasive monitoring of hepatic steatosis: controlled attenuation parameter and magnetic resonance imaging-proton density fat fraction in patients with nonalcoholic fatty liver disease. Expert Review of Gastroenterology & Hepatology 2019; 13(6) doi: 10.1080/17474124.2019.1608820
|
| 343 |
Kai Zhang, Manman Qi, Jingai Jian, Zhi Li, Haiyan Wang, Yue Liu, Jian Zhang. A study of [18F]fluoro-L-dopa PET/computed tomography imaging to evaluate the extent of liver fibrosis. Nuclear Medicine Communications 2025; 46(9) doi: 10.1097/MNM.0000000000002012
|
| 344 |
Carolina Elizabeth Olaez-Ramos, Karla Lizette Mojica-Zamudio, Ana Sandoval-Rodríguez, Juan Armendáriz-Borunda. Epidemiology and diagnostic of MASLD in Latin America: a yet to be met challenge. Frontiers in Pharmacology 2026; 16 doi: 10.3389/fphar.2025.1700072
|
| 345 |
A.B. Chukhlova, M.M. Bograya, S.S. Voronova, A.N. Stepanov, L.S. Litvinova. Immunological prospects of modern non-invasive and minimally invasive methods for diagnosing non-alcoholic fatty liver disease. Journal of Adaptive Medical Immunology and Public Health Issues 2026; 2(1) doi: 10.17116/immunology2026201142
|
| 346 |
Palanivelu Praveenraj, Rachel M. Gomes, Saravana Kumar, Purushothaman Karthikeyan, Annapoorni Shankar, Ramakrishnan Parthasarathi, Palanisamy Senthilnathan, Subbiah Rajapandian, Chinnusamy Palanivelu. Prevalence and Predictors of Non-Alcoholic Fatty Liver Disease in Morbidly Obese South Indian Patients Undergoing Bariatric Surgery. Obesity Surgery 2015; 25(11) doi: 10.1007/s11695-015-1655-1
|
| 347 |
Janet H. M. Lee, Chai Har Loo, Wooi Chiang Tan, Choon Kin Lee, Adawiyah Jamil, Yek Huan Khor. Comparison of noninvasive screening tools for hepatic fibrosis, association with methotrexate cumulative dose, and risk factors in psoriasis patients. Dermatologic Therapy 2022; 35(1) doi: 10.1111/dth.15203
|
| 348 |
Kiran Kumar Yelkur, Mahidhar Valeti, Sumanth Kankanala, Sahithi Jekkyreddy, Mithila Gade. Impact of Bariatric Surgery on Non-Alcoholic Fatty Liver Disease - Role of Non-Invasive Tests. Journal of Bariatric Surgery 2022; 1(2) doi: 10.4103/jbs.jbs_8_21
|
| 349 |
Safdar Wahid Inamdar, Abdulhamit Subasi. Applications of Artificial Intelligence in Healthcare and Biomedicine. 2024; doi: 10.1016/B978-0-443-22308-2.00015-9
|
| 350 |
Qi Zan, Li Fan, Wenjing Lu, Yuewei Zhang, Yunong Huang, Xue Yu, Yahong Han, Ruiping Zhang, Chuan Dong, Shaomin Shuang. Early Diagnosis of Liver Injury and Real‐Time Evaluation of Photothermal Therapy Efficacy with a Viscosity‐Responsive NIR‐II Smart Molecule. Advanced Healthcare Materials 2025; 14(1) doi: 10.1002/adhm.202402614
|
| 351 |
Yin-Yin Liao, Chih-Kuang Yeh, Kuo-Chin Huang, Po-Hsiang Tsui, Kuen-Cheh Yang. Metabolic Characteristics of a Novel Ultrasound Quantitative Diagnostic Index for Nonalcoholic Fatty Liver Disease. Scientific Reports 2019; 9(1) doi: 10.1038/s41598-019-44453-3
|
| 352 |
Dirk J. van der Windt, Vikas Sud, Hongji Zhang, Allan Tsung, Hai Huang. The Effects of Physical Exercise on Fatty Liver Disease. Gene Expression 2018; 18(2) doi: 10.3727/105221617X15124844266408
|
| 353 |
Zeinab Anwar Elkabany, Rasha Tarif Hamza, Eman Abdel Rahman Ismail, Aisha Elsharkawy, Ayman Yosry, Sherief Musa, Marwa Ahmad Khalaf, Roba Maher Elgawesh, Gamal Esmat. Serum visfatin level as a noninvasive marker for nonalcoholic fatty liver disease in children and adolescents with obesity: relation to transient elastography with controlled attenuation parameter. European Journal of Gastroenterology & Hepatology 2020; 32(8) doi: 10.1097/MEG.0000000000001608
|
| 354 |
Andrey Turchinovich, Ancha Baranova, Oksana Drapkina, Alexander Tonevitsky. Cell-Free Circulating Nucleic Acids as Early Biomarkers for NAFLD and NAFLD-Associated Disorders. Frontiers in Physiology 2018; 9 doi: 10.3389/fphys.2018.01256
|
| 355 |
Igor V Maev, Aleksey A Samsonov, Liudmila K Palgova, Chavdar S Pavlov, Elena I Vovk, Elena N Shirokova, Kirill M Starostin. Effectiveness of phosphatidylcholine in alleviating steatosis in patients with non-alcoholic fatty liver disease and cardiometabolic comorbidities (MANPOWER study). BMJ Open Gastroenterology 2020; 7(1) doi: 10.1136/bmjgast-2019-000341
|
| 356 |
Guangyi Zhang, Xiaohong Wang, Arinc Ozturk, Eugene Cheah, Peng Guo, Marian Martin, Angela Shih, Atul K. Bhan, Nancy Obuchowski, Amon Asgharpour, Arun J. Sanyal, Brian A. Telfer, Theodore T. Pierce, Anthony E. Samir. A precision-constrained framework for evaluating noninvasive biomarkers in MASLD and beyond. Nature Communications 2026; 17(1) doi: 10.1038/s41467-026-74472-4
|
| 357 |
Kei Higashikawa, Sawako Horiguchi, Makoto Tarisawa, Yuki Shibata, Kazue Ohkura, Hironobu Yasui, Hiroshi Takeda, Yuji Kuge. Preclinical investigation of potential use of thymidine phosphorylase-targeting tracer for diagnosis of nonalcoholic steatohepatitis. Nuclear Medicine and Biology 2020; doi: 10.1016/j.nucmedbio.2019.12.006
|
| 358 |
Giulia Besutti, Luca Valenti, Guido Ligabue, Maria Chiara Bassi, Pierpaolo Pattacini, Giovanni Guaraldi, Paolo Giorgi Rossi. Accuracy of imaging methods for steatohepatitis diagnosis in non‐alcoholic fatty liver disease patients: A systematic review. Liver International 2019; 39(8) doi: 10.1111/liv.14118
|
| 359 |
Naim Alkhouri, Monica Tincopa, Rohit Loomba, Stephen A. Harrison. What Does the Future Hold for Patients With Nonalcoholic Steatohepatitis: Diagnostic Strategies and Treatment Options in 2021 and Beyond?. Hepatology Communications 2021; 5(11) doi: 10.1002/hep4.1814
|
| 360 |
Yinghua Zhang, Chuanfang Wang, Hui Li, Yuanyuan Ding. Decreased liver stiffness by transient elastography indicates lower incidence of hepatocellular carcinoma in patients with chronic hepatitis B. Medicine 2019; 98(3) doi: 10.1097/MD.0000000000013929
|
| 361 |
Laura G. Draijer, Janneke P. M. van Oosterhout, Yasaman Vali, Sabrina Zwetsloot, Johanna H. van der Lee, Faridi S. van Etten‐Jamaludin, Malika Chegary, Marc A. Benninga, Bart G. P. Koot. Diagnostic accuracy of fibrosis tests in children with non‐alcoholic fatty liver disease: A systematic review. Liver International 2021; 41(9) doi: 10.1111/liv.14908
|
| 362 |
David Pérez Compte, Lucas Etourneau, Anne-Marie Hesse, Alexandra Kraut, Justine Barthelon, Nathalie Sturm, Hélène Borges, Salomé Biennier, Marie Courçon, Marc de Saint Loup, Victoria Mignot, Charlotte Costentin, Thomas Burger, Yohann Couté, Christophe Bruley, Thomas Decaens, Michel Jaquinod, Jérôme Boursier, Virginie Brun. Plasma ALS and Gal-3BP differentiate early from advanced liver fibrosis in MASLD patients. Biomarker Research 2024; 12(1) doi: 10.1186/s40364-024-00583-z
|
| 363 |
Zobair M. Younossi, Linda Henry, Scott Isaacs, Kenneth Cusi. Identification of High-Risk Patients With Nonalcoholic Fatty Liver Disease in Endocrinology Clinics. Endocrine Practice 2023; 29(11) doi: 10.1016/j.eprac.2023.06.012
|
| 364 |
Rachel Gingold-Belfer, Nadav Shinhar, Gil N. Bachar, Nidal Issa, Doron Boltin, Eran Sharon, Tzippy Shohat, Boris Sapoznikov, Ariel Swartz, Noam Peleg, Tom Konikoff, Hemda Schmilovitz-Weiss. Predictors of poor outcome following liver biopsy for the investigation of new hepatic space occupying lesion/s. Clinical Imaging 2023; 99 doi: 10.1016/j.clinimag.2023.04.001
|
| 365 |
Janki Patel, Ricki Bettencourt, Jeffrey Cui, Joanie Salotti, Jonathan Hooker, Archana Bhatt, Carolyn Hernandez, Phirum Nguyen, Hamed Aryafar, Mark Valasek, William Haufe, Catherine Hooker, Lisa Richards, Claude B. Sirlin, Rohit Loomba. Association of noninvasive quantitative decline in liver fat content on MRI with histologic response in nonalcoholic steatohepatitis. Therapeutic Advances in Gastroenterology 2016; 9(5) doi: 10.1177/1756283X16656735
|
| 366 |
Adrian T. Billeter, Sarah Wloka, Rouven Behnisch, Thomas Albrecht, Stephanie Roessler, Benjamin Goeppert, Sebastian Mueller, Felix Nickel, Beat Müller. Development and Validation of a Novel Scoring System for Noninvasive Nonalcoholic Steatohepatitis Detection in Bariatric Patients. Obesity Facts 2021; 14(5) doi: 10.1159/000517383
|
| 367 |
|
| 368 |
Cyrielle Caussy, Mosab H. Alquiraish, Phirum Nguyen, Carolyn Hernandez, Sandra Cepin, Lynda E. Fortney, Veeral Ajmera, Ricki Bettencourt, Summer Collier, Jonathan Hooker, Ethan Sy, Emily Rizo, Lisa Richards, Claude B. Sirlin, Rohit Loomba. Optimal threshold of controlled attenuation parameter with MRI‐PDFF as the gold standard for the detection of hepatic steatosis. Hepatology 2018; 67(4) doi: 10.1002/hep.29639
|
| 369 |
Dimitrios A. Koutoukidis, Nerys M. Astbury, Kate E. Tudor, Elizabeth Morris, John A. Henry, Michaela Noreik, Susan A. Jebb, Paul Aveyard. Association of Weight Loss Interventions With Changes in Biomarkers of Nonalcoholic Fatty Liver Disease. JAMA Internal Medicine 2019; 179(9) doi: 10.1001/jamainternmed.2019.2248
|
| 370 |
Zhizhan Fu, Fazhi Feng, Xingguang He, Tongtong Li, Xiansong Li, Jituome Ziluo, Zixing Huang, Jinlin Ye. SiameseNet based on multiple instance learning for accurate identification of the histological grade of ICC tumors. Frontiers in Oncology 2025; 15 doi: 10.3389/fonc.2025.1450379
|
| 371 |
Ingrid Jullian-Desayes, Wojciech Trzepizur, Jérôme Boursier, Marie Joyeux-Faure, Sébastien Bailly, Meriem Benmerad, Marc Le Vaillant, Sandrine Jaffre, Thierry Pigeanne, Acya Bizieux-Thaminy, Marie-Pierre Humeau, Claire Alizon, François Goupil, Charlotte Costentin, Jonathan Gaucher, Renaud Tamisier, Frédéric Gagnadoux, Jean-Louis Pépin. Obstructive sleep apnea, chronic obstructive pulmonary disease and NAFLD: an individual participant data meta-analysis. Sleep Medicine 2021; 77 doi: 10.1016/j.sleep.2020.04.004
|
| 372 |
Trong N. Nguyen, Anthony S. Podkowa, Alex Y. Tam, Eben C. Arnold, Rita J. Miller, Trevor H. Park, Minh N. Do, Michael L. Oelze. Characterizing Fatty Liver in vivo in Rabbits, Using Quantitative Ultrasound. Ultrasound in Medicine & Biology 2019; 45(8) doi: 10.1016/j.ultrasmedbio.2019.03.021
|
| 373 |
Yusuf Kagzi, Abuzar Asif, Yanzhi Wang, Jacqueline Fischer, Sonu Dhillon. Evaluating performance of non-invasive tests for fibrosis detection in MASLD with Type 2 Diabetes Mellitus: Insights from VCTE-Based assessment. Clinics and Research in Hepatology and Gastroenterology 2026; 50(7) doi: 10.1016/j.clinre.2026.102879
|
| 374 |
R. Todd Stravitz, Yaron Ilan. Potential use of metabolic breath tests to assess liver disease and prognosis: has the time arrived for routine use in the clinic?. Liver International 2017; 37(3) doi: 10.1111/liv.13268
|
| 375 |
Melissa M. Milito, Milos Mihajlovic, Alice Mallia, Stefania Ghilardi, Claudio Tiribelli, Deborah Bonazza, Natalia Rosso, Silvia Palmisano, Cristina Banfi, Pablo J. Giraudi. Low-Abundance Proteomics Reveal Pleiotrophin and Fibroblast Growth Factor-21 as Biomarkers of Metabolic Dysfunction-Associated Steatohepatitis. International Journal of Molecular Sciences 2025; 26(22) doi: 10.3390/ijms262210943
|
| 376 |
Tianpao Hao, Jingfeng Chen, Shaoce Zhi, Qiyu Zhang, Gang Chen, Fuxiang Yu. Comparison of bone marrow‑vs. adipose tissue‑derived mesenchymal stem cells for attenuating liver fibrosis. Experimental and Therapeutic Medicine 2017; doi: 10.3892/etm.2017.5333
|
| 377 |
Takashi Kobayashi, Koji Ogawa, Jun-ichi Furukawa, Hisatoshi Hanamatsu, Megumi Hato, Tomoyo Yoshinaga, Kenichi Morikawa, Goki Suda, Takuya Sho, Masato Nakai, Kenichi Higashino, Yoshito Numata, Yasuro Shinohara, Naoya Sakamoto. Quantifying Protein-Specific N-Glycome Profiles by Focused Protein and Immunoprecipitation Glycomics. Journal of Proteome Research 2019; 18(8) doi: 10.1021/acs.jproteome.9b00232
|
| 378 |
Toon J.I. De Munck, Pauline Verhaegh, Corinne Spooren, Zlatan Mujagic, Tobias Wienhold, Daisy Jonkers, Ad A.M. Masclee, Ger H. Koek, Jef Verbeek. Colonic permeability is increased in non-cirrhotic patients with nonalcoholic fatty liver disease. Digestive and Liver Disease 2023; 55(5) doi: 10.1016/j.dld.2022.12.022
|
| 379 |
Evgin Goceri, Zarine K. Shah, Rick Layman, Xia Jiang, Metin N. Gurcan. Quantification of liver fat: A comprehensive review. Computers in Biology and Medicine 2016; 71 doi: 10.1016/j.compbiomed.2016.02.013
|
| 380 |
Cornelius von Morze, Tyler Blazey, Ashley Shaw, William M. Spees, Kooresh I. Shoghi, Michael A. Ohliger. Detection of early-stage NASH using non-invasive hyperpolarized 13C metabolic imaging. Scientific Reports 2024; 14(1) doi: 10.1038/s41598-024-65951-z
|
| 381 |
Yijiang Zheng, Zhuoxin Long, Ruting Cheng, Boyuan Feng, Khashayar Vaziri, Xiaoke Zhang, James K. Hahn. Predicting Nonalcoholic Fatty Liver Disease in Obese Populations with 3D Body Scans. 2024 46th Annual International Conference of the IEEE Engineering in Medicine and Biology Society (EMBC) 2024; doi: 10.1109/EMBC53108.2024.10781798
|
| 382 |
Zixian Wang, Qiying Yu, Yanan Sun, Yanlou Liang, Shanshan Chen, Shuhui Xie, Jing Wu. A nomogram model integrating ultrasound-based multimodal radiomics features and clinical indexes for diagnosing significant hepatic fibrosis in AILD patients. Abdominal Radiology 2025; 51(7) doi: 10.1007/s00261-025-05342-8
|
| 383 |
Thomas J. Wang, Pichamol Jirapinyo, Raj Shah, Kimberly Schuster, David J. Papke, Christopher C. Thompson, Laura Doyon, David B. Lautz, Marvin Ryou. EUS-guided shear wave elastography for fibrosis screening in patients with obesity and metabolic dysfunction–associated steatotic liver disease: a pilot study (with video). Gastrointestinal Endoscopy 2025; 101(2) doi: 10.1016/j.gie.2024.10.054
|
| 384 |
Stephen A. Harrison, Rohit Loomba, Julie Dubourg, Vlad Ratziu, Mazen Noureddin. Clinical Trial Landscape in NASH. Clinical Gastroenterology and Hepatology 2023; 21(8) doi: 10.1016/j.cgh.2023.03.041
|
| 385 |
Bing Mao, Jingdong Ma, Shaobo Duan, Yuwei Xia, Yaru Tao, Lianzhong Zhang. Preoperative classification of primary and metastatic liver cancer via machine learning-based ultrasound radiomics. European Radiology 2021; 31(7) doi: 10.1007/s00330-020-07562-6
|
| 386 |
Sumeet K. Asrani. Incorporation of Noninvasive Measures of Liver Fibrosis Into Clinical Practice: Diagnosis and Prognosis. Clinical Gastroenterology and Hepatology 2015; 13(12) doi: 10.1016/j.cgh.2015.07.030
|
| 387 |
In-Ho Seo, Hye Sun Lee, Yong-Jae Lee. Fatty liver index as a predictor for incident type 2 diabetes in community-dwelling adults: longitudinal findings over 12 years. Cardiovascular Diabetology 2022; 21(1) doi: 10.1186/s12933-022-01642-1
|
| 388 |
Hiroshi Ishiba, Yoshio Sumida, Saiyu Tanaka, Masato Yoneda, Hideyuki Hyogo, Masafumi Ono, Hideki Fujii, Yuichiro Eguchi, Yasuaki Suzuki, Masashi Yoneda, Hirokazu Takahashi, Takashi Nakahara, Yuya Seko, Kojiro Mori, Kazuyuki Kanemasa, Keiji Shimada, Sunsuke Imai, Kento Imajo, Takumi Kawaguchi, Atsushi Nakajima, Kazuaki Chayama, Toshiji Saibara, Toshihide Shima, Kazuma Fujimoto, Takeshi Okanoue, Yoshito Itoh. The novel cutoff points for the FIB4 index categorized by age increase the diagnostic accuracy in NAFLD: a multi-center study. Journal of Gastroenterology 2018; 53(11) doi: 10.1007/s00535-018-1474-y
|
| 389 |
Norio Akuta, Yusuke Kawamura, Fumitaka Suzuki, Satoshi Saitoh, Yasuji Arase, Nozomu Muraishi, Shunichiro Fujiyama, Hitomi Sezaki, Tetsuya Hosaka, Masahiro Kobayashi, Mariko Kobayashi, Yoshiyuki Suzuki, Kenji Ikeda, Hiromitsu Kumada. Dynamics of Circulating miR-122 Predict Liver Cancer and Mortality in Japanese Patients with Histopathologically Confirmed NAFLD and Severe Fibrosis Stage. Oncology 2022; 100(1) doi: 10.1159/000519995
|
| 390 |
Jie Chen, Bo Zhang, Yong Cheng, Yuanchen Jia, Biao Zhou. Machine Learning-Based Non-Invasive Prediction of Metabolic Dysfunction-Associated Steatohepatitis in Obese Patients: A Retrospective Study. Diagnostics 2025; 15(9) doi: 10.3390/diagnostics15091096
|
| 391 |
Juanwen Zhang, Xuyao Zhang, Ying Zhao, Guocai Lv. Association Between Urinary Alpha1-Microglobulin Levels and Nonalcoholic Fatty Liver Disease: A Cross-Sectional Study. Annals of Nutrition and Metabolism 2018; 72(1) doi: 10.1159/000484255
|
| 392 |
|
| 393 |
I G Bakulin, Yu G Sandler, E V Vinnitskayа, V A Keiyan, S V Rodionova, D L Rotin. Diabetes mellitus and nonalcoholic fatty liver disease: The verges of contingency. Terapevticheskii arkhiv 2017; 89(2) doi: 10.17116/terarkh201789259-65
|
| 394 |
Naoyuki Fujimori, Naoki Tanaka, Soichiro Shibata, Kenji Sano, Tomoo Yamazaki, Tomohiro Sekiguchi, Hiroyuki Kitabatake, Yuki Ichikawa, Takefumi Kimura, Michiharu Komatsu, Takeji Umemura, Akihiro Matsumoto, Eiji Tanaka. Controlled attenuation parameter is correlated with actual hepatic fat content in patients with non‐alcoholic fatty liver disease with none‐to‐mild obesity and liver fibrosis. Hepatology Research 2016; 46(10) doi: 10.1111/hepr.12649
|
| 395 |
Ying-Hsiu Lin, Yung-Liang Wan, Dar-In Tai, Jeng-Hwei Tseng, Chiao-Yin Wang, Yu-Wei Tsai, Yi-Ru Lin, Tu-Yung Chang, Po-Hsiang Tsui. Considerations of Ultrasound Scanning Approaches in Non-alcoholic Fatty Liver Disease Assessment through Acoustic Structure Quantification. Ultrasound in Medicine & Biology 2019; 45(8) doi: 10.1016/j.ultrasmedbio.2019.04.018
|
| 396 |
Charles E Hill, Luca Biasiolli, Matthew D Robson, Vicente Grau, Michael Pavlides. Emerging artificial intelligence applications in liver magnetic resonance imaging. World Journal of Gastroenterology 2021; 27(40): 6825-6843 doi: 10.3748/wjg.v27.i40.6825
|
| 397 |
Kishor Pant, Senthil K. Venugopal. Circulating microRNAs: Possible role as non-invasive diagnostic biomarkers in liver disease. Clinics and Research in Hepatology and Gastroenterology 2017; 41(4) doi: 10.1016/j.clinre.2016.11.001
|
| 398 |
Jiarui Chen, Ronald Siyi Lu, Candela Diaz-Canestro, Erfei Song, Xi Jia, Yan Liu, Cunchuan Wang, Cynthia K.Y. Cheung, Gianni Panagiotou, Aimin Xu. Distinct changes in serum metabolites and lipid species in the onset and progression of NAFLD in Obese Chinese. Computational and Structural Biotechnology Journal 2024; 23 doi: 10.1016/j.csbj.2024.01.007
|
| 399 |
Fathima Shihana, Mugdha V. Joglekar, Tae-Hwi Schwantes-An, Anandwardhan A. Hardikar, Devanshi Seth. MicroRNAs Signature Panel Identifies Heavy Drinkers with Alcohol-Associated Cirrhosis from Heavy Drinkers without Liver Injury. Biology 2023; 12(10) doi: 10.3390/biology12101314
|
| 400 |
Cyrielle Caussy, Lars Johansson. Magnetic resonance‐based biomarkers in nonalcoholic fatty liver disease and nonalcoholic steatohepatitis. Endocrinology, Diabetes & Metabolism 2020; 3(4) doi: 10.1002/edm2.134
|
| 401 |
Lingling Wu, Yidi Wang, Xing Xu, Yilong Liu, Bingqian Lin, Mingxia Zhang, Jialu Zhang, Shuang Wan, Chaoyong Yang, Weihong Tan. Aptamer-Based Detection of Circulating Targets for Precision Medicine. Chemical Reviews 2021; 121(19) doi: 10.1021/acs.chemrev.0c01140
|
| 402 |
Luca Borz-Baba, Adem Aydin, Russell Parvin. Liver Biopsy in Metabolic-Associated Steatotic Liver Disease: Accuracy, Challenges, and Alternatives. Cureus 2026; doi: 10.7759/cureus.103284
|
| 403 |
Wanying Wu, Yuhu Guo, Qi Li, Congzhuo Jia. Exploring the potential of large language models in identifying metabolic dysfunction‐associated steatotic liver disease: A comparative study of non‐invasive tests and artificial intelligence‐generated responses. Liver International 2025; 45(4) doi: 10.1111/liv.16112
|
| 404 |
Chang Jie Mick Lee, Leah B. Kosyakovsky, Muhammad Shahzeb Khan, Feng Wu, Guo Chen, Joseph A. Hill, Jennifer E. Ho, Roger S.-Y. Foo, Faiez Zannad. Cardiovascular, Kidney, Liver, and Metabolic Interactions in Heart Failure: Breaking Down Silos. Circulation Research 2025; 136(11) doi: 10.1161/CIRCRESAHA.125.325602
|
| 405 |
A. R. Khurmatullina, D. N. Andreev, I. V. Maev, Yu. A. Kucheryavyy, A. V. Zaborovskiy. Effect of ursodeoxycholic acid on changes in non-invasive calculated indices of steatosis and fibrosis in patients with non-alcoholic fatty liver disease: A systematic review and meta-analysis. Meditsinskiy sovet = Medical Council 2026; (8) doi: 10.21518/ms2026-221
|
| 406 |
Jake B. Hermanson, Samar A. Tolba, Md Amran Gazi, Evan A. Chrisler, Manpreet Kaur, Ashley M. Sidebottom, Yongjun Liu, Guillermo Martinez-Boggio, Lauren N. Lucas, Daniel Amador-Noguez, Federico E. Rey, Vanessa A. Leone. Gut microbes mediate the synergistic effects of dietary cholesterol and saturated fat in driving fibrosing MASH. Gut Microbes 2026; 18(1) doi: 10.1080/19490976.2026.2668121
|
| 407 |
Rohit Kohli, Vlad Ratziu, Maria Isabel Fiel, Elisa Waldmann, Don P. Wilson, Manisha Balwani. Initial assessment and ongoing monitoring of lysosomal acid lipase deficiency in children and adults: Consensus recommendations from an international collaborative working group. Molecular Genetics and Metabolism 2020; 129(2) doi: 10.1016/j.ymgme.2019.11.004
|
| 408 |
Stella-Maris Chinma Egboh, Pantong Mark Davwar. The Burden of Occult Hepatitis B Virus Infection in Hepatocellular Carcinoma in Nigeria. Gastroenterology, Hepatology and Endoscopy Practice 2023; 3(2) doi: 10.4103/ghep.ghep_34_22
|
| 409 |
Cameron Gofton, Jacob George. Non-Invasive Testing in Metabolic Dysfunction Associated Fatty Liver Disease. Archives of Medical Research 2025; 56(8) doi: 10.1016/j.arcmed.2025.103337
|
| 410 |
M. H. Le, Y. H. Yeo, R. Cheung, V. W.-S. Wong, M. H. Nguyen. Ethnic influence on nonalcoholic fatty liver disease prevalence and lack of disease awareness in the United States, 2011–2016. Journal of Internal Medicine 2020; 287(6) doi: 10.1111/joim.13035
|
| 411 |
Dae-Jeong Koo, Mi Yeon Lee, Inha Jung, Sun Joon Moon, Hyemi Kwon, Se Eun Park, Eun-Jung Rhee, Won-Young Lee. Changes in Insulin Resistance Index and the Risk of Liver Fibrosis in Patients with Nonalcoholic Fatty Liver Disease without Diabetes: Kangbuk Samsung Health Study. Endocrinology and Metabolism 2021; 36(5) doi: 10.3803/EnM.2021.1110
|
| 412 |
Yasushi Honda, Masato Yoneda, Kento Imajo, Atsushi Nakajima. Elastography Techniques for the Assessment of Liver Fibrosis in Non-Alcoholic Fatty Liver Disease. International Journal of Molecular Sciences 2020; 21(11) doi: 10.3390/ijms21114039
|
| 413 |
Chaobang Zhang, Zhidong Qiu, Liangliang Zhang, Shulong Wang, Shulin Zhao, Qiufang Pang, Hong Liang. Mitochondria-Targeted Fluorescence/Photoacoustic Dual-Modality Imaging Probe Tailored for Visual Precise Diagnosis of Drug-Induced Liver Injury. Analytical Chemistry 2022; 94(16) doi: 10.1021/acs.analchem.2c00041
|
| 414 |
Queralt Martín-Saladich, Juan M. Pericàs, Andreea Ciudin, Clara Ramirez-Serra, Manuel Escobar, Jesús Rivera-Esteban, Santiago Aguadé-Bruix, Miguel A. González Ballester, José Raul Herance. Metabolic-associated fatty liver voxel-based quantification on CT images using a contrast adapted automatic tool. Medical Image Analysis 2024; 95 doi: 10.1016/j.media.2024.103185
|
| 415 |
Zekai Hu, Yajie Lin, Hainv Gao, Leyao Shuai, Zhaowei Tong, Chenqi Nie, Zhe Yang, Junsheng Zhao. Application of artificial intelligence in hepatology. Frontiers in Digital Health 2026; 8 doi: 10.3389/fdgth.2026.1851723
|
| 416 |
Somaia Mohammed Ali Mahfouz, Fatma Salah eldin Mohamed, Nivine Abdel Moneium Chalabi, Hazem Ibrahim Abdel-Rahman. Predicting of hepatic steatosis in living liver donor via CT liver attenuation index (LAI) and fibroscan controlled attenuation parameter (CAP) correlation with biopsy result. Egyptian Journal of Radiology and Nuclear Medicine 2024; 55(1) doi: 10.1186/s43055-024-01335-7
|
| 417 |
Lei Hu, Jing Yang, Cuifeng Zhang, Jin Pan, Shuting Shen, Liping Su, Xuebin Shen, Jing He, Hui Wang. A red-emission and viscosity-ultrasensitive probe for identifying non-alcoholic fatty liver via imaging lysosomal viscosity. Sensors and Actuators B: Chemical 2024; 398 doi: 10.1016/j.snb.2023.134776
|
| 418 |
Hongbing Sun. An Alternative Non-Invasive Screening Model for Liver Fibrosis among US Adults at Risk of MASLD. Diseases 2024; 12(7) doi: 10.3390/diseases12070150
|
| 419 |
Arezoo Gowhari Shabgah, Fatemeh Norouzi, Mahdiyeh Hedayati-Moghadam, Davood Soleimani, Naseh Pahlavani, Jamshid Gholizadeh Navashenaq. A comprehensive review of long non-coding RNAs in the pathogenesis and development of non-alcoholic fatty liver disease. Nutrition & Metabolism 2021; 18(1) doi: 10.1186/s12986-021-00552-5
|
| 420 |
Asad Izziddin Mustafa Dajani, Adnan M. Abu Hammour, Mohammed A. Zakaria, Mazen R. Al Jaberi, Mohammed A. Nounou, Abdul Ilah M. Semrin. Essential phospholipids as a supportive adjunct in the management of patients with NAFLD. Arab Journal of Gastroenterology 2015; 16(3-4) doi: 10.1016/j.ajg.2015.09.001
|
| 421 |
Newaz Hossain, Pushpjeet Kanwar, Smruti R. Mohanty. A Comprehensive Updated Review of Pharmaceutical and Nonpharmaceutical Treatment for NAFLD. Gastroenterology Research and Practice 2016; 2016 doi: 10.1155/2016/7109270
|
| 422 |
Faisal Abaalkhail, Faisal M. Sanai, Khalid AlSwat, Adnan Alzanbagi, Ahmed Aljedai, Ali Alshehri, Assim Alfadda, Hamdan Alghamdi, Majid Almadi, Mohammad Aleissa, Mona Ismail, Saud Alsifri, Turki Alzahrani, Saleh Alqahtani, Waleed Al Hamoudi. Metabolic dysfunction-associated steatotic liver disease management in Saudi Arabia: A modified Delphi-based adaptation of international standards. Saudi Journal of Gastroenterology 2026; 32(2) doi: 10.4103/sjg.sjg_199_25
|
| 423 |
Abeer Abd El-Rehim El-Henawy, Ahmed Abdel-Razik, Sahar Zakaria, Dina Elhammady, Niveen Saudy, Manar Sobh Azab. Is toxoplasmosis a potential risk factor for liver cirrhosis?. Asian Pacific Journal of Tropical Medicine 2015; 8(10) doi: 10.1016/j.apjtm.2015.09.003
|
| 424 |
HIROKI NISHIKAWA, YUKIO OSAKI, HIDEYUKI KOMEKADO, AZUSA SAKAMOTO, SUMIO SAITO, NORIHIRO NISHIJIMA, AKIHIRO NASU, AKIRA ARIMOTO, RYUICHI KITA, TORU KIMURA. Clinical significance of the FIB-4 index for non-B non-C hepatocellular carcinoma treated with surgical resection. Oncology Reports 2015; 33(1) doi: 10.3892/or.2014.3573
|
| 425 |
Haru Yamamoto, Tatsuya Usui, Kazuaki Sasaki. Development of liver organoids from NASH model mice and their application to drug discovery. Folia Pharmacologica Japonica 2021; 156(5) doi: 10.1254/fpj.21027
|
| 426 |
Seyed Hamid Moosavy, Ebrahim Eftekhar, Parivash Davoodian, Abdolazim Nejatizadeh, Mohammad Shadman, Shahram Zare, Mirza Ali Nazarnezhad. AST/ALT ratio, APRI, and FIB-4 compared to FibroScan for the assessment of liver fibrosis in patients with chronic hepatitis B in Bandar Abbas, Hormozgan, Iran. BMC Gastroenterology 2023; 23(1) doi: 10.1186/s12876-023-02780-w
|
| 427 |
Dawei Yang, Dan Li, Jinshui Li, Zhenghan Yang, Zhenchang Wang. Systematic review: The diagnostic efficacy of gadoxetic acid-enhanced MRI for liver fibrosis staging. European Journal of Radiology 2020; 125 doi: 10.1016/j.ejrad.2020.108857
|
| 428 |
Fernanda M. Martínez-Díaz, Elsie A. Jiménez-Cuevas, Mariana M. Ramírez-Mejía, Sarai Gómez-Camacho, Nahum Méndez-Sánchez. The interplay of insulin resistance, glycemic variability, and metabolic dysfunction-associated steatotic liver disease. Exploration of Digestive Diseases 2026; 5 doi: 10.37349/edd.2026.1005115
|
| 429 |
Amanda Hanson, Danielle Wilhelmsen, Johanna K. DiStefano. The Role of Long Non-Coding RNAs (lncRNAs) in the Development and Progression of Fibrosis Associated with Nonalcoholic Fatty Liver Disease (NAFLD). Non-Coding RNA 2018; 4(3) doi: 10.3390/ncrna4030018
|
| 430 |
Ali Mahmoudi, Alexandra E. Butler, Tannaz Jamialahmadi, Amirhossein Sahebkar. The role of exosomal miRNA in nonalcoholic fatty liver disease. Journal of Cellular Physiology 2022; 237(4) doi: 10.1002/jcp.30699
|
| 431 |
Tao Jiang, Pengfei Rong, Wei Wang. Chemical Probes for drug-induced Liver Injury Imaging. Future Medicinal Chemistry 2020; 12(9) doi: 10.4155/fmc-2019-0330
|
| 432 |
Dong Hyeon Lee, Se Un Sung, Yun Kyu Lee, Ik Hyeon Lim, Heejoon Jang, Sae Kyoung Joo, Jeong Hwan Park, Mee Soo Chang, Young Ho So, Won Kim. A sequential approach using the age‐adjusted fibrosis‐4 index and vibration‐controlled transient elastography to detect advanced fibrosis in Korean patients with non‐alcoholic fatty liver disease. Alimentary Pharmacology & Therapeutics 2022; 55(8) doi: 10.1111/apt.16766
|
| 433 |
Gourab Dey, Vikas Singh, Jayant Dewangan, P. Vineeth Daniel, Mohan Kamthan, Debabrata Ghosh, Prosenjit Mondal, Subrata Ghosh. Renal Clearable New NIR Probe: Precise Quantification of Albumin in Biofluids and Fatty Liver Disease State Identification through Tissue Specific High Contrast Imaging in Vivo. Analytical Chemistry 2017; 89(19) doi: 10.1021/acs.analchem.7b02187
|
| 434 |
Katherine F. Sweeny, Citlali Aguilera‐Rico, Christina Chan, Enju Liu, Christine K. Lee. Longitudinal changes in vibration‐controlled transient elastography in pediatric fatty liver disease. Journal of Pediatric Gastroenterology and Nutrition 2026; 82(6) doi: 10.1002/jpn3.70380
|
| 435 |
Jang Hwan Cho, Christopher M. Bull, Michael Thornton, Jing Gao, Jonathan M. Rubin, Idan Steinberg. Thermoacoustic Ultrasound Assessment of Liver Steatosis—A Novel Approach for MASLD Diagnosis. Diagnostics 2026; 16(5) doi: 10.3390/diagnostics16050804
|
| 436 |
Tilman Kühn, Tobias Nonnenmacher, Disorn Sookthai, Ruth Schübel, Daniel Antonio Quintana Pacheco, Oyunbileg von Stackelberg, Mirja E. Graf, Theron Johnson, Christopher L. Schlett, Romy Kirsten, Cornelia M. Ulrich, Rudolf Kaaks, Hans-Ulrich Kauczor, Johanna Nattenmüller. Anthropometric and blood parameters for the prediction of NAFLD among overweight and obese adults. BMC Gastroenterology 2018; 18(1) doi: 10.1186/s12876-018-0840-9
|
| 437 |
Dan Song, Chenchen Li, Mengting Zhu, Siyu Chi, Zhihong Liu. Tracking Hepatic Ischemia‐Reperfusion Injury in Real Time with a Reversible NIR‐IIb Fluorescent Redox Probe. Angewandte Chemie 2022; 134(44) doi: 10.1002/ange.202212721
|
| 438 |
Fan Zhang, Yan Han, Yonghua Mao, Guojun Zheng, Longgen Liu, Wenjian Li. Non-invasive prediction nomogram for predicting significant fibrosis in patients with metabolic-associated fatty liver disease: a cross-sectional study. Annals of Medicine 2024; 56(1) doi: 10.1080/07853890.2024.2337739
|
| 439 |
Ji-Hwan Park, Ji Su Han, Hyeong-Geon Kim, Jong-In Na. Potential utility of postmortem CT-based classification as a practical pre-autopsy assessment tool for hepatic steatosis. Scientific Reports 2026; 16(1) doi: 10.1038/s41598-026-55019-5
|
| 440 |
Besheer G. Elshafey, Ahmed Elfadadny, Samy Metwally, Asmaa G. Saleh, Rokaia F. Ragab, Rania Hamada, Ahmed S. Mandour, Amin Omar Hendawy, Luay Alkazmi, Hanan A. Ogaly, Gaber El-Saber Batiha. Association between biochemical parameters and ultrasonographic measurement for the assessment of hepatic lipidosis in dairy cows. Italian Journal of Animal Science 2023; 22(1) doi: 10.1080/1828051X.2023.2170284
|
| 441 |
Narges Ashraf Ganjooei, Tannaz Jamialahmadi, Mohsen Nematy, Ali Jangjoo, Ladan Goshayeshi, Majid Khadem-Rezaiyan, Željko Reiner, Mona Alidadi, Alexander M. Markin, Amirhossein Sahebkar. The Role of Lipid Profile as an Independent Predictor of Non-alcoholic Steatosis and Steatohepatitis in Morbidly Obese Patients. Frontiers in Cardiovascular Medicine 2021; 8 doi: 10.3389/fcvm.2021.682352
|
| 442 |
Xingyue Wei, Lianshuang Wang, Yuanyuan Wang, Lijie Huang, Qiong He, Yao Zhang, Jianwen Luo. Intelligent Grading of Liver Fibrosis, Inflammation and Steatosis Using Handcrafted and Deep Features From Multimodal Ultrasound Data. 2023 IEEE International Ultrasonics Symposium (IUS) 2023; doi: 10.1109/IUS51837.2023.10308093
|
| 443 |
Mohamed Omran, Mona Omr, Amal A. Mohamed, Reem A. Abdelghafour, Nashwa M. Muharram, Mohamed B. Hassan, Abobakrelsedik Fangry, Tarek Emran, Juan P. Arab, Jorge Arnold, Luis Antonio Diaz, Ming-Hua Zheng, Mohamed El-Kassas. Development and validation of nonalcoholic fatty liver disease test: a simple sensitive and specific marker for early diagnosis of nonalcoholic fatty liver disease. European Journal of Gastroenterology & Hepatology 2023; 35(8) doi: 10.1097/MEG.0000000000002575
|
| 444 |
Monica A. Tincopa. Diagnostic and interventional circulating biomarkers in nonalcoholic steatohepatitis. Endocrinology, Diabetes & Metabolism 2020; 3(4) doi: 10.1002/edm2.177
|
| 445 |
Dan Song, Chenchen Li, Mengting Zhu, Siyu Chi, Zhihong Liu. Tracking Hepatic Ischemia‐Reperfusion Injury in Real Time with a Reversible NIR‐IIb Fluorescent Redox Probe. Angewandte Chemie International Edition 2022; 61(44) doi: 10.1002/anie.202212721
|
| 446 |
Amélio F. Godoy-Matos, Wellington S. Silva Júnior, Cynthia M. Valerio. NAFLD as a continuum: from obesity to metabolic syndrome and diabetes. Diabetology & Metabolic Syndrome 2020; 12(1) doi: 10.1186/s13098-020-00570-y
|
| 447 |
Stephen A. Harrison, Alina M. Allen, Julie Dubourg, Mazen Noureddin, Naim Alkhouri. Challenges and opportunities in NASH drug development. Nature Medicine 2023; 29(3) doi: 10.1038/s41591-023-02242-6
|
| 448 |
Eunsook S. Jin, A. Dean Sherry, Craig R. Malloy. An Oral Load of [13C3]Glycerol and Blood NMR Analysis Detect Fatty Acid Esterification, Pentose Phosphate Pathway, and Glycerol Metabolism through the Tricarboxylic Acid Cycle in Human Liver. Journal of Biological Chemistry 2016; 291(36) doi: 10.1074/jbc.M116.742262
|
| 449 |
Shu-Fu Shih, Holden H. Wu. Free-breathing MRI techniques for fat and R2* quantification in the liver. Magnetic Resonance Materials in Physics, Biology and Medicine 2024; 37(4) doi: 10.1007/s10334-024-01187-2
|
| 450 |
Amedeo Lonardo, Mohamad Jamalinia, Ralf Weiskirchen. Current Insights into Liver Fibrosis: Epidemiological Patterns, Etiopathogenesis, Clinical Correlates, and Research Agenda. Livers 2026; 6(5) doi: 10.3390/livers6050086
|
| 451 |
Rawi Hazzan, Nur Abu Ahmad, Abu Shqara Habib, Igbaria Saleh, Neeman Ziv. Suboptimal reliability of FIB‐4 and NAFLD‐fibrosis scores for staging of liver fibrosis in general population. JGH Open 2024; 8(2) doi: 10.1002/jgh3.13034
|
| 452 |
Michael Hagan, Sumeet K Asrani, Jayant Talwalkar. Non-invasive assessment of liver fibrosis and prognosis. Expert Review of Gastroenterology & Hepatology 2015; 9(10) doi: 10.1586/17474124.2015.1075391
|
| 453 |
Niketa Sharma, Swarupa Chakole, Bhushan Wandile. Uncovering the Cardiovascular Threat: A Comprehensive Examination of Liver Fibrosis and Subclinical Atherosclerosis in Non-alcoholic Fatty Liver Disease. Cureus 2023; doi: 10.7759/cureus.46946
|
| 454 |
Solène Marie, David K.K. Tripp, Nathan J. Cherrington. Strategies to Diagnose Nonalcoholic Steatohepatitis: A Novel Approach to Take Advantage of Pharmacokinetic Alterations. Drug Metabolism and Disposition 2022; 50(4) doi: 10.1124/dmd.121.000413
|
| 455 |
Marcelo do Rego Maciel Souto Maior, Nathália de Lacerda Interaminense Ribeiro, Hannah Vicentini Vitoriano Silva, Edmundo Pessoa Lopes, Emilia Chagas Costa. Metabolic Dysfunction-Associated Steatotic Liver Disease as a Risk Factor for Chronic Kidney Disease: A Narrative Review. Biomedicines 2025; 13(9) doi: 10.3390/biomedicines13092162
|
| 456 |
Lindsay Spitz, Stefan Saadiq, Navkiran K. Shokar, Marc J. Zuckerman, Nancy A. Casner, Roy Valenzuela, Jennifer J. Salinas. Characterization of an At-Risk Population for Nonalcoholic Fatty Liver Disease (NAFLD) in a Primary Care Setting Along the U.S.–Mexico Border. Journal of Transcultural Nursing 2025; 36(1) doi: 10.1177/10436596241271265
|
| 457 |
Paula Iruzubieta, Marta González, Joaquín Cabezas, María Teresa Arias-Loste, Javier Crespo. Liver Research and Clinical Management. 2018; doi: 10.5772/intechopen.72668
|
| 458 |
|
| 459 |
Matthew M. Yeh, Elizabeth M. Brunt. Pathological Features of Fatty Liver Disease. Gastroenterology 2014; 147(4) doi: 10.1053/j.gastro.2014.07.056
|
| 460 |
Yong‐ho Lee, Seung Up Kim, Kijun Song, Jun Yong Park, Do Young Kim, Sang Hoon Ahn, Byung‐Wan Lee, Eun Seok Kang, Bong‐Soo Cha, Kwang‐Hyub Han. Sarcopenia is associated with significant liver fibrosis independently of obesity and insulin resistance in nonalcoholic fatty liver disease: Nationwide surveys (KNHANES 2008‐2011). Hepatology 2016; 63(3) doi: 10.1002/hep.28376
|
| 461 |
Srijyotsna Volety, James Rice, Wonhyeok Lee, Caroline Doctor, Jack Gwertzman, Greta Boehm, Melih Eriten, Ali Pirasteh, Alejandro Roldán-Alzate, Diego Hernando. Quantitative evaluation of shear stiffness and the apparent diffusion coefficient using anthropomorphic multi-stiffness liver phantoms under static and motion conditions. Magnetic Resonance Imaging 2027; 135 doi: 10.1016/j.mri.2026.110782
|
| 462 |
Darcey Black, Sarah Brockbank, Simon Cruwys, Kim Goldenstein, Peter Hein, Bob Humphries. The future R&D landscape in non-alcoholic steatohepatitis (NASH). Drug Discovery Today 2019; 24(2) doi: 10.1016/j.drudis.2018.09.020
|
| 463 |
Zhitang Liang, Renhao Huang, Lingyun Zhang. Correlation between hepatic steatosis severity diagnosed by ultrasound and metabolic indexes in elderly patients with MAFLD. Frontiers in Medicine 2025; 11 doi: 10.3389/fmed.2024.1467773
|
| 464 |
Jisuk Yun, Young‐Sun Min. Association Between Perfluoroalkyl Substance (PFAS) Exposure and Nonalcoholic Fatty Liver Disease in Korean Adults: Results From the KoNEHS 2018–2020: A Cross‐Sectional Study. American Journal of Industrial Medicine 2025; 68(7) doi: 10.1002/ajim.23732
|
| 465 |
Leen J. M. Heyens, Dana Busschots, Ger H. Koek, Geert Robaeys, Sven Francque. Liver Fibrosis in Non-alcoholic Fatty Liver Disease: From Liver Biopsy to Non-invasive Biomarkers in Diagnosis and Treatment. Frontiers in Medicine 2021; 8 doi: 10.3389/fmed.2021.615978
|
| 466 |
Vikrant Sood, Snehavardhan Pandey, Mohit Kehar, Alexandre Louvet, Mariana M. Ramírez-Mejía, Nahum Méndez-Sánchez. Metabolic Dysfunction-Associated Steatotic Liver Disease. 2024; doi: 10.1007/978-981-97-9519-2_12
|
| 467 |
Haijiang Dai, Weijun Wang, Ruifang Chen, Zhiheng Chen, Yao Lu, Hong Yuan. Lipid accumulation product is a powerful tool to predict non-alcoholic fatty liver disease in Chinese adults. Nutrition & Metabolism 2017; 14(1) doi: 10.1186/s12986-017-0206-2
|
| 468 |
Muhammad Naeem, Robin Bülow, Sabine Schipf, Nicole Werner, Marcus Dörr, Markus M. Lerch, Jens-Peter Kühn, Wolfgang Rathmann, Matthias Nauck, Marcello Ricardo Paulista Markus, Till Ittermann, Henry Völzke. Association of hepatic steatosis derived from ultrasound and quantitative MRI with prediabetes in the general population. Scientific Reports 2021; 11(1) doi: 10.1038/s41598-021-92681-3
|
| 469 |
Palanivelu Praveenraj, Rachel Maria Gomes, Srikanth Basuraju, Saravana Kumar, Palanisamy Senthilnathan, Ramakrishnan Parathasarathi, Subbiah Rajapandian, Chinnusamy Palanivelu. Preliminary Evaluation of Acoustic Radiation Force Impulse Shear Wave Imaging to Detect Hepatic Fibrosis in Morbidly Obese Patients Before Bariatric Surgery. Journal of Laparoendoscopic & Advanced Surgical Techniques 2016; 26(3) doi: 10.1089/lap.2015.0396
|
| 470 |
Jeung Hui Pyo, Soo Jin Cho, Jaehwan Jee, Goeun Park, Joonghyun Ahn, Kyunga Kim, Mira Kang, Aladar D. Ronaszeki, Pál Novák Kaposi, Elio Damato, Patrizia Pacini, Carmen Solito, Vito Cantisani, Young Hye Byun. Ethnic Differences in the Diagnostic Accuracy of a Quantitative Ultrasound‐Derived Fat Fraction Estimator for Hepatic Steatosis: External Validation in Asian and Caucasian Cohorts. Journal of Clinical Ultrasound 2026; 54(1) doi: 10.1002/jcu.70024
|
| 471 |
Maryam Mahjoubin-Tehran, Antonio De Vincentis, Dimitri P. Mikhailidis, Stephen L. Atkin, Christos S. Mantzoros, Tannaz Jamialahmadi, Amirhossein Sahebkar. Non-alcoholic fatty liver disease and steatohepatitis: State of the art on effective therapeutics based on the gold standard method for diagnosis. Molecular Metabolism 2021; 50 doi: 10.1016/j.molmet.2020.101049
|
| 472 |
Swarna Bharathi Kalli, Nagaraju Bandaru, Hemanth Kumar Gorubala, Nalla Swathi, Mohan Gandi Bonthu, Bandla Aswani. Theranostics in Cancer Management. 2026; doi: 10.1016/B978-0-443-34199-1.00003-X
|
| 473 |
W.‐K. Chan, S. Treeprasertsuk, K. Imajo, A. Nakajima, Y. Seki, K. Kasama, S. Kakizaki, J.‐G. Fan, M. J. Song, S. K. Yoon, Y.‐Y. Dan, L. Lesmana, K.‐Y. Ho, K.‐L. Goh, V. W.‐S. Wong. Clinical features and treatment of nonalcoholic fatty liver disease across the Asia Pacific region—the GO ASIA initiative. Alimentary Pharmacology & Therapeutics 2018; 47(6) doi: 10.1111/apt.14506
|
| 474 |
Ana Maria Sanchez-Bao, Alfonso Soto-Gonzalez, Manuel Delgado-Blanco, Vanesa Balboa-Barreiro, Diego Bellido. Identifying advanced MAFLD in a cohort of T2DM and clinical features. Frontiers in Endocrinology 2023; 14 doi: 10.3389/fendo.2023.1058995
|
| 475 |
Zhuhuang Zhou, Dar-In Tai, Yung-Liang Wan, Jeng-Hwei Tseng, Yi-Ru Lin, Shuicai Wu, Kuen-Cheh Yang, Yin-Yin Liao, Chih-Kuang Yeh, Po-Hsiang Tsui. Hepatic Steatosis Assessment with Ultrasound Small-Window Entropy Imaging. Ultrasound in Medicine & Biology 2018; 44(7) doi: 10.1016/j.ultrasmedbio.2018.03.002
|
| 476 |
Adhan Narasimhan, Harshil Jain, Kowshika Muniandy, Raja Chinnappan, Naresh Kumar Mani. Bio-analysis of Saliva Using Paper Devices and Colorimetric Assays. Journal of Analysis and Testing 2024; 8(1) doi: 10.1007/s41664-023-00282-y
|
| 477 |
Jeongin Yoo, Jeong Min Lee, Ijin Joo, Dong Ho Lee, Jeong Hee Yoon, Hyo-Jin Kang, Su Joa Ahn. Reproducibility of ultrasound attenuation imaging for the noninvasive evaluation of hepatic steatosis. Ultrasonography 2020; 39(2) doi: 10.14366/usg.19034
|
| 478 |
Pengcheng Chen, Ze Yang, Lingyun Guo, Yingfei Huang, Jingjia Li, Xin Chen. Effects of homocysteine on nonalcoholic fatty liver related disease: A mendelian randomization study. Frontiers in Molecular Biosciences 2022; 9 doi: 10.3389/fmolb.2022.1083855
|
| 479 |
Huiyan Yu, Xiuli Han, Nayi Zhang, Kepeng Xu, Jie Liu, Yao Zhong, Xiaoyu Wang, Yuxia Qi. The application of explainable machine learning for the identification of MASLD in non-obese populations. Frontiers in Public Health 2026; 14 doi: 10.3389/fpubh.2026.1851486
|
| 480 |
Zhi Yu, Caina Nian, Wenmei Sun, Xinhua Liu, Xueyuan Nian. Elevated serum HE4 levels as a novel biomarker of disease severity and hepatic fibrosis in autoimmune hepatitis. Clinica Chimica Acta 2024; 559 doi: 10.1016/j.cca.2024.119682
|
| 481 |
Michele Barone, Andrea Iannone, Natale Daniele Brunetti, Francesco Sebastiani, Onofrio Cecere, Elsa Berardi, Gianfranco Antonica, Alfredo Di Leo. Liver stiffness and portal blood flow modifications induced by a liquid meal consumption: pathogenetic mechanisms and clinical relevance. Scandinavian Journal of Gastroenterology 2015; 50(5) doi: 10.3109/00365521.2014.1003396
|
| 482 |
Yasushi Honda, Masato Yoneda, Takashi Kobayashi, Michihiro Iwaki, Nobuyoshi Kawamura, Asako Nogami, Takaomi Kessoku, Yuji Ogawa, Wataru Tomeno, Kento Imajo, Nobuyuki Horita, Satoru Saito, Takeshi Kaneko, Atsushi Nakajima. Meta‐analysis of the diagnostic accuracy of serum type IV collagen 7S concentration for the staging of liver fibrosis in nonalcoholic fatty liver disease. Hepatology Research 2023; 53(3) doi: 10.1111/hepr.13857
|
| 483 |
Georgiana-Emmanuela Gîlcă-Blanariu, Daniela Simona Budur, Dana Elena Mitrică, Elena Gologan, Oana Timofte, Gheorghe Gh Bălan, Vasile Andrei Olteanu, Gabriela Ștefănescu. Advances in Noninvasive Biomarkers for Nonalcoholic Fatty Liver Disease. Metabolites 2023; 13(11) doi: 10.3390/metabo13111115
|
| 484 |
Anton Volniansky, Thierry L. Lefebvre, Merve Kulbay, Boyan Fan, Emre Aslan, Kim-Nhien Vu, Emmanuel Montagnon, Bich Ngoc Nguyen, Giada Sebastiani, Jeanne-Marie Giard, Marie-Pierre Sylvestre, Guillaume Gilbert, Guy Cloutier, An Tang. Inter-visit and inter-reader reproducibility of multi-parametric diffusion-weighted MR imaging in longitudinally imaged patients with metabolic dysfunction-associated fatty liver disease and healthy volunteers.. Magnetic Resonance Imaging 2024; 113 doi: 10.1016/j.mri.2024.110223
|
| 485 |
Poulami Samaddar, Keerthy Gopalakrishnan, Priyanka Anvekar, Poushali Samadder, Ivone Cristina Igreja E Sa, Rachel Bayer, Sunil Gaddam, Dipankar Mitra, Sayan Roy, Petra Hirsova, Shivaram P. Arunachalam. Multiclass Classification of Nonalcoholic Steatohepatitis Mouse Models Using Dielectric Properties as Disease Biomarker. 2022 IEEE International Conference on Bioinformatics and Biomedicine (BIBM) 2022; doi: 10.1109/BIBM55620.2022.9995712
|
| 486 |
Xinyu Hu, Wenqiao Tan, Shasha Cheng, Yuezhong Xian, Cuiling Zhang. Nucleic acid and nanomaterial-assisted signal-amplified strategies in fluorescent analysis of circulating tumor cells and small extracellular vesicles. Analytical and Bioanalytical Chemistry 2023; 415(18) doi: 10.1007/s00216-022-04509-2
|
| 487 |
Francesca Lanzaro, Stefano Guarino, Elisabetta D'Addio, Alessandra Salvatori, Josè Alberto D'Anna, Pierluigi Marzuillo, Emanuele Miraglia del Giudice, Anna Di Sessa. Metabolic-associated fatty liver disease from childhood to adulthood: State of art and future directions. World Journal of Hepatology 2022; 14(6): 1087-1098 doi: 10.4254/wjh.v14.i6.1087
|
| 488 |
Naoyuki Fujimori, Takeji Umemura, Takefumi Kimura, Naoki Tanaka, Ayumi Sugiura, Tomoo Yamazaki, Satoru Joshita, Michiharu Komatsu, Yoko Usami, Kenji Sano, Koji Igarashi, Akihiro Matsumoto, Eiji Tanaka. Serum autotaxin levels are correlated with hepatic fibrosis and ballooning in patients with non-alcoholic fatty liver disease. World Journal of Gastroenterology 2018; 24(11): 1239-1249 doi: 10.3748/wjg.v24.i11.1239
|
| 489 |
Lauren A. Newman, Michael J. Sorich, Andrew Rowland. Role of Extracellular Vesicles in the Pathophysiology, Diagnosis and Tracking of Non-Alcoholic Fatty Liver Disease. Journal of Clinical Medicine 2020; 9(7) doi: 10.3390/jcm9072032
|
| 490 |
Fajuan Rui, Liang Xu, Yee Hui Yeo, Yayun Xu, Wenjing Ni, Youwen Tan, Qi Zheng, Xiaorong Tian, Qing-Lei Zeng, Zebao He, Yuanwang Qiu, Chuanwu Zhu, Weimao Ding, Jian Wang, Rui Huang, Qi Xue, Xueqi Wang, Yunliang Chen, Junqing Fan, Zhiwen Fan, Eiichi Ogawa, Min-Sun Kwak, Xiaolong Qi, Junping Shi, Vincent Wai-Sun Wong, Chao Wu, Jie Li. Machine Learning–Based Models for Advanced Fibrosis and Cirrhosis Diagnosis in Chronic Hepatitis B Patients With Hepatic Steatosis. Clinical Gastroenterology and Hepatology 2024; 22(11) doi: 10.1016/j.cgh.2024.06.014
|
| 491 |
Mauro Viganò, Nicola Pugliese, Federica Cerini, Federica Turati, Vincenzo Cimino, Sofia Ridolfo, Simone Rocchetto, Francesca Foglio, Maria Terrin, Carlo La Vecchia, Maria Grazia Rumi, Alessio Aghemo. Accuracy of FIB-4 to Detect Elevated Liver Stiffness Measurements in Patients with Non-Alcoholic Fatty Liver Disease: A Cross-Sectional Study in Referral Centers. International Journal of Molecular Sciences 2022; 23(20) doi: 10.3390/ijms232012489
|
| 492 |
Preeti Gupta, Ankita Rana, Durgesh Shukla, Vivek Gupta, Vineet V. Nair, Sangeeta Saxena, Anil Sharma, Ashok Sharma. Accuracy and Utility of Noninvasive Tools in Screening Adult Population for Hepatic Steatosis: A Validation Study in Southeast Rajasthan. CHRISMED Journal of Health and Research 2026; 13(1) doi: 10.4103/cjhr.cjhr_132_25
|
| 493 |
Qiuju Li, Bing Yu, Xi Tian, Xing Cui, Rongguo Zhang, Qiyong Guo. Deep residual nets model for staging liver fibrosis on plain CT images. International Journal of Computer Assisted Radiology and Surgery 2020; 15(8) doi: 10.1007/s11548-020-02206-y
|
| 494 |
Swasthika Gurjar, Ramanarayana Bhat A, Raghavendra Upadhya, Revathi P. Shenoy. Extracellular vesicle-mediated approaches for the diagnosis and therapy of MASLD: current advances and future prospective. Lipids in Health and Disease 2025; 24(1) doi: 10.1186/s12944-024-02396-3
|
| 495 |
Haiyan Chen, Siqi Dai, Yimin Fang, Liubo Chen, Kai Jiang, Qichun Wei, Kefeng Ding. Hepatic Steatosis Predicts Higher Incidence of Recurrence in Colorectal Cancer Liver Metastasis Patients. Frontiers in Oncology 2021; 11 doi: 10.3389/fonc.2021.631943
|
| 496 |
Xu Chen, Xiaoyuan Sun, Tianran Shen, Qian Chen, Shen Chen, Juan Pang, Jiaxin Mi, Yi Tang, Yiran You, Huihui Xu, Wenhua Ling. Lower adropin expression is associated with oxidative stress and severity of nonalcoholic fatty liver disease. Free Radical Biology and Medicine 2020; 160 doi: 10.1016/j.freeradbiomed.2020.08.005
|
| 497 |
Lu Wang, Wen Dai, Jie Rao, Yichen Wang, Kun Liu, Xing Li, Hua Wang, Jiahuan Ye, Zhonggang Fang, Xin Zheng. Rapid detection of Golgi protein 73 by MAGLUMI chemiluminescent immunoassay and the clinical value to liver fibrosis/cirrhosis patients with chronic liver disease. Frontiers in Cellular and Infection Microbiology 2025; 15 doi: 10.3389/fcimb.2025.1576045
|
| 498 |
A.C. Igual Rouilleault, S. Jiménez, J. Moreno, E. Belmonte, J.R. Ayuso, Á. García-Criado. Imaging findings of hepatic storage diseases. Radiología (English Edition) 2026; 68(4) doi: 10.1016/j.rxeng.2026.101670
|
| 499 |
Masayuki Mizuno, Toshihide Shima, Hirohisa Oya, Yasuhide Mitsumoto, Chiemi Mizuno, Satoshi Isoda, Mizue Kuramoto, Masanori Taniguchi, Masashi Noda, Kyoko Sakai, Noriyuki Koyama, Takeshi Okanoue. Classification of patients with non‐alcoholic fatty liver disease using rapid immunoassay of serum type IV collagen compared with liver histology and other fibrosis markers. Hepatology Research 2017; 47(2) doi: 10.1111/hepr.12710
|
| 500 |
Jingtong Qin, Peng Cao, Xuexuan Ding, Zeyao Zeng, Liyan Deng, Lianxiang Luo. Machine learning identifies ferroptosis-related gene ANXA2 as potential diagnostic biomarkers for NAFLD. Frontiers in Endocrinology 2023; 14 doi: 10.3389/fendo.2023.1303426
|
| 501 |
Eloa de Castro Noguerol, Luis Ronan Marquez Ferreira de Souza, Valdair Francisco Muglia, Jorge Elias Jr.. Quantification of hepatic fat: evaluation of different magnetic resonance imaging measurement strategies in cases of homogeneous and heterogeneous distribution. Radiologia Brasileira 2024; 57 doi: 10.1590/0100-3984.2024.0009-en
|
| 502 |
Li‐Li Dai, Shu‐De Li, Yi‐Cheng Ma, Jun‐Rui Tang, Jun‐Yan Lv, Yuan‐Qing Zhang, Ying‐Lei Miao, Yan‐Qiong Ma, Chun‐Mei Li, Yi‐You Chu, Kun‐Hua Wang, Lan‐Qing Ma, Cheng‐Gang Zou. MicroRNA‐30b regulates insulin sensitivity by targeting SERCA2b in non‐alcoholic fatty liver disease. Liver International 2019; 39(8) doi: 10.1111/liv.14067
|
| 503 |
Quentin M. Anstee, Jeremy Magnanensi, Yacine Hajji, Alexandra Caron, Zouher Majd, Christian Rosenquist, Dean W. Hum, Bart Staels, Margery A. Connelly, Rohit Loomba, Stephen A. Harrison, Vlad Ratziu, Arun J. Sanyal. Impact of age on NIS2+™ and other non-invasive blood tests for the evaluation of liver disease and detection of at-risk MASH. JHEP Reports 2024; 6(4) doi: 10.1016/j.jhepr.2024.101011
|
| 504 |
Mohamed Abdel-Samiee, Essam Salah Ibrahim, Mohamed Kohla, Eman Abdelsameea, Mohsen Salama. Regression of hepatic fibrosis after pharmacological therapy for nonalcoholic steatohepatitis. World Journal of Gastrointestinal Pharmacology and Therapeutics 2024; 15(6): 97381 doi: 10.4292/wjgpt.v15.i6.97381
|
| 505 |
Amin Derakhshanfar, Javad Moayedi , Mahjoob Vahedi , Abouzar Valizadeh. Arum conophalloides Aqueous Extract Induced Hepatotoxicity in Rat; Histopathological, Biochemical, and mir-122 Assessments. MicroRNA 2020; 9(3) doi: 10.2174/2211536608666191016142400
|
| 506 |
Taylor J. Kelty, Alexa A. Krause, R. Scott Rector. Ketone metabolites in metabolic dysfunction-associated steatotic liver disease progression: optimizing keto-therapeutic strategies. American Journal of Physiology-Endocrinology and Metabolism 2025; 329(2) doi: 10.1152/ajpendo.00178.2025
|
| 507 |
Akira Sasaki, Akira Umemura, Kazuyuki Ishida, Naoto Takahashi, Haruka Nikai, Hiroyuki Nitta, Yasuhiro Takikawa, Keisuke Kakisaka, Tamami Abe, Masao Nishiya, Tamotsu Sugai. The Concept of Indeterminable NASH Inducted by Preoperative Diet and Metabolic Surgery: Analyses of Histopathological and Clinical Features. Biomedicines 2022; 10(2) doi: 10.3390/biomedicines10020453
|
| 508 |
Andrius Sakalauskas, Rytis Jurkonis, Sigita Gelman, Arūnas Lukoševičius, Limas Kupčinskas. Investigation of Radiofrequency Ultrasound‐Based Fibrotic Tissue Strain Imaging Method Employing Endogenous Motion. Journal of Ultrasound in Medicine 2019; 38(9) doi: 10.1002/jum.14925
|
| 509 |
Reyhane Ebrahimi, Mehrnoosh Shanaki, Samaneh Mohassel Azadi, Alireza Bahiraee, Amir Reza Radmard, Hossein Poustchi, Solaleh Emamgholipour. Low level of adiponectin predicts the development of Nonalcoholic fatty liver disease: is it irrespective to visceral adiposity index, visceral adipose tissue thickness and other obesity indices?. Archives of Physiology and Biochemistry 2022; 128(1) doi: 10.1080/13813455.2019.1661496
|
| 510 |
Gong Feng, Na He, Jing Gao, Xiao‐Cheng Li, Fen‐Na Zhang, Cheng‐Cheng Liu, Giovanni Targher, Christopher D. Byrne, Man Mi, Ming‐Hua Zheng, Feng Ye. Causal relationship between key genes and metabolic dysfunction‐associated fatty liver disease risk mediated by immune cells: A Mendelian randomization and mediation analysis. Diabetes, Obesity and Metabolism 2024; 26(12) doi: 10.1111/dom.15925
|
| 511 |
Yongyong Xiong, Jilan Huang, Huijun Zhu, Ying Sun, Xishun Zhu, Jianhua J. Wu, Yang Yue. Identifying subtypes of primary liver tumors based on ConvNeXt and efficient channel-spatial attention mechanism. Second International Academic Conference on Optics and Photonics (IACOP 2024) 2025; doi: 10.1117/12.3060213
|
| 512 |
E. Han, Y.‐h. Lee, B. K. Kim, J. Y. Park, D. Y. Kim, S. H. Ahn, B.‐W. Lee, E. S. Kang, B.‐S. Cha, K.‐H. Han, S. U. Kim. Sarcopenia is associated with the risk of significant liver fibrosis in metabolically unhealthy subjects with chronic hepatitis B. Alimentary Pharmacology & Therapeutics 2018; 48(3) doi: 10.1111/apt.14843
|
| 513 |
Le Xue, Dawei Deng, Jianfei Sun. Magnetoferritin: Process, Prospects, and Their Biomedical Applications. International Journal of Molecular Sciences 2019; 20(10) doi: 10.3390/ijms20102426
|
| 514 |
Prabhitha Geethakumari, Prathima Kampa, Rakesh Parchuri, Renu Bhandari, Ali R Alnasser, Aqsa Akram , Saikat Kar, Fatema Osman, Ghadi D Mashat, Hadrian Hoang-Vu Tran, Neway A Urgessa, Ann Kashmer Yu. Accuracy of Ultrasonography vs. Elastography in Patients With Non-alcoholic Fatty Liver Disease: A Systematic Review. Cureus 2022; doi: 10.7759/cureus.29967
|
| 515 |
Omar Elshaarawy, Johannes Mueller, Sina Straub, Sebastian Mueller. Nicht-alkoholische Fettlebererkrankung. 2022; doi: 10.1007/978-3-662-62484-5_13
|
| 516 |
Guilherme A. Soares, Gabriele M. Pereira, Guilherme R. Romualdo, Gabriel G. A. Biasotti, Erick G. Stoppa, Andris F. Bakuzis, Oswaldo Baffa, Luis F. Barbisan, Jose R. A. Miranda. Biodistribution Profile of Magnetic Nanoparticles in Cirrhosis-Associated Hepatocarcinogenesis in Rats by AC Biosusceptometry. Pharmaceutics 2022; 14(9) doi: 10.3390/pharmaceutics14091907
|
| 517 |
Heba Abdel Rahman Eltony, Gamal Kasem, Radwa Mahmoud Elsharaby, Rehab Badawi, Eman M. Helal. Non-invasive detection of fibrosis in non-alcoholic fatty liver disease by serum microfibrillar-associated protein 4 and its correlation with FIB-4 and transient elastography. Egyptian Liver Journal 2025; 15(1) doi: 10.1186/s43066-025-00439-7
|
| 518 |
Youngwoo Lee, Eunho Choi, Young-Sun Lee. Role of MicroRNAs in Precision Hepatology. Journal of Digestive Cancer Research 2026; 14(1) doi: 10.52927/jdcr.2026.14.1.102
|
| 519 |
Yi Shen, Dan Zhou, Jie Sun, Xiaoze Wang, Ruoting Men, Maoyao Wen, Xiaoli Fan, Xianglin Wang, Fan Yang, Li Yang. Genuine acute autoimmune hepatitis has better therapeutic response and prognosis. Hepatology International 2026; 20(2) doi: 10.1007/s12072-025-10999-w
|
| 520 |
Diagnostic Accuracy of Noninvasive Tests for Metabolic Dysfunction-Associated Steatotic Liver Disease Across Age, Type 2 Diabetes, and Obesity Subgroups: A Multinational Study. Clinical Gastroenterology and Hepatology 2026; 24(9) doi: 10.1016/j.cgh.2026.01.016
|
| 521 |
Victoria S. Jensen, Pernille Tveden-Nyborg, Christina Zacho-Rasmussen, Michelle L. Quaade, David H. Ipsen, Henning Hvid, Christian Fledelius, Erik M. Wulff, Jens Lykkesfeldt. Variation in diagnostic NAFLD/NASH read-outs in paired liver samples from rodent models. Journal of Pharmacological and Toxicological Methods 2020; 101 doi: 10.1016/j.vascn.2019.106651
|
| 522 |
Flavia Noelia Mazzini, Frank Cook, John Gounarides, Sebastián Marciano, Leila Haddad, Ana Jesica Tamaroff, Paola Casciato, Adrián Narvaez, María Florencia Mascardi, Margarita Anders, Federico Orozco, Nicolás Quiróz, Marcelo Risk, Susana Gutt, Adrián Gadano, Celia Méndez García, Martin L. Marro, Alberto Penas-Steinhardt, Julieta Trinks. Plasma and stool metabolomics to identify microbiota derived-biomarkers of metabolic dysfunction-associated fatty liver disease: effect of PNPLA3 genotype. Metabolomics 2021; 17(7) doi: 10.1007/s11306-021-01810-6
|
| 523 |
Matteo Garcovich, Mattia Paratore, Maria Elena Ainora, Laura Riccardi, Maurizio Pompili, Antonio Gasbarrini, Maria Assunta Zocco. Shear Wave Dispersion in Chronic Liver Disease: From Physical Principles to Clinical Usefulness. Journal of Personalized Medicine 2023; 13(6) doi: 10.3390/jpm13060945
|
| 524 |
Torsten Schröder, Klaus J. Schmidt, Vera Olsen, Steffen Möller, Tilo Mackenroth, Christian Sina, Hendrik Lehnert, Klaus Fellermann, Jürgen Büning. Liver steatosis is a risk factor for hepatotoxicity in patients with inflammatory bowel disease under immunosuppressive treatment. European Journal of Gastroenterology & Hepatology 2015; 27(6) doi: 10.1097/MEG.0000000000000350
|
| 525 |
Xintian Cai, Xiayire Aierken, Ayguzal Ahmat, Yuanyuan Cao, Qing Zhu, Ting Wu, Nanfang Li, Marcello Maida. A Nomogram Model Based on Noninvasive Bioindicators to Predict 3‐Year Risk of Nonalcoholic Fatty Liver in Nonobese Mainland Chinese: A Prospective Cohort Study. BioMed Research International 2020; 2020(1) doi: 10.1155/2020/8852198
|
| 526 |
Sahar H. Elhini, Engy A. Wahsh, Ahmed A. Elberry, Nadia F. El Ameen, Ahmed Abdelfadil Saedii, Shereen Mahmoud Refaie, Asmaa A. Elsayed, Hoda M. Rabea. The Impact of an SGLT2 Inhibitor versus Ursodeoxycholic Acid on Liver Steatosis in Diabetic Patients. Pharmaceuticals 2022; 15(12) doi: 10.3390/ph15121516
|
| 527 |
ACHILES QUEIROZ MONTEIRO DE REZENDE, MARTINHO ANTÔNIO GESTIC, MURILLO PIMENTEL UTRINI, FELIPE DAVID MENDONÇA CHAIM, HELENA PAES DE ALMEIDA DE SAITO, ELINTON ADAMI CHAIM, FRANCISCO CALLEJAS-NETO, EVERTON CAZZO. Is there a link between non-alcoholic fatty liver disease aspects and pancreatic cancer? Results of a case-matched study. Revista do Colégio Brasileiro de Cirurgiões 2021; 48 doi: 10.1590/0100-6991e-20202913
|
| 528 |
Kei Higashikawa, Riho Uehara, Sawako Horiguchi, Yuki Shibata, Naoto Okubo, Yuki Mizuno, Hironobu Yasui, Shunsuke Ohnishi, Hiroshi Takeda, Yuji Kuge. Thymidine Phosphorylase Imaging Probe for Differential Diagnosis of Metabolic dysfunction-associated Steatohepatitis. Molecular Imaging and Biology 2024; 26(6) doi: 10.1007/s11307-024-01964-4
|
| 529 |
Andreas Vadarlis, Sofia Chantavaridou, Georgios Kalopitas, Dimitra Rafailia Bakaloudi, Evangelia Karanika, Eirini Tsekitsidi, Michail Chourdakis. Τhe anthropometric and biochemical profile of pediatric non-alcoholic fatty liver disease: A systematic review and a meta-analysis. Clinical Nutrition 2022; 41(1) doi: 10.1016/j.clnu.2021.11.016
|
| 530 |
Julia Y. Payne, Naim Alkhouri, Phuc Le, Michael B. Rothberg, Prido Polanco, Celine Sakkal, Srinivasan Dasarathy. Prevalence of at-risk NASH and its association with metabolic syndrome in US adults with NAFLD, 2017–2018. Hepatology Communications 2023; 7(1) doi: 10.1097/HC9.0000000000000019
|
| 531 |
Robert J. Wong, Nandita Kachru, Diane J. Martinez, Meghan Moynihan, A. Burak Ozbay, Stuart C. Gordon. Real-world Comorbidity Burden, Health Care Utilization, and Costs of Nonalcoholic Steatohepatitis Patients With Advanced Liver Diseases. Journal of Clinical Gastroenterology 2021; 55(10) doi: 10.1097/MCG.0000000000001409
|
| 532 |
Sumi Sung, Jieun Kim, Youngmi Jung. Liver-Derived Exosomes and Their Implications in Liver Pathobiology. International Journal of Molecular Sciences 2018; 19(12) doi: 10.3390/ijms19123715
|
| 533 |
Gong Feng, Na He, Yi-Fan Zhou, Xue-Ping Li, Chunyan Niu, Man-ling Liu, Ke-lin Zhang, Ya Li, Ya-ming Li, Ming-Hua Zheng, Man Mi. A simpler diagnostic formula for screening nonalcoholic fatty liver disease. Clinical Biochemistry 2019; 64 doi: 10.1016/j.clinbiochem.2018.11.011
|
| 534 |
Min‐Sun Kwak, Eunyoung Kim, Eun Jin Jang, Chang‐Hoon Lee. The association of non‐alcoholic fatty liver disease with lung function: A survey design analysis using propensity score. Respirology 2018; 23(1) doi: 10.1111/resp.13127
|
| 535 |
Yakun Li, Koen C. van Son, Sandra Serna-Salas, Justina C. Wolters, Nienke P. M. Wassenaar, Stan Driessen, Anne Linde Mak, Anne-Marieke van Dijk, Veera A. T. Houttu, Julia J. Witjes, Diona Zwirs, Michail Doukas, Joanne Verheij, Robin P. F. Dullaart, Hans Blokzijl, Adriaan G. Holleboom, Han Moshage. Plasma Extracellular Vesicles Contain Protein Biomarkers for Capturing Stages of Metabolic Dysfunction-Associated Steatotic Liver Disease: A Preliminary Exploratory Study. Biomolecules 2025; 15(11) doi: 10.3390/biom15111596
|
| 536 |
Jessie Torgersen, Craig W Newcomb, Dean M Carbonari, Shanae M Smith, Katherine L Brecker, Chamith S Rajapakse, Brandon C Jones, Christiana Cottrell, Rasleen Grewal, Jennifer C Price, Joshua F Baker, Jay R Kostman, Stacey Trooskin, Rebecca A Hubbard, Babette S Zemel, Mary B Leonard, Vincent Lo Re. Changes in Three-Dimensional Volumetric Liver Fat Fraction after Cure of Chronic Hepatitis C Infection With Direct-Acting Antivirals. Open Forum Infectious Diseases 2026; 13(10) doi: 10.1093/ofid/ofag023
|
| 537 |
Lauren A. Newman, Zivile Useckaite, Jillian Johnson, Michael J. Sorich, Ashley M. Hopkins, Andrew Rowland. Selective Isolation of Liver-Derived Extracellular Vesicles Redefines Performance of miRNA Biomarkers for Non-Alcoholic Fatty Liver Disease. Biomedicines 2022; 10(1) doi: 10.3390/biomedicines10010195
|
| 538 |
Norio Akuta, Yusuke Kawamura, Fumitaka Suzuki, Satoshi Saitoh, Yasuji Arase, Shunichiro Fujiyama, Hitomi Sezaki, Tetsuya Hosaka, Masahiro Kobayashi, Yoshiyuki Suzuki, Mariko Kobayashi, Kenji Ikeda, Hiromitsu Kumada. Analysis of association between circulating miR-122 and histopathological features of nonalcoholic fatty liver disease in patients free of hepatocellular carcinoma. BMC Gastroenterology 2016; 16(1) doi: 10.1186/s12876-016-0557-6
|
| 539 |
Iman Rafati, Elijah Van Houten, Amirhossein B. Najar, Audrey Fohlen, Bich N. Nguyen, Guy Cloutier, An Tang. Quantitative Ultrasound–Based Compression and Shear Wave Attenuation for Metabolic Dysfunction–Associated Steatotic Liver Disease Grading. Ultrasound in Medicine & Biology 2026; 52(11) doi: 10.1016/j.ultrasmedbio.2026.07.017
|
| 540 |
Mingqi Zhao, Changjun Song, Tao Luo, Tianyue Huang, Shiming Lin. Fatty Liver Disease Prediction Model Based on Big Data of Electronic Physical Examination Records. Frontiers in Public Health 2021; 9 doi: 10.3389/fpubh.2021.668351
|
| 541 |
Jennifer Phillips, Rebecca Preskey, Chris Penfold, Fiona Gordon, Jonathan Tyrrell-Price. Liver steatosis is a risk factor for hepatotoxicity in inflammatory bowel disease patients treated with azathioprine. European Journal of Gastroenterology & Hepatology 2020; 32(10) doi: 10.1097/MEG.0000000000001683
|
| 542 |
Nicholas Viceconti, Silvia Andaloro, Mattia Paratore, Sara Miliani, Giulia D’Acunzo, Giuseppe Cerniglia, Fabrizio Mancuso, Elena Melita, Antonio Gasbarrini, Laura Riccardi, Matteo Garcovich. Harnessing artificial intelligence for the assessment of liver fibrosis and steatosis <i>via</i> multiparametric ultrasound. World Journal of Gastroenterology 2026; 32(2): 113059 doi: 10.3748/wjg.v32.i2.113059
|
| 543 |
Ana Ninić, Marija Zdravković, Vojislav Radosavljević, Vera Gardijan, Lidija Memon, Jelena Vekić, Vesna Spasojević-Kalimanovska. Non-alcoholic fatty liver disease as metabolic consequence of obstructive sleep apnea. Arhiv za farmaciju 2020; 70(6) doi: 10.5937/arhfarm70-27586
|
| 544 |
Sheena Bhushan, Aalam Sohal, Mazen Noureddin, Kris V. Kowdley. Resmetirom: the first approved therapy for treating metabolic dysfunction associated steatohepatitis. Expert Opinion on Pharmacotherapy 2025; 26(6) doi: 10.1080/14656566.2025.2478917
|
| 545 |
Mislav Barisic-Jaman, Marko Milosevic, Viktoria Skurla, David Dohoczky, Josip Stojic, Petra Dinjar Kujundzic, Maja Cigrovski Berkovic, Ana Majic-Tengg, Ana Matijaca, Tomo Lucijanic, Mirjana Kardum-Pejic, Vlatka Pandzic Jaksic, Srecko Marusic, Ivica Grgurevic. Compensated Advanced Chronic Liver Disease and Steatosis in Patients with Type 2 Diabetes as Assessed through Shear Wave Measurements and Attenuation Measurements. Biomedicines 2024; 12(2) doi: 10.3390/biomedicines12020323
|
| 546 |
Emily Truong, Cheng Han, Mark Muthiah, Mazen Noureddin. Risk Stratification for Hepatocellular Carcinoma in Patients with Non-alcoholic Fatty Liver Disease. Current Hepatology Reports 2023; 22(1) doi: 10.1007/s11901-023-00595-7
|
| 547 |
Eloa de Castro Noguerol, Luis Ronan Marquez Ferreira de Souza, Valdair Francisco Muglia, Jorge Elias Jr.. Quantificação da gordura hepática: avaliação de diferentes estratégias de medidas pela ressonância magnética nos casos de distribuição homogênea e heterogênea. Radiologia Brasileira 2024; 57 doi: 10.1590/0100-3984.2024.0009
|
| 548 |
Sabina Sabharwal, Amit Grover, Paul Mitchell, Jessica Serino‐Cipoletta, Akiko Shimamura, Rima Fawaz. Liver stiffness in patients with Shwachman‐Diamond syndrome. JPGN Reports 2026; 7(2) doi: 10.1002/jpr3.70138
|
| 549 |
Elham Nazari, Ghazaleh Khalili-Tanha, Alireza Asadnia, Ghazaleh Pourali, Mina Maftooh, Majid Khazaei, Mohammadreza Nasiri, Seyed Mahdi Hassanian, Majid Ghayour-Mobarhan, Gordon A. Ferns, Mohammad Ali Kiani, Amir Avan. Bioinformatics analysis and machine learning approach applied to the identification of novel key genes involved in non-alcoholic fatty liver disease. Scientific Reports 2023; 13(1) doi: 10.1038/s41598-023-46711-x
|
| 550 |
Hewei Peng, Junchao Zhang, Xianhua Huang, Miao Xu, Jingru Huang, Yunli Wu, Xian-E. Peng. Development and validation of an online dynamic nomogram based on the atherogenic index of plasma to screen nonalcoholic fatty liver disease. Lipids in Health and Disease 2023; 22(1) doi: 10.1186/s12944-023-01808-0
|
| 551 |
Niki Katsiki, Christos Mantzoros. Making progress towards a better pathophysiological understanding and more promising therapeutic options for treating non-alcoholic steatohepatitis (NASH)/DASH (dysmetabolism associated steatohepatitis). Metabolism 2021; 114 doi: 10.1016/j.metabol.2020.154333
|
| 552 |
Nutthachoke Mahachai, Chaiwat Washirasaksiri, Pinyapat Ariyakunaphan, Chayanis Kositamongkol, Tullaya Sitasuwan, Rungsima Tinmanee, Chonticha Auesomwang, Naruemit Sayabovorn, Thanet Chaisathaphol, Pochamana Phisalprapa, Phunchai Charatcharoenwitthaya, Weerachai Srivanichakorn. Clinical Predictive Score for Identifying Metabolic Dysfunction-Associated Steatotic Liver Disease in Individuals with Prediabetes Using Transient Elastography. Journal of Clinical Medicine 2023; 12(24) doi: 10.3390/jcm12247617
|
| 553 |
Bala Nivetha Kanakaraj, Sujatha Narayanan Unni. Model-based quantitative optical biopsy in multilayer in vitro soft tissue models for whole field assessment of nonmelanoma skin cancer. Journal of Medical Imaging 2018; 5(01) doi: 10.1117/1.JMI.5.1.014506
|
| 554 |
Arosh S Perera Molligoda Arachchige, Ana Claudia Teixeira de Castro Gonçalves Ortega, Federica Catapano, Letterio S Politi, Michael N Hoff. From strength to precision: A systematic review exploring the clinical utility of 7-Tesla magnetic resonance imaging in abdominal imaging. World Journal of Radiology 2024; 16(1): 20-31 doi: 10.4329/wjr.v16.i1.20
Abstract(795) |
Core Tip(760) |
Full Article(HTML)(3253)
|
Full Article (PDF)-2158K(314)
|
Full Article with Cover (PDF)-2419K(242)
|
Full Article (Word)-1039K(52)
|
Full Article (XML)-123K(194)
|
Audio-544K(28)
|
Peer-Review Report-179K(172)
|
Answering Reviewers-203K(148)
|
Times Cited (8)
|
Total Visits (5289)
|
Open
|
| 555 |
Norio Akuta, Yusuke Kawamura, Yasuji Arase, Satoshi Saitoh, Shunichiro Fujiyama, Hitomi Sezaki, Tetsuya Hosaka, Masahiro Kobayashi, Mariko Kobayashi, Yoshiyuki Suzuki, Fumitaka Suzuki, Kenji Ikeda, Hiromitsu Kumada. Circulating MicroRNA‐122 and Fibrosis Stage Predict Mortality of Japanese Patients With Histopathologically Confirmed NAFLD. Hepatology Communications 2020; 4(1) doi: 10.1002/hep4.1445
|
| 556 |
Sedighe Hosseini Shabanan, Vitor F. Martins, Tanya Wolfson, Jake T. Weeks, Lael Ceriani, Cynthia Behling, Victoria Chernyak, Ahmed El Kaffas, Amir A. Borhani, Aiguo Han, Kang Wang, Kathryn J. Fowler, Claude B. Sirlin. MASLD: What We Have Learned and Where We Need to Go—A Call to Action. RadioGraphics 2024; 44(11) doi: 10.1148/rg.240048
|
| 557 |
Fatma Beyazit, Alpaslan Tanoglu. Letters to the Editor. Menopause 2015; 22(7) doi: 10.1097/GME.0000000000000497
|
| 558 |
Kathleen Corey, Anurag Mehta, Kamal Kant Mangla, Abhishek Shankar Chandramouli, Ahsan Shoeb, Niels Krarup, Margarida Augusto, Katrine Grau, Sharat Varma, Elisabetta Bugianesi. Liver fibrosis is associated with clinical and economic burden of cardiovascular disease in MASH. JHEP Reports 2026; 8(1) doi: 10.1016/j.jhepr.2025.101621
|
| 559 |
Cynthia Hsu, Cyrielle Caussy, Kento Imajo, Jun Chen, Siddharth Singh, Kellee Kaulback, Minh-Da Le, Jonathan Hooker, Xin Tu, Ricki Bettencourt, Meng Yin, Claude B. Sirlin, Richard L. Ehman, Atsushi Nakajima, Rohit Loomba. Magnetic Resonance vs Transient Elastography Analysis of Patients With Nonalcoholic Fatty Liver Disease: A Systematic Review and Pooled Analysis of Individual Participants. Clinical Gastroenterology and Hepatology 2019; 17(4) doi: 10.1016/j.cgh.2018.05.059
|
| 560 |
Hidekatsu Kuroda, Yudai Fujiwara, Tamami Abe, Tomoaki Nagasawa, Takuma Oguri, Sachiyo Noguchi, Naohisa Kamiyama, Yasuhiro Takikawa, Gianfranco D. Alpini. Two-dimensional shear wave elastography and ultrasound-guided attenuation parameter for progressive non-alcoholic steatohepatitis. PLOS ONE 2021; 16(4) doi: 10.1371/journal.pone.0249493
|
| 561 |
Loek P. Smits, Bram F. Coolen, Maria D. Panno, Jurgen H. Runge, Wouter H. Nijhof, Joanne Verheij, Max Nieuwdorp, Jaap Stoker, Ulrich H. Beuers, Aart J. Nederveen, Erik S. Stroes. Noninvasive Differentiation between Hepatic Steatosis and Steatohepatitis with MR Imaging Enhanced with USPIOs in Patients with Nonalcoholic Fatty Liver Disease: A Proof-of-Concept Study. Radiology 2016; 278(3) doi: 10.1148/radiol.2015150952
|
| 562 |
Abdulrahman Ismaiel, Blal El Hosiny, Mohamed Ismaiel, Daniel-Corneliu Leucuta, Stefan-Lucian Popa, Cristina Sorina Catana, Dan L. Dumitrascu. Waist to height ratio in nonalcoholic fatty liver disease – Systematic review and meta-analysis. Clinics and Research in Hepatology and Gastroenterology 2023; 47(7) doi: 10.1016/j.clinre.2023.102160
|
| 563 |
Dae-Jeong Koo, Mi Yeon Lee, Inha Jung, Sun Joon Moon, Hyemi Kwon, Eun-Jung Rhee, Cheol-Young Park, Won-Young Lee, Ki Won Oh, Se Eun Park. Increased Risk of NAFLD in Adults with Glomerular Hyperfiltration: An 8-Year Cohort Study Based on 147,162 Koreans. Journal of Personalized Medicine 2022; 12(7) doi: 10.3390/jpm12071142
|
| 564 |
Toni A. Pringle, Erik Ramon-Gil, Jack Leslie, Fiona Oakley, Matthew C. Wright, James C. Knight, Saimir Luli. Synthesis and preclinical evaluation of a 89Zr-labelled human single chain antibody for non-invasive detection of hepatic myofibroblasts in acute liver injury. Scientific Reports 2024; 14(1) doi: 10.1038/s41598-023-50779-w
|
| 565 |
Ali Buktash, Abdül Kadir Görür. Self-Supervised Learning with BYOL for Non-Alcoholic Fatty Liver Disease Diagnosis Using Ultrasound Imaging. Signal, Image and Video Processing 2025; 19(15) doi: 10.1007/s11760-025-04811-3
|
| 566 |
Ali Pirasteh, Sarvesh Periyasamy, Jennifer Jean Meudt, Yongjun Liu, Laura M. Lee, Kyle M. Schachtschneider, Lawrence B. Schook, Ron C. Gaba, Lu Mao, Adnan Said, Alan Blair McMillan, Paul F. Laeseke, Dhanansayan Shanmuganayagam. Staging Liver Fibrosis by Fibroblast Activation Protein Inhibitor PET in a Human-Sized Swine Model. Journal of Nuclear Medicine 2022; 63(12) doi: 10.2967/jnumed.121.263736
|
| 567 |
Maryam Ghadimi, Roya Rezvani Habibabadi, Bita Hazhirkarzar, Mohammadreza Shaghaghi, Sanaz Ameli, Pegah Khoshpouri, Mounes Aliyari Ghasabeh, Ahmet Gurakar, Timothy M. Pawlik, Ihab R. Kamel. Advances in Imaging of Diffuse Parenchymal Liver Disease. Journal of Clinical Gastroenterology 2020; 54(8) doi: 10.1097/MCG.0000000000001380
|
| 568 |
Simona Cernea, Itamar Raz. NAFLDin type 2 diabetes mellitus: Still many challenging questions. Diabetes/Metabolism Research and Reviews 2021; 37(2) doi: 10.1002/dmrr.3386
|
| 569 |
Chan-Hee Jung, Eun-Jung Rhee, Hyemi Kwon, Yoosoo Chang, Seungho Ryu, Won-Young Lee. Visceral-to-Subcutaneous Abdominal Fat Ratio Is Associated with Nonalcoholic Fatty Liver Disease and Liver Fibrosis. Endocrinology and Metabolism 2020; 35(1) doi: 10.3803/EnM.2020.35.1.165
|
| 570 |
Rachel Maria Gomes, Praveen Raj Palanivelu. Bariatric Surgical Practice Guide. 2017; doi: 10.1007/978-981-10-2705-5_16
|
| 571 |
Nevine I. Musa, Eslam Safwat, Sara M. Abdelhakam, Amir M. Farid, Waleed M. Hetta. Noninvasive tool for the diagnosis of NAFLD in association with atherosclerotic cardiovascular risk. Egyptian Liver Journal 2019; 9(1) doi: 10.1186/s43066-019-0002-y
|
| 572 |
Agostina M. Onorato, Lucía Lameroli Mauriz, Juan Bayo, Esteban Fiore, María José Cantero, Barbara Bueloni, Mariana García, Cecilia Lagües, Pedro Martínez-Duartez, Gabriel Menaldi, Nicolas Paleari, Catalina Atorrasagasti, Guillermo D. Mazzolini. Hepatic SPARC Expression Is Associated with Inflammasome Activation during the Progression of Non-Alcoholic Fatty Liver Disease in Both Mice and Morbidly Obese Patients. International Journal of Molecular Sciences 2023; 24(19) doi: 10.3390/ijms241914843
|
| 573 |
Flavia Spreafico, Rafael Carvalho Sales, Judit Gil-Zamorano, Priscylla da Costa Medeiros, Maria-Jesús Latasa, Monique Ribeiro Lima, Sergio Augusto Lopes de Souza, Roberto Martin-Hernández, Diego Gómez-Coronado, Eduardo Iglesias-Gutierrez, Diana C. Mantilla-Escalante, Maria das Graças Tavares do Carmo, Alberto Dávalos. Dietary supplementation with hybrid palm oil alters liver function in the common Marmoset. Scientific Reports 2018; 8(1) doi: 10.1038/s41598-018-21151-0
|
| 574 |
Eugene Han, Yong-ho Lee, Jae Seung Lee, Hye Won Lee, Beom Kyung Kim, Jun Yong Park, Do Young Kim, Sang Hoon Ahn, Byung-Wan Lee, Eun Seok Kang, Bong-Soo Cha, Seung Up Kim. Fibrotic Burden Determines Cardiovascular Risk among Subjects with Metabolic Dysfunction-Associated Fatty Liver Disease. Gut and Liver 2022; 16(5) doi: 10.5009/gnl210290
|
| 575 |
Bo Yang, Huaguan Lu, Yinghui Ran. Advancing non-alcoholic fatty liver disease prediction: a comprehensive machine learning approach integrating SHAP interpretability and multi-cohort validation. Frontiers in Endocrinology 2024; 15 doi: 10.3389/fendo.2024.1450317
|
| 576 |
Johanna K. DiStefano, Glenn S. Gerhard. Circulating microRNAs in nonalcoholic fatty liver disease. Expert Review of Gastroenterology & Hepatology 2016; 10(2) doi: 10.1586/17474124.2016.1125290
|
| 577 |
Rawi Hazzan, Tor Regev-Sadeh, Tamar Dola, Hila Shemer-Shamay, Alona Umansky, Ehud Zigmond, Ziv Neeman. Ultrasound Shear Wave Elastography and Shear Wave Dispersion: Correlation with Histopathological Changes in Autoimmune Hepatitis Patients. Ultrasound in Medicine & Biology 2025; 51(5) doi: 10.1016/j.ultrasmedbio.2025.01.009
|
| 578 |
Yassin Labyed, Andy Milkowski. Novel Method for Ultrasound‐Derived Fat Fraction Using an Integrated Phantom. Journal of Ultrasound in Medicine 2020; 39(12) doi: 10.1002/jum.15364
|
| 579 |
Yvelise Ferro, Roberta Pujia, Elisa Mazza, Lidia Lascala, Oscar Lodari, Samantha Maurotti, Arturo Pujia, Tiziana Montalcini. A new nutraceutical (Livogen Plus®) improves liver steatosis in adults with non-alcoholic fatty liver disease. Journal of Translational Medicine 2022; 20(1) doi: 10.1186/s12967-022-03579-1
|
| 580 |
Na Wu, Mofan Feng, Hanhua Zhao, Shuang Wei, Xinyu Shi, Xinying Xiong, Wenjun Zhou, Shengfu You, Hualing Song, Huiting Yu, Jianyang Wang, Lei Zhang, Guang Ji, Baocheng Liu. Prediction of Metabolic Dysfunction–Associated Steatotic Liver Disease via Advanced Machine Learning Among Chinese Han Population. Obesity Surgery 2025; 35(10) doi: 10.1007/s11695-025-08096-w
|